Page last updated: 2024-10-25

diazepam and Disease Models, Animal

diazepam has been researched along with Disease Models, Animal in 488 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"The main site of action of diazepam, as with other benzodiazepines, is at the GABA(A) receptor, although it has been suggested that some of the potentially beneficial actions of diazepam in nerve agent poisoning are mediated through other means."8.82The role of diazepam in the treatment of nerve agent poisoning in a civilian population. ( Marrs, TC, 2004)
"To investigate the effects of different doses of esculetin on epileptiform activity, behavioral seizures, memory impairment, and cortical and hippocampal NF-κB, as a mediator of pro-inflammatory gene induction, and pro-inflammatory cytokines in penicillin- and pentylenetetrazole(PTZ)-induced seizure models in rats."8.31Esculetin alleviates pentylenetetrazole-induced seizures, cognitive impairment and pro-inflammatory cytokines and suppresses penicillin-induced epileptiform activity in rats. ( Ankarali, H; Baranoglu Kilinc, Y; Danis, A; Hanci, F; Kilinc, E; Torun, IE, 2023)
" We aim to test the effect of combining the therapeutic action of tSMS and diazepam, a drug used to treat status epilepticus."8.31Synergistic effects of applying static magnetic fields and diazepam to improve EEG abnormalities in the pilocarpine epilepsy rat model. ( Cudeiro, J; de Labra, C; Rivadulla, C, 2023)
" The present study has been designed to evaluate the neuroprotective effect of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice."8.02Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations. ( Alfuraih, BS; Alsuhaibani, NA; Elsayed, AM; Mahmoud, RH; Nadwa, EH; Rashed, LA; Said, ES, 2021)
" Therefore, we propose a hypothesis that diazepam monotherapy or diazepam-ketamine dual therapy could terminate seizures and reduce mortality in the SE model at different time points during ongoing SE."8.02Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model. ( Cao, X; Li, Z; Wang, Y; Yu, J; Zhou, R, 2021)
" The seizures were induced with pentylenetetrazole (PTZ) intraperitoneally at 170 mg/kg, and diazepam (DZP) was used as the control anticonvulsant (2 mg/kg, oral); PA was tested at 10, 50, and 100 mg/kg orally."8.02Perillyl alcohol decreases the frequency and severity of convulsive-like behavior in the adult zebrafish model of acute seizures. ( Borges, RS; Carvalho, JCT; da Silva Hage-Melim, LI; de Melo, EL; Hu, X; Matias Pereira, AC; Sánchez-Ortíz, BL, 2021)
"diazepam attenuated pain induced by dentin hypersensitivity in rats exposed to stress."7.91Diazepam as attenuator of pain induced by dentin hypersensitivity in rats exposed to stress. ( Barbosa Suffredini, I; Bernardi, MM; Coury Saraceni, CH; Kabadayan, F; Tonetti Ciaramicoli, M, 2019)
"Diazepam could regulate immune system and inflammation, which might be a potential therapeutic agent for pulmonary fibrosis in clinic."7.91Diazepam inhibited lipopolysaccharide (LPS)-induced pyroptotic cell death and alleviated pulmonary fibrosis in mice by specifically activating GABA ( Bo, F; Deng, M; Li, Y; Song, D; Tang, X, 2019)
" Lobeline increased the latency to the first seizure and decreased the percentage of seizures in a similar way as diazepam, used as control."7.88DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism. ( Boaretto, FBM; da Costa E Silva, LD; da Silva, LL; Hoffmann, C; Morás, AM; Moura, DJ; Pereira, P; Pflüger, P; Picada, JN; Regner, GG; Steffens, LR, 2018)
"Part 1: Anxiety at 3 hours was significantly lower following minocycline (20 mg/kg i."7.88Minocycline in Alcohol Withdrawal Induced Anxiety and Alcohol Relapse in Rats. ( Gajbhiye, SV; Petare, A; Potey, AV; Shankar, A; Tripathi, RK, 2018)
"To evaluate acute and long-term effects of intravenous brivaracetam (BRV) and BRV + diazepam (DZP) combination treatment in a rat model of self-sustaining status epilepticus (SSSE)."7.85Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. ( Klitgaard, H; Matagne, A; Niquet, J; Suchomelova, L; Thompson, K; Wasterlain, C, 2017)
"CD1 and CD2 characterized as bergenin, exhibited significant antianxiety activity at 80mg/kg, po which was statistically comparable to that of diazepam (2mg/kg, po)."7.85Antianxiety activity guided isolation and characterization of bergenin from Caesalpinia digyna Rottler roots. ( Kumar, A; Sharma, A; Singh, J, 2017)
" The objective of this study was to evaluate the effect of non-steroidal anti-inflammatory diclofenac sodium on the severity of seizures and levels of pro-inflammatory interleukins in animals with kindling model induced by PTZ."7.83Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model. ( Coitinho, AS; Glassmann, D; Gomez, R; Marafon, P; Pereira, P; Vieira, V, 2016)
"The pilocarpine rat model, in which status epilepticus (SE) leads to epilepsy with spontaneous recurrent seizures (SRS), is widely used to study the mechanisms of epileptogenesis and develop strategies for epilepsy prevention."7.81Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. ( Brandt, C; Bröer, S; Klee, R; Löscher, W; Töllner, K, 2015)
"Piperine produced significant antianxiety-like activity in unstressed and stressed mice."7.80Possible involvement of GABAergic and nitriergic systems for antianxiety-like activity of piperine in unstressed and stressed mice. ( Dhingra, D; Gilhotra, N, 2014)
"Levetiracetam has been reported to be well tolerated and effective in status epilepticus (SE) refractory to benzodiazepine."7.79The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus. ( Choi, HC; Kang, TC; Kim, JE; Kim, YI; Lee, DS; Ryu, HJ; Song, HK, 2013)
"Experiments were conducted to evaluate the effects of transcranial focal electrical stimulation (TFS) applied via tripolar concentric ring electrodes, alone and associated with a sub-effective dose of diazepam (DZP) on the expression of status epilepticus (SE) induced by lithium-pilocarpine (LP) and subsequent neuronal damage in the hippocampus."7.79Effects of transcranial focal electrical stimulation alone and associated with a sub-effective dose of diazepam on pilocarpine-induced status epilepticus and subsequent neuronal damage in rats. ( Besio, W; Cuellar-Herrera, M; Luna-Munguia, H; Orozco-Suárez, S; Rocha, L, 2013)
"The anxiolytic-like effects of topiramate were assessed during several estrous cycle phases in Wistar rats tested in two animal models of anxiety-like behavior."7.79Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior. ( Jaramillo, MT; Molina-Hernández, M; Olivera-López, JI; Téllez-Alcántara, NP, 2013)
"Here we examined the effects of Ro 64-6198 on unconditioned conflict anxiety using stimuli with different salience and on regulation of autonomic reactivity and compared these to the effects of benzodiazepine receptor agonists."7.78Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair. ( Goeldner, C; Prinssen, EP; Spooren, W; Wichmann, J, 2012)
"Injection of the seaweed toxin kainic acid (KA) in rats induces a severe status epilepticus initiating complex neuropathological changes in limbic brain areas and subsequently spontaneous recurrent seizures."7.78Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex. ( Drexel, M; Preidt, AP; Sperk, G, 2012)
") and seizures terminated after 2 h with diazepam (10 mg/kg, i."7.78N (w) -propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses. ( Beamer, E; Otahal, J; Sills, GJ; Thippeswamy, T, 2012)
"The aim of present research was to study, by means of descriptive and multivariate t-pattern analyses, the effects of the reference anxiolytic drug diazepam (DZP) on temporal structure of a rat's anxiety-related behavior in HB."7.77T-pattern analysis of diazepam-induced modifications on the temporal organization of rat behavioral response to anxiety in hole board. ( Casarrubea, M; Crescimanno, G; Magnusson, MS; Sorbera, F, 2011)
"In the present study, the effects of intraamygdalar administrations of melatonin (1 and 100μg/kg), saline and diazepam on the anxiety-like behavior and spatial memory performance in pinealectomized and sham-pinealectomized Wistar rats were investigated."7.77The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. ( Coşkun, H; Gündüz, B; Karakaş, A; Kaya, A; Kücük, A, 2011)
"The aim of the present study was to investigate the role of GABAergic and nitriergic modulation in the antianxiety effect of thymoquinone, a major constituent of Nigella sativa, in mice under unstressed and stressed conditions."7.77Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels. ( Dhingra, D; Gilhotra, N, 2011)
"The anti-inflammatory activity of amitriptyline, diazepam and a new, Russian tranquilizer mebicar was studied in a wide range of therapeutic doses on carrageenan-induced paw edema in rats."7.77[Anti-inflammatory effects of amitriptyline, diazepam and mebicar using model of acute carrageenan-induced paw edema in rats]. ( Kaziakhmetova, VN; Valeeva, IKh; Ziganshina, LE, 2011)
"Benzodiazepines such as diazepam may fail to effectively treat status epilepticus because benzodiazepine-sensitive GABA(A) receptors are progressively internalized with continued seizure activity."7.76Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. ( Fritsch, B; Joelle Donofrio, J; Rogawski, MA; Stott, JJ, 2010)
"In the present study the effectiveness of different diazepam-ketamine combinations to control kainic acid-induced status epilepticus in rats was evaluated."7.76The control of kainic acid-induced status epilepticus. ( Clinckers, R; Massie, A; Michotte, Y; Smolders, I; Vermoesen, K, 2010)
" We have shown recently that topiramate (TPM) dose-dependently protects hippocampal CA1 and CA3 neurons during initial status epilepticus in the rat pilocarpine model of temporal lobe epilepsy by inhibition of mitochondrial transition pore opening."7.74Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent. ( Elger, CE; Frisch, C; Helmstaedter, C; Kudin, AP; Kunz, WS, 2007)
"By intravenous administration of group I metabotropic glutamate receptor antagonists at 1 or 2h during pilocarpine induced status epilepticus (PISE), we showed that mGluR1 antagonists AIDA or LY367385 (at dosages ranging from 25 to 200mg/kg), mGluR5 antagonists SIB1757 (at dosages ranging from 25 to 200mg/kg), SIB1893 (from 25 to 100mg/kg), MPEP (from 25 to 100mg/kg) injected at 1 or 2h during PISE were ineffective in controlling status epilepticus (SE)."7.74Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus. ( Chen, PM; Lee, WL; Tang, FR; Tang, YC; Tsai, MC, 2007)
"To investigate changes in free benzodiazepine receptor density in response to repeated, long-term administration of diazepam in epilepsy, we assessed 125I-iomazenil (125I-IMZ) binding in a mouse model."7.73Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse. ( Fukumitsu, N; Mori, Y; Ogi, S; Uchiyama, M, 2006)
"This study evaluated the effectiveness of fosphenytoin as a single or adjunctive anticonvulsant treatment for nerve agent-induced status epilepticus."7.72Effects of fosphenytoin on nerve agent-induced status epilepticus. ( Benjamin, A; McDonough, JH; McMonagle, JD; Rowland, T; Shih, TM, 2004)
"Previously, it was shown that subchronic application of the NMDA receptor antagonist ketamine (Ket) induces schizophrenia-related alterations, e."7.72Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. ( Becker, A; Grecksch, G, 2004)
"Status epilepticus is usually initially treated with a benzodiazepine such as diazepam."7.71Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. ( Esmaeil, N; Jones, DM; Macdonald, RL; Maren, S, 2002)
"The anxiolytic effects of aniracetam have not been proven in animals despite its clinical usefulness for post-stroke anxiety."7.71Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. ( Kurasawa, M; Nakamura, K, 2001)
"The protective and adverse effect potentials of levetiracetam ((S)-alpha-ethyl-2-oxo-pyrrolidine acetamide) in rodent models of seizures and epilepsy were compared with the profile of several currently prescribed and newly developed antiepileptic drugs."7.70Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. ( Gobert, J; Klitgaard, H; Matagne, A; Wülfert, E, 1998)
"To examine the putative seizure-protective properties of felbamate in an animal model of self-sustaining status epilepticus (SSSE)."7.70Felbamate in experimental model of status epilepticus. ( Baldwin, RA; Mazarati, AM; Sofia, RD; Wasterain, CG, 2000)
"Perimenstrual catamenial epilepsy, the exacerbation of seizures in association with menstruation, may in part be due to withdrawal of the progesterone metabolite allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one), an endogenous anticonvulsant neurosteroid that is a positive allosteric modulator of gamma-aminobutyric acid(A) receptors."7.70Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. ( Reddy, DS; Rogawski, MA, 2000)
"The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus."7.70Anticonvulsant effect of nimodipine alone and in combination with diazepam and phenytoin in a mouse model of status epilepticus. ( Khosla, P; Pandhi, P, 2000)
"The profile of action of ondansetron was assessed in a novel animal model of anxiety."7.69Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model. ( Kulkarni, SK; Roychoudhury, M, 1997)
"The repeated administration of nicotine at small doses, which do not produce whole body tremor or convulsion, causes tremor only in the tail (tail-tremor) of rats."7.69[Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model]. ( Gomita, Y; Kawasaki, H; Suemaru, K, 1997)
"We examined the anticonvulsant effects of BW1003C87 (5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine ethane sulphonic acid), which is structurally related to the new antiepileptic drug, lamotrigine, and compared its effects to those of the conventional antiepileptic drugs, phenytoin and carbamazopine, using the rat amygdala-kindling model of epilepsy."7.69BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. ( Morimoto, K; Sato, H; Sato, K; Sato, S; Yamada, N, 1997)
"Sound-induced seizures in genetically epilepsy-prone rats were used to compare the anticonvulsant effect of phenytoin and diazepam with compounds which decrease glutamatergic neurotransmission including excitatory amino acid antagonists acting at N-methyl-D-aspartate (NMDA) receptors: D(-)CPPene, CGP 37849 and MK 801 or at the glycine/NMDA site: ACPC (1-aminocyclopropane-dicarboxylic acid) (partial agonist) or non-NMDA receptors: NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]-quinoxaline."7.68Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. ( al-Zubaidy, ZA; Chapman, AG; Meldrum, BS; Smith, SE, 1993)
"Harmine, a hallucinogen with potent monoamine oxidase inhibitory properties, induced abnormal behavior, including tremor, scratching, head twitch and cage biting, in the mouse."7.66Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. ( Fujiwara, M; Hashimoto, Y; Kataoka, Y; Kawanishi, K; Ueki, S, 1981)
" Novel data indicated that neither FSL nor FRL rats exhibited alterations in swim test immobility following chronic administration of the psychomotor stimulant amphetamine (2 mg/kg) and the anticholinergic scopolamine (2 mg/kg), which typically reduce immobility after acute administration."6.39Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. ( Janowsky, DS; Overstreet, DH; Pucilowski, O; Rezvani, AH, 1995)
"Quercetin treatment was found to significantly reduce anxiety-like behaviors in mTBI-induced mice."5.51Quercetin mitigates anxiety-like behavior and normalizes hypothalamus-pituitary-adrenal axis function in a mouse model of mild traumatic brain injury. ( Ghorbanihaghjo, A; Kosari-Nasab, M; Mesgari-Abbasi, M; Salari, AA; Shokouhi, G, 2019)
"Diazepam-resistant SE was induced in adult mice fed with standard or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice."5.48Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet. ( Butler, CR; Guilmette, E; Pauletti, A; Piro, JR; Porcu, L; Rizzi, M; Salamone, A; Samad, TA; Sheehan, MJ; Terrone, G; Vezzani, A; Villa, BR, 2018)
"Riluzole is an antiglutamatergic agent and the only drug to offer some effect on the life expectancy of ALS patients."5.46Excitatory-inhibitory imbalance in the brain of the wobbler mouse model of amyotrophic lateral sclerosis substantiated by riluzole and diazepam. ( Andreasen, SR; Christensen, TB; Holm, MM; Lundbye, CJ; Schmitt-John, T; Thielsen, KD, 2017)
"Recently, the use of acute seizure tests in epileptic rats or mice has been proposed as a novel strategy for evaluating novel AEDs for increased antiseizure efficacy."5.43Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures. ( Löscher, W; Töllner, K; Twele, F, 2016)
"Diazepam treated animals showed significant alterations in the neurobehavior and neuro-histoarchitecture, which were improved after X-irradiation."5.43Low dose X-irradiation mitigates diazepam induced depression in rat brain. ( Dhawan, DK; Kaur, A; Singla, N, 2016)
"Curcumin is a biologically active phytochemical presents in turmeric and has pharmacological actions that benefit patients with depression and anxiety."5.42The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. ( Li, J; Pan, J; Wang, R; Wu, S; Xie, X; Xu, Y; Yu, X; Yu, Y; Zheng, L, 2015)
"Pilocarpine-induced SE was used to determine if COX-2 inhibition with NS-398, when administered alone or with diazepam, decreases the duration and/or intensity of SE and/or reduces neuronal injury in the rat hippocampus."5.42Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus. ( Dudek, FE; Ekstrand, JJ; Pouliot, WA; Trandafir, CC, 2015)
"The pilocarpine model of TLE has been widely used to study characteristics of human TLE, including behavioral comorbidities."5.42Evaluation of potential gender-related differences in behavioral and cognitive alterations following pilocarpine-induced status epilepticus in C57BL/6 mice. ( Fighera, MR; Funck, VR; Furian, AF; Grigoletto, J; Oliveira, CV; Oliveira, MS; Ribeiro, LR; Royes, LF, 2015)
"Tetramethylenedisulfotetramine (TETS) is a potent convulsant GABAA receptor blocker."5.42Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. ( Austin, AT; Bruun, DA; Cao, Z; Hammock, BD; Hulsizer, S; Inceoglu, B; Lein, PJ; Pessah, IN; Rogawski, MA; Tancredi, DJ; Vito, ST, 2015)
"Trials of novel compounds for the treatment of schizophrenia are typically tested in patients following brief withdrawal of ongoing medication despite known long-term changes in the dopamine (DA) system following chronic antipsychotic drug therapy."5.40Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. ( Cook, JM; Gill, KM; Grace, AA; Poe, MM, 2014)
"Paraoxon (POX) is an active metabolite of organophosphate (OP) pesticide parathion that has been weaponized and used against civilian populations."5.40Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication. ( Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Phillips, KF, 2014)
"Tetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved antidote."5.40Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. ( Austin, AT; Banks, CN; Bruun, DA; Hammock, BD; Inceoglu, B; Lein, PJ; Rogawski, MA; Tancredi, DJ; Vito, ST; Zolkowska, D, 2014)
"Spontaneous epileptic seizures in this model are known to be resistant to major antiepileptic drugs."5.40Low doses of ethanol markedly potentiate the anti-seizure effect of diazepam in a mouse model of difficult-to-treat focal seizures. ( Bankstahl, M; Gramer, M; Hausknecht, M; Klein, S; Löscher, W, 2014)
"Spontaneous seizures occurred in the 1, 2 and 4 h SE groups, and the seizure frequency increased with the prolongation of SE."5.39One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death. ( Chen, LL; Feng, HF; Mao, XX; Ye, Q; Zeng, LH, 2013)
" The doses of modulators were selected on the basis of dose-response studies."5.39Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam. ( Bhutada, P; Deshmukh, P; Dixit, P; Kaulaskar, S; Thakur, K, 2013)
"Gabapentin was used to provide an anxiolytic effect on drug-free days."5.38Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. ( Açikmeşe, B; Enginar, N; Hatipoğlu, I; Haznedar, S, 2012)
"Diazepam (2mg/kg) was also tested at three times during the 24-h day in the elevated plus maze: at the beginning and end of the lights-on period (Zeitgeber times 23 and 11, respectively) and once in the dark just before the room lights came on (Zeitgeber time 20)."5.37The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam. ( Batista, N; Delagrange, P; Gannon, RL; Hester, I; Huntley, C; Lungwitz, E; Millan, MJ; Peacock, A, 2011)
"The treatment with haloperidol worsened the adverse effects of chronic social stress having effects similar to stress on reward and motivation-related behaviours."5.35Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam. ( Abumaria, N; Flügge, G; Fuchs, E; Havemann-Reinecke, U; Hiemke, C; Rüther, E; Rygula, R; Zernig, G, 2008)
"In addition, convulsions induced by lithium-methomyl treatment were associated with widespread neurodegeneration of limbic structures."5.34Lithium-methomyl induced seizures in rats: a new model of status epilepticus? ( Blaszczak, P; Calderazzo, L; Cavalheiro, EA; Dekundy, A; Kaminski, RM; Parada-Turska, J; Turski, WA, 2007)
"Levetiracetam (LEV) is a structurally novel antiepileptic drug (AED) which has demonstrated a broad spectrum of anticonvulsant activities both in experimental and clinical studies."5.34Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. ( Bethmann, K; Brandt, C; Fedrowitz, M; Gastens, AM; Glien, M; Löscher, W; Potschka, H; Volk, HA, 2007)
"If epilepsy developed, the seizures were less frequent in DZP-treated animals compared to the vehicle group (median 16."5.33Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. ( Kharatishvili, I; Lukasiuk, K; Narkilahti, S; Nissinen, J; Pitkänen, A, 2005)
"Pre-treatment with diazepam, 10 and 20mg/kg, and chlormethiazole, 50 and 100mg/kg, attenuated the development of hyperthermia."5.32Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2003)
"Numbers of ictal events (seizure) and latency to the first event were reduced by prophylactic DZP."5.32Diazepam prophylaxis for bicuculline-induced seizures: a rat dose-response model. ( Anschel, DJ; Fisher, RS; Ortega, E, 2004)
"Using an amygdala-kindled seizure paradigm, we evaluated the acute and chronic anticonvulsant effects of lamotrigine (LTG)."5.31Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. ( Heynen, T; Krupp, E; Li, XL; Post, RM; Weiss, SR, 2000)
"(-)-Baclofen was the only one of the three compounds tested that reversed in a dose-dependent manner the effects of tone exposure on both the amplitude of the click-evoked potentials recorded from the IC and on measures of the changes in temporal integration based on these potentials."5.29Effects of (-)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. ( Møller, AR; Szczepaniak, WS, 1996)
"Evidence suggests that soman-induced convulsions may be associated with postexposure brain neuropathology."5.28Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. ( Capacio, BR; Koviak, TA; Shih, TM, 1991)
"Diazepam treatment alleviates in the first session aversion towards open space and hight in the elevated plus-maze only in the genetically hypertensive rats of both sexes and in the normotensive males."5.28Animal model of anxiety: effect of acute diazepam treatment in the older adult genetically hypertensive rats of Koletsky type and in the older adult rats of Wistar strain. ( Golda, V; Petr, R, 1989)
"QUIN seizures showed particular sensitivity to carbamazepine (5 mg/kg) but were resistant to diphenylhydantoin unless a relatively high dose was used (100 mg/kg)."5.27Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. ( Samanin, R; Tullii, M; Vezzani, A; Wu, HQ, 1986)
"The main site of action of diazepam, as with other benzodiazepines, is at the GABA(A) receptor, although it has been suggested that some of the potentially beneficial actions of diazepam in nerve agent poisoning are mediated through other means."4.82The role of diazepam in the treatment of nerve agent poisoning in a civilian population. ( Marrs, TC, 2004)
"Benzodiazepine withdrawal, spontaneous or precipitated by the receptor antagonist, flumazenil, produces anxiety that can be measured in animal models."4.78The benzodiazepines: anxiolytic and withdrawal effects. ( Little, HJ, 1991)
"To investigate the effects of different doses of esculetin on epileptiform activity, behavioral seizures, memory impairment, and cortical and hippocampal NF-κB, as a mediator of pro-inflammatory gene induction, and pro-inflammatory cytokines in penicillin- and pentylenetetrazole(PTZ)-induced seizure models in rats."4.31Esculetin alleviates pentylenetetrazole-induced seizures, cognitive impairment and pro-inflammatory cytokines and suppresses penicillin-induced epileptiform activity in rats. ( Ankarali, H; Baranoglu Kilinc, Y; Danis, A; Hanci, F; Kilinc, E; Torun, IE, 2023)
" We aim to test the effect of combining the therapeutic action of tSMS and diazepam, a drug used to treat status epilepticus."4.31Synergistic effects of applying static magnetic fields and diazepam to improve EEG abnormalities in the pilocarpine epilepsy rat model. ( Cudeiro, J; de Labra, C; Rivadulla, C, 2023)
" We validated this as anxiety-like behaviors with diazepam reducing, and caffeine increasing the time spent in the bottom of the novel environment."4.12The larval diving response (LDR): Validation of an automated, high-throughput, ecologically relevant measure of anxiety-related behavior in larval zebrafish (Danio rerio). ( Fontana, BD; Parker, MO, 2022)
" The present study has been designed to evaluate the neuroprotective effect of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice."4.02Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations. ( Alfuraih, BS; Alsuhaibani, NA; Elsayed, AM; Mahmoud, RH; Nadwa, EH; Rashed, LA; Said, ES, 2021)
" Therefore, we propose a hypothesis that diazepam monotherapy or diazepam-ketamine dual therapy could terminate seizures and reduce mortality in the SE model at different time points during ongoing SE."4.02Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model. ( Cao, X; Li, Z; Wang, Y; Yu, J; Zhou, R, 2021)
" The seizures were induced with pentylenetetrazole (PTZ) intraperitoneally at 170 mg/kg, and diazepam (DZP) was used as the control anticonvulsant (2 mg/kg, oral); PA was tested at 10, 50, and 100 mg/kg orally."4.02Perillyl alcohol decreases the frequency and severity of convulsive-like behavior in the adult zebrafish model of acute seizures. ( Borges, RS; Carvalho, JCT; da Silva Hage-Melim, LI; de Melo, EL; Hu, X; Matias Pereira, AC; Sánchez-Ortíz, BL, 2021)
" The present study was designed to investigate the effect of acute and chronic administration of thiamine alone and in combination with sub-effective dose of diazepam on pentylenetetrazole (PTZ)-induced tonic-clonic seizures in mice."3.91Anticonvulsant effects of thiamine on pentylenetetrazole-induced seizure in mice. ( Abed, A; Alinejad, M; Banafshe, HR; Heydari, A; Mesdaghinia, A, 2019)
"diazepam attenuated pain induced by dentin hypersensitivity in rats exposed to stress."3.91Diazepam as attenuator of pain induced by dentin hypersensitivity in rats exposed to stress. ( Barbosa Suffredini, I; Bernardi, MM; Coury Saraceni, CH; Kabadayan, F; Tonetti Ciaramicoli, M, 2019)
"Diazepam could regulate immune system and inflammation, which might be a potential therapeutic agent for pulmonary fibrosis in clinic."3.91Diazepam inhibited lipopolysaccharide (LPS)-induced pyroptotic cell death and alleviated pulmonary fibrosis in mice by specifically activating GABA ( Bo, F; Deng, M; Li, Y; Song, D; Tang, X, 2019)
" Lobeline increased the latency to the first seizure and decreased the percentage of seizures in a similar way as diazepam, used as control."3.88DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism. ( Boaretto, FBM; da Costa E Silva, LD; da Silva, LL; Hoffmann, C; Morás, AM; Moura, DJ; Pereira, P; Pflüger, P; Picada, JN; Regner, GG; Steffens, LR, 2018)
"Part 1: Anxiety at 3 hours was significantly lower following minocycline (20 mg/kg i."3.88Minocycline in Alcohol Withdrawal Induced Anxiety and Alcohol Relapse in Rats. ( Gajbhiye, SV; Petare, A; Potey, AV; Shankar, A; Tripathi, RK, 2018)
" The aim of the present study was to explore the effect of a selective CB2 receptor agonist β-caryophyllene (BCP) in models of seizures and cognition in mice."3.88Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice. ( da Conceição Machado, K; de Carvalho Melo Cavalcante, AA; Gomes Júnior, AL; Momchilova, A; Tchekalarova, J; Tzoneva, R, 2018)
"We previously showed that nicotine evoked kinetic tremor by activating the inferior olive, which is implicated in the pathogenesis of essential tremor, via α7 nicotinic acetylcholine receptors."3.88Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents. ( Abe, K; Hashimura, M; Iha, HA; Iwai, C; Kato, M; Kawaji, S; Kawakita, K; Kunisawa, N; Ogawa, M; Ohno, Y; Shimizu, S, 2018)
"To evaluate acute and long-term effects of intravenous brivaracetam (BRV) and BRV + diazepam (DZP) combination treatment in a rat model of self-sustaining status epilepticus (SSSE)."3.85Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. ( Klitgaard, H; Matagne, A; Niquet, J; Suchomelova, L; Thompson, K; Wasterlain, C, 2017)
"CD1 and CD2 characterized as bergenin, exhibited significant antianxiety activity at 80mg/kg, po which was statistically comparable to that of diazepam (2mg/kg, po)."3.85Antianxiety activity guided isolation and characterization of bergenin from Caesalpinia digyna Rottler roots. ( Kumar, A; Sharma, A; Singh, J, 2017)
"Rutin is a bioflavonoid found in medicinal plants used to reduce anxiety."3.85The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala. ( Fernández-Guasti, A; González-Trujano, ME; Hernandez-Leon, A, 2017)
"Diazepam can reduce the excitability of lateral amygdala and eventually suppress the excitability of the auditory cortex in rats following salicylate treatment, indicating the regulating effect of lateral amygdala to the auditory cortex in the tinnitus procedure."3.83Diazepam reduces excitability of amygdala and further influences auditory cortex following sodium salicylate treatment in rats. ( Liu, J; Ma, F; Mao, L; Song, Y, 2016)
" The objective of this study was to evaluate the effect of non-steroidal anti-inflammatory diclofenac sodium on the severity of seizures and levels of pro-inflammatory interleukins in animals with kindling model induced by PTZ."3.83Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model. ( Coitinho, AS; Glassmann, D; Gomez, R; Marafon, P; Pereira, P; Vieira, V, 2016)
"The pilocarpine rat model, in which status epilepticus (SE) leads to epilepsy with spontaneous recurrent seizures (SRS), is widely used to study the mechanisms of epileptogenesis and develop strategies for epilepsy prevention."3.81Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. ( Brandt, C; Bröer, S; Klee, R; Löscher, W; Töllner, K, 2015)
" AP521 showed equal or more potent anxiolytic-like effects compared with diazepam, a benzodiazepine receptor agonist, or tandospirone, a partial 5-hydroxytryptamine (5-HT)1A receptor agonist, in three rat anxiety models; the Vogel-type conflict test, elevated plus maze test, and conditioned fear stress test."3.81The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats. ( Hashimoto, S; Hattori, T; Kasahara, K; Kawakubo, H; Kawasaki, K; Nagatani, T; Nakazono, O; Takao, K; Tsujita, R, 2015)
" Diazepam produced a dose-dependent protection against 6-Hz seizures in control and pilocarpine mice, both at 2 weeks and 8 weeks after SE, but with a more pronounced increase in potency in post-SE animals at 2 weeks."3.81Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model. ( Kaminski, RM; Leclercq, K, 2015)
"The effects of mitragynine on anxiety-related behaviours in the open-field and elevated plus-maze tests were evaluated."3.80Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats. ( Hazim, AI; Mansor, SM; Muzaimi, M; Parthasarathy, S; Ramanathan, S, 2014)
"Piperine produced significant antianxiety-like activity in unstressed and stressed mice."3.80Possible involvement of GABAergic and nitriergic systems for antianxiety-like activity of piperine in unstressed and stressed mice. ( Dhingra, D; Gilhotra, N, 2014)
"It was the aim of this study to determine the potential effect of walnut kernel extract (WKE) on experimentally induced seizures in rats and to evaluate the role of benzodiazepines and ethosuximide (ESM) within these pathways."3.80Potential mechanisms involved in the anticonvulsant effect of walnut extract on pentylenetetrazole-induced seizure. ( Asadi-Shekaari, M; Eslami, A; Joukar, S; Kalantaripour, T, 2014)
"Levetiracetam has been reported to be well tolerated and effective in status epilepticus (SE) refractory to benzodiazepine."3.79The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus. ( Choi, HC; Kang, TC; Kim, JE; Kim, YI; Lee, DS; Ryu, HJ; Song, HK, 2013)
"Experiments were conducted to evaluate the effects of transcranial focal electrical stimulation (TFS) applied via tripolar concentric ring electrodes, alone and associated with a sub-effective dose of diazepam (DZP) on the expression of status epilepticus (SE) induced by lithium-pilocarpine (LP) and subsequent neuronal damage in the hippocampus."3.79Effects of transcranial focal electrical stimulation alone and associated with a sub-effective dose of diazepam on pilocarpine-induced status epilepticus and subsequent neuronal damage in rats. ( Besio, W; Cuellar-Herrera, M; Luna-Munguia, H; Orozco-Suárez, S; Rocha, L, 2013)
" This new method documented that seizures in the zebrafish EAST model were ameliorated by pentobarbitone, but not diazepam, validating its usefulness."3.79Epilepsy in kcnj10 morphant zebrafish assessed with a novel method for long-term EEG recordings. ( Bockenhauer, D; Kleta, R; Mahmood, F; Russell, C; Stanescu, HC; Zdebik, AA, 2013)
"The anxiolytic-like effects of topiramate were assessed during several estrous cycle phases in Wistar rats tested in two animal models of anxiety-like behavior."3.79Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior. ( Jaramillo, MT; Molina-Hernández, M; Olivera-López, JI; Téllez-Alcántara, NP, 2013)
"Here we examined the effects of Ro 64-6198 on unconditioned conflict anxiety using stimuli with different salience and on regulation of autonomic reactivity and compared these to the effects of benzodiazepine receptor agonists."3.78Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair. ( Goeldner, C; Prinssen, EP; Spooren, W; Wichmann, J, 2012)
"Catamenial epilepsy is caused by fluctuations in progesterone-derived GABA(A) receptor-modulating anticonvulsant neurosteroids, such as allopregnanolone, that play a significant role in the pathophysiology of epilepsy."3.78A mouse kindling model of perimenstrual catamenial epilepsy. ( Gangisetty, O; Gould, J; Reddy, DS, 2012)
"  The endocannabinoid system is known to modulate seizure activity in several in vivo and in vitro models, and CB(1) -receptor activation is anticonvulsant in the rat pilocarpine model of acquired epilepsy (AE)."3.78Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain. ( Blair, RE; DeLorenzo, RJ; Nguyen, PT; Sayers, KW; Sim-Selley, LJ, 2012)
" Results from 2413 mice were evaluated for effects of sex, age, body weight, and latency between administration of atropine methyl bromide and pilocarpine."3.78Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy. ( Buckmaster, PS; Haney, MM, 2012)
"Injection of the seaweed toxin kainic acid (KA) in rats induces a severe status epilepticus initiating complex neuropathological changes in limbic brain areas and subsequently spontaneous recurrent seizures."3.78Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex. ( Drexel, M; Preidt, AP; Sperk, G, 2012)
"Melatonin (MLT) is a neurohormone known to be involved in the regulation of anxiety."3.78Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. ( Bedini, A; Comai, S; Fraschini, F; Gobbi, G; Mor, M; Ochoa-Sanchez, R; Rainer, Q; Rivara, S; Spadoni, G; Tarzia, G, 2012)
") and seizures terminated after 2 h with diazepam (10 mg/kg, i."3.78N (w) -propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses. ( Beamer, E; Otahal, J; Sills, GJ; Thippeswamy, T, 2012)
" Systemic administration of the anxiolytic, diazepam, decreased the frequency of two behaviors associated with anxiety and defensiveness, upright and jump escape, as well as crawl under behavior."3.77A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice. ( Blanchard, DC; Blanchard, RJ; Bolivar, VJ; Defensor, EB; Pearson, BL; Pobbe, RL, 2011)
"The aim of present research was to study, by means of descriptive and multivariate t-pattern analyses, the effects of the reference anxiolytic drug diazepam (DZP) on temporal structure of a rat's anxiety-related behavior in HB."3.77T-pattern analysis of diazepam-induced modifications on the temporal organization of rat behavioral response to anxiety in hole board. ( Casarrubea, M; Crescimanno, G; Magnusson, MS; Sorbera, F, 2011)
"In the present study, the effects of intraamygdalar administrations of melatonin (1 and 100μg/kg), saline and diazepam on the anxiety-like behavior and spatial memory performance in pinealectomized and sham-pinealectomized Wistar rats were investigated."3.77The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. ( Coşkun, H; Gündüz, B; Karakaş, A; Kaya, A; Kücük, A, 2011)
"We have shown previously that aberrant hippocampal (HPC) output underlies the dopamine (DA) dysfunction observed in the methylazoxymethanol acetate (MAM) developmental model of schizophrenia in the rodent."3.77A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. ( Aras, S; Cook, JM; Gill, KM; Grace, AA; Lodge, DJ, 2011)
"Acute application of human ASCs-E before SE led to earlier attenuation of seizure spike activities after treatment with diazepam, reduction of BBB leakage, and inhibition of the development of epilepsy."3.77A cell-free extract from human adipose stem cells protects mice against epilepsy. ( Ban, JJ; Chu, K; Jeon, D; Jung, KH; Kang, KM; Kim, M; Kim, S; Lee, SK; Lee, ST; Roh, JK; Seo, JS; Won, CH, 2011)
"The aim of the present study was to investigate the role of GABAergic and nitriergic modulation in the antianxiety effect of thymoquinone, a major constituent of Nigella sativa, in mice under unstressed and stressed conditions."3.77Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels. ( Dhingra, D; Gilhotra, N, 2011)
"05) the onset and reduced the duration of the seizures induced by picrotoxin (5 mg/kg, i."3.77Anticonvulsant activity of the methanolic extract of Justicia extensa T. Anders. ( Adio, O; Fageyinbo, S; Sowemimo, AA, 2011)
"The anti-inflammatory activity of amitriptyline, diazepam and a new, Russian tranquilizer mebicar was studied in a wide range of therapeutic doses on carrageenan-induced paw edema in rats."3.77[Anti-inflammatory effects of amitriptyline, diazepam and mebicar using model of acute carrageenan-induced paw edema in rats]. ( Kaziakhmetova, VN; Valeeva, IKh; Ziganshina, LE, 2011)
"Benzodiazepines such as diazepam may fail to effectively treat status epilepticus because benzodiazepine-sensitive GABA(A) receptors are progressively internalized with continued seizure activity."3.76Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. ( Fritsch, B; Joelle Donofrio, J; Rogawski, MA; Stott, JJ, 2010)
" Because early-life treatment with WAY-100,635 in Swiss-Webster mice reduced diazepam sensitivity and increased GABA(A)R alpha subunit levels in the prefrontal cortex and hippocampus, our data suggest a putative link between early-life disruption of the serotonergic system and the emergence of increased anxiety and decreased benzodiazepine responsivity at adult age."3.76Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity. ( Groenink, L; Olivier, B; Oosting, RS; van Bogaert, MJ; Vinkers, CH, 2010)
"Using the four-plate test (FPT) model of anxiety in mice the potential anxiolytic-like effect of etifoxine was first to re-evaluate."3.76Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice. ( Bourin, M; Hascoët, M, 2010)
"Pre-treatment with GABA (40 mg/kg), diazepam, phenobarbital, AOAA and DABA abolished the appearance of seizures induced by 50 mg/kg (PhSe)₂ in rat pups."3.76Diphenyl diselenide-induced seizures in rat pups: possible interaction with GABAergic system. ( Nogueira, CW; Prigol, M; Wilhelm, EA; Zeni, G, 2010)
"In the present study the effectiveness of different diazepam-ketamine combinations to control kainic acid-induced status epilepticus in rats was evaluated."3.76The control of kainic acid-induced status epilepticus. ( Clinckers, R; Massie, A; Michotte, Y; Smolders, I; Vermoesen, K, 2010)
"Diazepam-reduced experimental anxiety was paralleled by antinociceptive effects."3.76Parallel anxiolytic-like and antinociceptive actions of diazepam in the anterior basolateral amygdala and dorsal periaqueductal gray. ( Fernández-Guasti, A; Jiménez-Velázquez, G; López-Muñoz, FJ, 2010)
"2 s, while chemical seizures were induced by intraperitoneal injection of pentylenetetrazole at its CD97 dose (97% convulsive dose for the clonic phase)."3.76Influence of etoricoxib on anticonvulsant activity of phenytoin and diazepam in experimental seizure models in mice. ( Anitha, T; Gajera, K; Jayaraman, R; Joshi, VD; Ladani, K; Manisenthil, KT; Palei, NN, 2010)
" In acute study, seizures were induced by either pentylenetetrazole (PTZ) injection or maximal electroshock seizures, while in the chronic study, kindling was induced by injecting PTZ (30 mg/kg, s."3.76Effect of phosphamidon on convulsive behavior and biochemical parameters: modulation by progesterone and 4'-chlorodiazepam in rats. ( Arora, T; Banerjee, BD; Joshi, V; Mahajan, P; Mediratta, PK; Mehta, AK; Mehta, KD; Rathor, N; Sharma, AK; Sharma, KK, 2010)
"Diazepam decreased the number of LLC metastases in anxious losers, whereas in the winners and control mice, without anxiety state, diazepam was ineffective."3.75Limiting effect of diazepam on Lewis Lung carcinoma metastasis in anxious male mice. ( Kaledin, VI; Kudryavtseva, NN; Llnitskaya, SI; Nikolin, VP; Popova, NA; Smagin, DA, 2009)
"Flupirtine appears more effective than either of two commonly used antiepileptic drugs, phenobarbital and diazepam, in preventing and suppressing seizures in both the kainic acid and flurothyl models of symptomatic neonatal seizures."3.75A KCNQ channel opener for experimental neonatal seizures and status epilepticus. ( Brooks-Kayal, AR; Cooper, EC; Keating, JG; Lapides, DA; Raol, YH, 2009)
" Here, we describe a lesion that destroys the perforant path in CA3 after status epilepticus (SE) induced by pilocarpine injection in 8-week-old rats."3.74Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticus. ( Avoli, M; Baldelli, E; Biagini, G; Contri, MB; Gelosa, P; Guerrini, U; Longo, D; Ragsdale, DS; Sironi, L; Zini, I, 2008)
" We have shown recently that topiramate (TPM) dose-dependently protects hippocampal CA1 and CA3 neurons during initial status epilepticus in the rat pilocarpine model of temporal lobe epilepsy by inhibition of mitochondrial transition pore opening."3.74Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent. ( Elger, CE; Frisch, C; Helmstaedter, C; Kudin, AP; Kunz, WS, 2007)
" (PQS) was studied in male mice by using a number of experimental paradigms of anxiety and compared with that of the known anxiolytic compound diazepam."3.74Anxiolytic effect of saponins from Panax quinquefolium in mice. ( Wang, JH; Wei, XY; Wu, CF; Yang, JY, 2007)
"Continued usage of cocaine is determined by genetic, conditioned and homeostatic factors, while it is reinforced by drug-induced reward and the emotionally negative state of drug withdrawal, which includes anxiety."3.74Anxiogenic effects of cocaine withdrawal in zebrafish. ( Cabral, H; López-Patiño, MA; Yu, L; Zhdanova, IV, 2008)
"By intravenous administration of group I metabotropic glutamate receptor antagonists at 1 or 2h during pilocarpine induced status epilepticus (PISE), we showed that mGluR1 antagonists AIDA or LY367385 (at dosages ranging from 25 to 200mg/kg), mGluR5 antagonists SIB1757 (at dosages ranging from 25 to 200mg/kg), SIB1893 (from 25 to 100mg/kg), MPEP (from 25 to 100mg/kg) injected at 1 or 2h during PISE were ineffective in controlling status epilepticus (SE)."3.74Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus. ( Chen, PM; Lee, WL; Tang, FR; Tang, YC; Tsai, MC, 2007)
"Partial limbic seizures in rodents induced by pilocarpine progress from stages I-II (mouth and facial movements; head nodding) to stage III (forelimb clonus) and then progress rapidly to stages IV-V (generalized limbic seizures; rearing, and rearing with falling) followed by status epilepticus (SE)."3.74Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus. ( Feng, HJ; Kao, C; Macdonald, RL; Mathews, GC, 2008)
"We determined the efficacy of diazepam (DZP) and pentobarbital (PTB) in controlling prolonged status epilepticus (SE) in developing rats."3.74Effective treatments of prolonged status epilepticus in developing rats. ( Hasson, H; Kim, M; Moshé, SL, 2008)
" Single doses of 5-HT2 antagonists, mianserin (5mg/kg) and ritanserin (1mg/kg), effectively ameliorated withdrawal anxiety in the rat, returning behavioural function in the social interaction test and elevated plus maze to levels comparable to vehicle-treated animals."3.73Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists. ( Begg, DP; Hallam, KT; Norman, TR, 2005)
"This study analyzes the long-term effects of ovariectomy on the basal experimental anxiety of rats and the influence of this condition on the anxiolytic properties of diazepam and the 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)."3.73Influence of the post-ovariectomy time frame on the experimental anxiety and the behavioural actions of some anxiolytic agents. ( Estrada-Camarena, E; Hernandez-Aragon, A; Picazo, O, 2006)
" To determine if immediate post-traumatic events such as seizures may activate Rho, we examined RhoA activation in the brains of rats with kainic acid-induced seizures."3.73Activation of Rho after traumatic brain injury and seizure in rats. ( Deschamps, K; Dubreuil, CI; Marklund, N; McIntosh, TK; McKerracher, L, 2006)
"Mice with point-mutated alpha2 GABAA receptor subunits (rendering them diazepam insensitive) are resistant to the anxiolytic-like effects of benzodiazepines (BZs) in unconditioned models of anxiety."3.73Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. ( Atack, JR; Dawson, GR; Morris, HV; Reynolds, DS; Stephens, DN, 2006)
"Lithium-pilocarpine induces status epilepticus (SE), leading to extensive damage and spontaneous recurrent seizures (SRS)."3.73The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. ( Ferrandon, A; François, J; Koning, E; Nehlig, A, 2006)
"6 microg/microl) effectively prevented seizures induced by the unilateral GABAergic blockade of Area tempestas (bicuculline, 0."3.73Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae). ( Beleboni, Rde O; Coutinho-Netto, J; Cunha, AO; dos Santos, WF; Gelfuso, EA; Liberato, JL; Mortari, MR, 2006)
"To investigate changes in free benzodiazepine receptor density in response to repeated, long-term administration of diazepam in epilepsy, we assessed 125I-iomazenil (125I-IMZ) binding in a mouse model."3.73Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse. ( Fukumitsu, N; Mori, Y; Ogi, S; Uchiyama, M, 2006)
"High doses of diazepam (10-20 mg/kg) were shown to reduce the volume of acute carrageenan-induced inflammatory paw edema in rats."3.72Reduction of inflammation in rats by diazepam: tolerance development. ( de Nucci, G; Lazzarini, R; Malucelli, BE; Muscará, MN; Palermo-Neto, J, 2003)
"This study evaluated the effectiveness of fosphenytoin as a single or adjunctive anticonvulsant treatment for nerve agent-induced status epilepticus."3.72Effects of fosphenytoin on nerve agent-induced status epilepticus. ( Benjamin, A; McDonough, JH; McMonagle, JD; Rowland, T; Shih, TM, 2004)
"In the present study we examined the effects of 1-aminoindan-1,5-dicarboxylic acid (AIDA), regarded as a selective and competitive mGluR1 antagonist, in animal models of anxiety."3.72The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. ( Chojnacka-Wójcik, E; Kłodzińska, A; Stachowicz, K; Tatarczyńska, E, 2004)
"Previously, it was shown that subchronic application of the NMDA receptor antagonist ketamine (Ket) induces schizophrenia-related alterations, e."3.72Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. ( Becker, A; Grecksch, G, 2004)
"Status epilepticus is usually initially treated with a benzodiazepine such as diazepam."3.71Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. ( Esmaeil, N; Jones, DM; Macdonald, RL; Maren, S, 2002)
"The 5-HT2B/2C receptor antagonist SB 206553 exerts anxiolytic effects in rat models of anxiety."3.71Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze. ( Berton, O; Chaouloff, F; Mormède, P; Takahashi, RN, 2001)
"The anxiolytic effects of aniracetam have not been proven in animals despite its clinical usefulness for post-stroke anxiety."3.71Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. ( Kurasawa, M; Nakamura, K, 2001)
"Perimenstrual catamenial epilepsy may in part be due to withdrawal of the endogenous progesterone-derived neurosteroid allopregnanolone that potentiates gamma-aminobutyric acidA (GABA(A)) receptor-mediated inhibition."3.71Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. ( Reddy, DS; Rogawski, MA, 2001)
"The protective and adverse effect potentials of levetiracetam ((S)-alpha-ethyl-2-oxo-pyrrolidine acetamide) in rodent models of seizures and epilepsy were compared with the profile of several currently prescribed and newly developed antiepileptic drugs."3.70Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. ( Gobert, J; Klitgaard, H; Matagne, A; Wülfert, E, 1998)
") administration of (+/-) pentazocine (10, 30 & 50 mg/kg), a Sigma opioid agonist, resulted in a dose dependent anticonvulsant action against maximal electroshock seizures in mice."3.70Opioid receptor mediated anticonvulsant effect of pentazocine. ( Khanna, N; Khosla, R; Kohli, J, 1998)
"The present study extended the previous studies to determine the effects of acute and repeated administration of caffeine, a non-specific phosphodiesterase (PDE) inhibitor and pentoxyfylline, a specific type-4 phosphodiesterase (PDE4) inhibitor on (1) baseline anxiety-like behavior and (2) the response to an acute challenge with diazepam on anxiety-like behavior in the hole-board test."3.70Effects of acute and repeated dose administration of caffeine and pentoxifylline on diazepam-induced mouse behavior in the hole-board test. ( Campos, AR; Paula, WG; Rao, VS; Santos, FA; Silva, RM, 1999)
"To examine the putative seizure-protective properties of felbamate in an animal model of self-sustaining status epilepticus (SSSE)."3.70Felbamate in experimental model of status epilepticus. ( Baldwin, RA; Mazarati, AM; Sofia, RD; Wasterain, CG, 2000)
"Perimenstrual catamenial epilepsy, the exacerbation of seizures in association with menstruation, may in part be due to withdrawal of the progesterone metabolite allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one), an endogenous anticonvulsant neurosteroid that is a positive allosteric modulator of gamma-aminobutyric acid(A) receptors."3.70Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. ( Reddy, DS; Rogawski, MA, 2000)
"The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus."3.70Anticonvulsant effect of nimodipine alone and in combination with diazepam and phenytoin in a mouse model of status epilepticus. ( Khosla, P; Pandhi, P, 2000)
"The profile of action of ondansetron was assessed in a novel animal model of anxiety."3.69Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model. ( Kulkarni, SK; Roychoudhury, M, 1997)
"The repeated administration of nicotine at small doses, which do not produce whole body tremor or convulsion, causes tremor only in the tail (tail-tremor) of rats."3.69[Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model]. ( Gomita, Y; Kawasaki, H; Suemaru, K, 1997)
"The possibility that diazepam will influence spinal cord evoked potentials (SCEP), edema formation and cell changes following spinal cord injury (SCI) was examined in a rat model."3.69Benzodiazepine receptors influence spinal cord evoked potentials and edema following trauma to the rat spinal cord. ( Sharma, HS; Stålberg, E; Westman, J; Winkler, T, 1997)
"We examined the anticonvulsant effects of BW1003C87 (5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine ethane sulphonic acid), which is structurally related to the new antiepileptic drug, lamotrigine, and compared its effects to those of the conventional antiepileptic drugs, phenytoin and carbamazopine, using the rat amygdala-kindling model of epilepsy."3.69BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. ( Morimoto, K; Sato, H; Sato, K; Sato, S; Yamada, N, 1997)
"Adult rats submitted to a protein deprivation schedule at perinatal age (from 14th day of fetal life until 50 days of age) and then recovered on balanced chow (D rats) were assayed in the elevated plus-maze test for anticonflict effects of diazepam and drugs with therapeutic efficacy in panic disorders as compared with controls (C rats)."3.68Perinatally protein-deprived rats and reactivity to anxiolytic drugs in the plus-maze test: an animal model for screening antipanic agents? ( Cordoba, NE; Laino, CH; Orsingher, OA, 1993)
"Sound-induced seizures in genetically epilepsy-prone rats were used to compare the anticonvulsant effect of phenytoin and diazepam with compounds which decrease glutamatergic neurotransmission including excitatory amino acid antagonists acting at N-methyl-D-aspartate (NMDA) receptors: D(-)CPPene, CGP 37849 and MK 801 or at the glycine/NMDA site: ACPC (1-aminocyclopropane-dicarboxylic acid) (partial agonist) or non-NMDA receptors: NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]-quinoxaline."3.68Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. ( al-Zubaidy, ZA; Chapman, AG; Meldrum, BS; Smith, SE, 1993)
"We describe a novel model of status epilepticus produced by the focal application of bicuculline methiodide into the deep prepiriform cortex of rats pretreated with lithium chloride."3.68A rodent model of focally evoked self-sustaining status epilepticus. ( Gale, K; Pazos, A; Peterson, CJ; Vinayak, S, 1992)
"Brain extracts from rats with hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure contained 4- to 6-fold higher concentrations of substances that inhibit radioligand binding to benzodiazepine receptors than corresponding control rat extracts."3.68Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. ( Basile, AS; Fales, HM; Gammal, SH; Jaouni, T; Jones, EA; Pannell, L; Skolnick, P, 1990)
" The development of hepatic encephalopathy due to galactosamine-induced fulminant hepatic failure was consistently associated with a series of distinctive changes in the visual evoked potential waveform."3.67Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. ( Brody, LE; Jacobs, R; Jones, EA; Pappas, SC; Schafer, DF, 1984)
"Thrombophlebitis is a common complication associated with infusion of intravenous sedatives, especially diazepam."3.67Development of an in vivo model for assessment of drug-induced vascular injury. ( Herrera, GQ; Jeske, AH; Johnson, JV; McDaniel, HK, 1989)
"In a proposed rat model for anxiety (electrical stimulation of the periaqueductal grey region), progabide (a GABA agonist) and diazepam both increased the latency to escape to a safe compartment and also the current needed to induce the escape response (escape threshold)."3.66Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region. ( Bovier, P; Broekkamp, CL; Lloyd, KG, 1982)
"Seven GABAmimetic drugs, namely cetyl gamma-aminobutyric acid (cetyl GABA), 4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridine-3-ol, progabide, aminooxyacetic acid, alpha-acetylenic GABA, (-)-nipecotic acid ethyl ester and (+/-)-cis-4-hydroxynipecotic acid methyl ester, were tested for their potency to block "major" (generalized clonic-tonic) seizures in gerbils, induced by blowing at the animals with compressed air."3.66High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy. ( Frey, HH; Löscher, W; Reiche, R; Schultz, D, 1983)
"Repeated seizures, whether induced by kindling or electroshock, caused a long-lasting (at least 24 hr) increase of [3H]diazepam binding in hippocampal membranes of Sprague-Dawley rats."3.66Repeated seizures induce long-term increase in hippocampal benzodiazepine receptors. ( McNamara, JO; Patrone, V; Peper, AM, 1980)
"Harmine, a hallucinogen with potent monoamine oxidase inhibitory properties, induced abnormal behavior, including tremor, scratching, head twitch and cage biting, in the mouse."3.66Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. ( Fujiwara, M; Hashimoto, Y; Kataoka, Y; Kawanishi, K; Ueki, S, 1981)
"Intra-amygdaloid unilateral application of low doses of kainic acid rapidly elicits, in both chronic and acute conditions, secondarily generalized convulsive seizures which often culminate in fatal true status epilepticus unless appropriate anti-epileptic drugs are provided."3.66[Epileptogenic action of intra-amygdaloid injection of kainic acid]. ( Ben-Ari, Y; Lagowska, J, 1978)
"Senegalese baboons (Papio papio), with a natural syndrome of photosensitive epilepsy, consistently show generalized myoclonic jerks if stimulated stroboscopically at hourly intervals, two to eight hours after the intravenous administration of allylglycine, 200 mg/kg."3.65A primate model for testing anticonvulsant drugs. ( Horton, RW; Meldrum, BS; Toseland, PA, 1975)
"Based on data from diverse seizure models, we hypothesized that cholinergic mechanisms are involved in the mechanisms underlying ASD resistance of SE."2.52Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. ( Löscher, W, 2015)
" Novel data indicated that neither FSL nor FRL rats exhibited alterations in swim test immobility following chronic administration of the psychomotor stimulant amphetamine (2 mg/kg) and the anticholinergic scopolamine (2 mg/kg), which typically reduce immobility after acute administration."2.39Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. ( Janowsky, DS; Overstreet, DH; Pucilowski, O; Rezvani, AH, 1995)
"5-Hydroxytryptophan has the opposite effect exacerbating the behavioural response to the aversive situation."2.38The pharmacology of the 5-HT4 receptor. ( Costall, B; Naylor, RJ, 1993)
"Acute colitis was induced with 5 days of dextran sodium sulfate (DSS, 3%) in the drinking water."1.72Peripheral GABAA receptor signaling contributes to visceral hypersensitivity in a mouse model of colitis. ( Gold, MS; Loeza-Alcocer, E, 2022)
"Only diazepam significantly increased seizure freedom."1.72Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs. ( Billingsley, P; Metcalf, CS; Pruess, T; Rueda, C; Saunders, GW; Smith, MD; Thomson, K; West, PJ; Wilcox, KS, 2022)
" Using an animal model of chemically-induced epileptic seizures, we tested exercise alone as non-pharmacological therapy, and exercise combined with an anti-inflammatory drug."1.72Aerobic exercise, alone or combined with an anti-inflammatory drug, reduces the severity of epileptic seizures and levels of central pro-inflammatory cytokines in an animal model of epileptic seizures. ( Barbosa, BB; Coitinho, AS; de Lima Rosa, G; Domingues, AM; Guzzo, EFM; Nunes, SEB; Padilha, RB; Siqueira, IR, 2022)
"The fact that inflammation triggers epileptic seizures brings to mind the antiepileptic properties of anti-inflammatory drugs."1.72The antiinflammatory and electrophysiological effects of fingolimod on penicillin-induced rats. ( Çelik, H; Çetinkaya, A; Torun, İE; Türel, CA; Türel, İ, 2022)
"camptopus in acute models of epileptic seizures in Wistar rats."1.62Anticonvulsant effects of the aqueous and methanol extracts from the stem bark of Psychotria camptopus Verdc. (Rubiacaea) in rats. ( Chouna, R; Dongmo, AK; Fokoua, AR; Kaptué Wuyt, A; Ndjenda, MK; Nguelefack, TB; Nkeng-Efouet, PA; Tatsinkou Bomba, FD, 2021)
"Amantadine treatment also reduces the production of NO and metabolism of GABA."1.56Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways. ( Garg, C; Garg, M; Walia, V, 2020)
"Aged insomnia rat model was established with subcutaneous injection of D-galactose for 42 days and then intraperitoneal injection of para-chlorophenylalanine for 3 days."1.56Sedative and Hypnotic Effects and Transcriptome Analysis of Polygala tenuifolia in Aged Insomnia Rats. ( Peng, ZP; Ren, XJ; Wang, GY; Wang, QQ; Zhang, XP, 2020)
"Memantine pretreatment (18 mg/kg sc) produced in rats poisoned with soman significantly better protective ratios (PRs) than the two carbamates - 1."1.51Prophylactic potential of memantine against soman poisoning in rats. ( Bokonjić, D; Jokanović, M; Kilibarda, V; Škrbić, R; Stojiljković, MP; Vulović, M, 2019)
"Quercetin treatment was found to significantly reduce anxiety-like behaviors in mTBI-induced mice."1.51Quercetin mitigates anxiety-like behavior and normalizes hypothalamus-pituitary-adrenal axis function in a mouse model of mild traumatic brain injury. ( Ghorbanihaghjo, A; Kosari-Nasab, M; Mesgari-Abbasi, M; Salari, AA; Shokouhi, G, 2019)
"Diazepam-resistant SE was induced in adult mice fed with standard or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice."1.48Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet. ( Butler, CR; Guilmette, E; Pauletti, A; Piro, JR; Porcu, L; Rizzi, M; Salamone, A; Samad, TA; Sheehan, MJ; Terrone, G; Vezzani, A; Villa, BR, 2018)
"Seizures affect about 50 million people around the world."1.48Clarified Açaí ( ( Arrifano, GPF; Carvalho, JCT; Crespo-López, ME; Farina, M; Lichtenstein, MP; Rogez, H; Souza-Monteiro, JR; Suñol, C, 2018)
"Cunaniol-induced seizures displayed a cyclic development of electrocorticographic seizures, presenting interictal-like spike and ictal period, which correlates to the behavioral observations and is in line with acute seizures induced by pentylenetetrazole."1.48Cunaniol-elicited seizures: Behavior characterization and electroencephalographic analyses. ( Barbas, LAL; de Mello, VJ; do Nascimento, JLM; Dos Santos Batista, L; Dos Santos Batista, P; Farias, RAF; Gomes-Leal, W; Hamoy, M; Hutchison, WD; Marcondes, HC; Taylor, JG; Torres, MF, 2018)
" The dose-response curve for diazepam indicated that the 0."1.48Sensitivity to diazepam after a single session of forced swim stress in weaning Wistar rats. ( Bernal-Morales, B; Contreras, CM; Cueto-Escobedo, J; Guillén-Ruiz, G; Rodríguez-Landa, JF, 2018)
"Riluzole is an antiglutamatergic agent and the only drug to offer some effect on the life expectancy of ALS patients."1.46Excitatory-inhibitory imbalance in the brain of the wobbler mouse model of amyotrophic lateral sclerosis substantiated by riluzole and diazepam. ( Andreasen, SR; Christensen, TB; Holm, MM; Lundbye, CJ; Schmitt-John, T; Thielsen, KD, 2017)
"Diazepam, however, was more effective than escitalopram in suppressing MB."1.46Marble burying as compulsive behaviors in male and female mice. ( Chourbaji, S; Lerch, S; Taylor, GT, 2017)
"Diazepam (2mg/kg) was used as positive control."1.46Anxiolytic properties of N-acetylcysteine in mice. ( Benvenutti, R; Elisabetsky, E; Gama, CS; Giongo, F; Herrmann, AP; Noetzold, G; Piato, AL; Santos, P, 2017)
"Humanin (HN) is an endogenous 24-residue peptide."1.46Humanin ameliorates diazepam-induced memory deficit in mice. ( Maruyama, T; Murakami, M; Nagahama, M; Niikura, T, 2017)
"Febrile seizures are the most common type of convulsive events in children."1.43Forebrain-independent generation of hyperthermic convulsions in infant rats. ( Blumberg, MS; Kaila, K; Pospelov, AS; Puskarjov, M; Yukin, AY, 2016)
" Moreover, chronic administration of EA at dose 30 mg/kg ameliorated the memory deficit induced by diazepam (1 mg/kg, i."1.43Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments. ( Farbood, Y; Mansouri, MT; Mirshekar, MA; Naghizadeh, B; Sarkaki, A; Shabani, S, 2016)
"Recently, the use of acute seizure tests in epileptic rats or mice has been proposed as a novel strategy for evaluating novel AEDs for increased antiseizure efficacy."1.43Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures. ( Löscher, W; Töllner, K; Twele, F, 2016)
"Diazepam treated animals showed significant alterations in the neurobehavior and neuro-histoarchitecture, which were improved after X-irradiation."1.43Low dose X-irradiation mitigates diazepam induced depression in rat brain. ( Dhawan, DK; Kaur, A; Singla, N, 2016)
"Hypothermia is proposed to be an index of nausea in rats."1.43Autonomic changes induced by provocative motion in rats bred for high (HAB) and low (LAB) anxiety-related behavior: Paradoxical responses in LAB animals. ( Andrews, PL; Carnevali, L; Nalivaiko, E; Neumann, ID; Sgoifo, A, 2016)
"Curcumin is a biologically active phytochemical presents in turmeric and has pharmacological actions that benefit patients with depression and anxiety."1.42The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. ( Li, J; Pan, J; Wang, R; Wu, S; Xie, X; Xu, Y; Yu, X; Yu, Y; Zheng, L, 2015)
"Diazepam was used as reference anticonvulsant drug."1.42Anticonvulsant activity of the ethanolic extract of Punica granatum L. seed. ( FallahHuseini, H; Ghaznavi, H; Gholamine, B; Hosseinzadeh, A; Mehrzadi, S; Sadr, S; Shahbazi, A, 2015)
"Pilocarpine-induced SE was used to determine if COX-2 inhibition with NS-398, when administered alone or with diazepam, decreases the duration and/or intensity of SE and/or reduces neuronal injury in the rat hippocampus."1.42Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus. ( Dudek, FE; Ekstrand, JJ; Pouliot, WA; Trandafir, CC, 2015)
"In a first step, we examined anti-seizure effects of 6 AEDs on spontaneous recurrent focal electrographic seizures and secondarily generalized convulsive seizures in epileptic mice, showing that the focal nonconvulsive seizures were resistant to carbamazepine and phenytoin, whereas valproate and levetiracetam exerted moderate and phenobarbital and diazepam marked anti-seizure effects."1.42Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. ( Bankstahl, M; Klein, S; Löscher, W, 2015)
"The pilocarpine model of TLE has been widely used to study characteristics of human TLE, including behavioral comorbidities."1.42Evaluation of potential gender-related differences in behavioral and cognitive alterations following pilocarpine-induced status epilepticus in C57BL/6 mice. ( Fighera, MR; Funck, VR; Furian, AF; Grigoletto, J; Oliveira, CV; Oliveira, MS; Ribeiro, LR; Royes, LF, 2015)
"Treatment-resistant seizures affect about a third of patients suffering from epilepsy."1.42Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish. ( Afrikanova, T; Buenafe, OE; Crawford, AD; De Prins, A; de Witte, PA; Esguerra, CV; Kaminski, RM; Langlois, M; Leclercq, K; Rospo, CC; Smolders, I; Van Eeckhaut, A, 2015)
"Tetramethylenedisulfotetramine (TETS) is a potent convulsant GABAA receptor blocker."1.42Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. ( Austin, AT; Bruun, DA; Cao, Z; Hammock, BD; Hulsizer, S; Inceoglu, B; Lein, PJ; Pessah, IN; Rogawski, MA; Tancredi, DJ; Vito, ST, 2015)
"In mice, influenza induced dynamic changes in immune cell GABAA subunit expression: α1 subunits decreased on alveolar macrophage, but increased on monocytes, CD4+ and CD8+ T cells."1.42Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection. ( Godlee, A; Goulding, J; Grover, V; Gurney, S; Hussell, T; Ma, D; Maze, M; Sanders, RD; Singh, S; Snelgrove, R, 2015)
"Pain is the most common reason a patient sees a physician."1.40Antinociceptive properties of physalins from Physalis angulata. ( Evangelista, AF; Lima, Mda S; Pereira Soares, MB; Ribeiro, IM; Santos, GG; Tomassini, TC; Villarreal, CF, 2014)
"Trials of novel compounds for the treatment of schizophrenia are typically tested in patients following brief withdrawal of ongoing medication despite known long-term changes in the dopamine (DA) system following chronic antipsychotic drug therapy."1.40Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. ( Cook, JM; Gill, KM; Grace, AA; Poe, MM, 2014)
"Paraoxon (POX) is an active metabolite of organophosphate (OP) pesticide parathion that has been weaponized and used against civilian populations."1.40Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication. ( Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Phillips, KF, 2014)
" Although monoamine oxidase activity remained unaltered by oleanolic acid, chronic administration of oleanolic acid augmented hippocampal BDNF level."1.40Plurality of anxiety and depression alteration mechanism by oleanolic acid. ( Costa, EA; Da Rocha, FF; Fajemiroye, JO; Florentino, IF; Galdino, PM; Ghedini, PC; Polepally, PR; Zjawiony, JK, 2014)
"Tetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved antidote."1.40Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. ( Austin, AT; Banks, CN; Bruun, DA; Hammock, BD; Inceoglu, B; Lein, PJ; Rogawski, MA; Tancredi, DJ; Vito, ST; Zolkowska, D, 2014)
"Spontaneous epileptic seizures in this model are known to be resistant to major antiepileptic drugs."1.40Low doses of ethanol markedly potentiate the anti-seizure effect of diazepam in a mouse model of difficult-to-treat focal seizures. ( Bankstahl, M; Gramer, M; Hausknecht, M; Klein, S; Löscher, W, 2014)
"Spontaneous seizures occurred in the 1, 2 and 4 h SE groups, and the seizure frequency increased with the prolongation of SE."1.39One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death. ( Chen, LL; Feng, HF; Mao, XX; Ye, Q; Zeng, LH, 2013)
" The doses of modulators were selected on the basis of dose-response studies."1.39Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam. ( Bhutada, P; Deshmukh, P; Dixit, P; Kaulaskar, S; Thakur, K, 2013)
"Diazepam-induced sleep was used for the evaluation of the sedative properties."1.39The anticonvulsant and sedative effects of Gladiolus dalenii extracts in mice. ( Moto, FC; Ngah, E; Ngo Bum, E; Ngoupaye, GT; Rakotonirina, A; Rakotonirina, SV; Taiwe, GS; Talla, E, 2013)
"CD-1 mice were dosed with Bacille Calmette-Guérin (BCG) and measures of body weight, locomotor activity, and immobility in the tail suspension test (TST) were made."1.39A depressive phenotype induced by Bacille Calmette Guérin in 'susceptible' animals: sensitivity to antidepressants. ( Clark, JA; Klee, N; Nizami, M; Platt, B; Schulenberg, J, 2013)
"Pretreatment with diazepam (DZP) significantly attenuated seizure severity."1.39Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization. ( Baggio, S; Battastini, AM; Calcagnotto, ME; Campos, MM; de Oliveira, DL; Dias, RD; Leite, CE; Moro, L; Mussulini, BH; Rico, EP; Rosemberg, DB; Souza, TM; Zenki, KC, 2013)
"Phenytoin has two important properties that are advantageous for assessing the validity of the theta suppression model: 1) it is a standard antiepileptic drug with no known anxiolytic effects, and 2) its primary mechanism of action is through suppression of the persistent sodium current, an effect that should also suppress hippocampal theta."1.38A critical test of the hippocampal theta model of anxiolytic drug action. ( Dickson, CT; Treit, D; Yeung, M, 2012)
"CFA-induced mechanical allodynia resulted in increased anxiety-like behaviors as evidenced by: (1) a significant decrease in percentage of time spent and number of entries in open arms of the elevated-plus maze (EPM), (2) a decrease in number of central squares visited in the open field (OF), and (3) a reduction in active social interactions in the social interaction test (SI)."1.38Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. ( Beaudet, N; Beaudry, H; Bergeron, J; Bérubé, P; Drolet, G; Gendron, L; Parent, AJ; Sarret, P, 2012)
"Gabapentin was used to provide an anxiolytic effect on drug-free days."1.38Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. ( Açikmeşe, B; Enginar, N; Hatipoğlu, I; Haznedar, S, 2012)
"Pretreatment with clonidine or yohimbine failed to affect basal plasma corticosterone and ACTH concentrations, but abolished diazepam-induced inhibition of the HPA axis activity."1.38The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats. ( Muck-Šeler, D; Pivac, N; Švob Štrac, D, 2012)
" We used male NMRI mice (28-32 g) and first established the dose-response relationship for pilocarpine (250-400 mg/kg; ip) to induce status epilepticus (SE)."1.38Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. ( Kaminski, RM; Kumar, G; Mazzuferi, M; Rospo, C, 2012)
"Flumazenil treatment before BCAO reduced ischaemic neuronal damage exacerbated by benzodiazepine tolerance (P<0."1.38Effects of diazepam and flumazenil on forebrain ischaemia in a rat model of benzodiazepine tolerance. ( Furuya, H; Inoue, S; Iwata, M; Kawaguchi, M, 2012)
"CSL also reversed successfully the memory deficits induced by scopolamine (0."1.37Reversal of memory deficits by Coriandrum sativum leaves in mice. ( Abdul Majeed, AB; Mani, V; Parle, M; Ramasamy, K, 2011)
"Diazepam (2mg/kg) was also tested at three times during the 24-h day in the elevated plus maze: at the beginning and end of the lights-on period (Zeitgeber times 23 and 11, respectively) and once in the dark just before the room lights came on (Zeitgeber time 20)."1.37The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam. ( Batista, N; Delagrange, P; Gannon, RL; Hester, I; Huntley, C; Lungwitz, E; Millan, MJ; Peacock, A, 2011)
"Temporal lobe epilepsy is prevalent and can be difficult to treat effectively."1.37Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. ( Buckmaster, PS; Lew, FH, 2011)
"Diazepam effects were blocked by flumazenil."1.37Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. ( Cardenas, R; Quintero, L; Suarez-Roca, H, 2011)
"Epilepsy affects 0."1.37Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats. ( Cammarota, M; DaCosta, JC; Greggio, S; Machado, DC; Marinowic, DR; Venturin, GT; Zanirati, G, 2011)
"Imidazenil is an imidazo-benzodiazepine derivative with high intrinsic efficacy and selectivity for α2-, α3-, and α5- but low intrinsic efficacy for α1-containing GABA(A) receptors."1.37Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage. ( Auta, J; Davis, JM; Gocel, J; Guidotti, A; Kadriu, B; Larson, J; Nambiar, MP, 2011)
"pramipexole) known to produce compulsive behaviors in humans would increase marble burying."1.37Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. ( Jimenez-Gomez, C; Osentoski, A; Woods, JH, 2011)
"Epilepsy is a common and refractory neurological disorder, but the neuronal regulatory mechanisms of epileptogenesis remain largely unclear."1.37Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. ( Hu, XL; Liu, YY; Mei, L; Tan, GH; Xiong, ZQ; Yin, DM, 2011)
"The effects of GB-115 dipeptide, a retroanalog of endogenous CCK-4, on the behavioral indices in "elevated plus maze" (EPM) test and on the content of biogenic amines in the brain structures after discontinuation of a chronic administration of benzodiazepine (BZ) derivatives phenazepam (2."1.37[Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome]. ( Gudasheva, TA; Kadnikov, IA; Kolik, LG; Seredenin, SB; Zhukov, VN, 2011)
"The presence of multiple seizures prior to medical treatment has been suggested as a potential predictor of poor outcome."1.36High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy. ( Brandt, C; Löscher, W, 2010)
"Diazepam and phenytoin were administered intraperitoneally at doses of 2 and 30 mg/kg, respectively, and brain and plasma concentrations were determined 60 min after administration using liquid chromatography-mass spectrometry."1.36Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy. ( Charman, SA; Davies, PJ; Nicolazzo, JA; Petrou, S; Steuten, JA; Taylor, N, 2010)
"The latency for development of convulsions and mortality rate was recorded in these models using mice."1.36Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. ( Bansod, K; Bhutada, P; Dixit, P; Mundhada, D; Mundhada, Y; Umathe, S, 2010)
"Muscimol was effective in reducing AEP in both LA and HA rats."1.36GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure. ( Brandão, ML; Cabral, A; Nobre, MJ, 2010)
"Diazepam was used as a positive control."1.35Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice. ( Barron, S; Farook, JM; Krazem, A; Lewis, B; Littleton, JM; Morrell, DJ, 2008)
"To observe yin deficiency model mice anxiety action by means of the elevated plus-maze and light-dark transitions of mice."1.35[Effects of Semen Ziziphi Spinosae on the anxiety behavior of the yin deficiency mice]. ( Cui, Y; Dai, YX; Rong, CL, 2008)
"Diazepam significantly increase incidence of paradoxical sleep episodes with maximal duration till to 5 min."1.35Influence of diazepam on different behavioral states of sleep-waking cycle. ( Chkhartishvili, E; Dzadzamia, Sh; Mchedlidze, O; Nachkebia, N; Oniani, T, 2009)
"The anxiolytic activity and adverse benzodiazepine-like effects of a bovine alpha s1-casein tryptic hydrolysate (CH) were evaluated."1.35Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats. ( Desor, D; Lalonde, R; Messaoudi, M; Schroeder, H, 2009)
"Diazepam (DIZ) was used as anticonvulsant."1.35A substance in broad beans (Vicia faba) is protective against experimentally induced convulsions in mice. ( Mustafa, AA; Salih, MA, 2008)
" Data obtained showed an anxiolytic- and anxiogenic-like profile of the chronic intake of and withdrawal from diazepam regimen in the EPM test, 22-KHz USV and startle reflex."1.35Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats. ( Brandão, ML; Castilho, VM; De Ross, J; Nobre, MJ, 2008)
"The treatment with haloperidol worsened the adverse effects of chronic social stress having effects similar to stress on reward and motivation-related behaviours."1.35Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam. ( Abumaria, N; Flügge, G; Fuchs, E; Havemann-Reinecke, U; Hiemke, C; Rüther, E; Rygula, R; Zernig, G, 2008)
"A pharmacological model of migraine is described using ultrasound vocalization (USV) of rats following central inflammation-induced sensitization to tactile stimulation."1.35Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo. ( Martino, G; Perkins, MN, 2008)
"In addition, convulsions induced by lithium-methomyl treatment were associated with widespread neurodegeneration of limbic structures."1.34Lithium-methomyl induced seizures in rats: a new model of status epilepticus? ( Blaszczak, P; Calderazzo, L; Cavalheiro, EA; Dekundy, A; Kaminski, RM; Parada-Turska, J; Turski, WA, 2007)
"The current first line treatment of status epilepticus (SE) is based on the use of compounds that enhance GABAergic transmission or block sodium channels."1.34Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat. ( Mathiesen, C; Møller, A; Nissinen, J; Pitkänen, A; Rønn, LC, 2007)
"The aim of this study was to assess the efficacy of a structurally novel, potent, selective mGlu2/3 receptor agonist with improved bioavailability (LY404039) in animal models predictive of antipsychotic and anxiolytic efficacy."1.34In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. ( Griffey, KI; Johnson, BG; Knitowski, KM; McKinzie, DL; Monn, JA; Perry, KW; Rorick-Kehn, LM; Salhoff, CR; Schoepp, DD; Tizzano, JP; Witkin, JM, 2007)
"Levetiracetam (LEV) is a structurally novel antiepileptic drug (AED) which has demonstrated a broad spectrum of anticonvulsant activities both in experimental and clinical studies."1.34Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. ( Bethmann, K; Brandt, C; Fedrowitz, M; Gastens, AM; Glien, M; Löscher, W; Potschka, H; Volk, HA, 2007)
"A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for the GABA(A)alpha2 and -alpha3 subtypes is reported."1.33Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders. ( Atack, JR; Blackaby, WP; Brown, N; Castro, JL; Cook, SM; Crawforth, JM; Ferris, P; Goodacre, SC; Hallett, DJ; Kelly, S; Lewis, RT; Marshall, G; Owens, AP; Pike, A; Smith, AJ; Sohal, B; Stanley, J; Street, LJ; Wafford, KA, 2006)
"Chronic focal epilepsy was induced by injecting 25-50 ng of tetanus toxin or vehicle alone (controls) into the motor neocortex of rats."1.33Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat. ( Cock, HR; Nilsen, KE; Walker, MC, 2005)
"If epilepsy developed, the seizures were less frequent in DZP-treated animals compared to the vehicle group (median 16."1.33Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. ( Kharatishvili, I; Lukasiuk, K; Narkilahti, S; Nissinen, J; Pitkänen, A, 2005)
"Diazepam was used as a reference compound."1.33The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action. ( Chojnacka-Wójcik, E; Kłodzińska, A; Tatarczyńska, E, 2005)
"Rodent seizure models have significantly contributed to our basic understanding of epilepsy."1.33Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. ( Baier, H; Baraban, SC; Castro, PA; Taylor, MR, 2005)
"Increased seizure duration [3,522 +/- 660 sec (SEM) vs."1.33Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. ( Allan, SM; Davies, RE; Heenan, LE; Patel, HC; Ross, FM; Rothwell, NJ, 2006)
"Rats treated with isoflurane had the best cognitive recovery (p < 0."1.33Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats. ( Alexander, H; Clark, RS; Dixon, CE; Jenkins, L; Kochanek, PM; Statler, KD; Vagni, V, 2006)
"Onset, duration of clonic convulsions and percentage mortality/recovery were recorded."1.33Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action. ( Dhir, A; Kulkarni, SK; Naidu, PS, 2006)
"Pre-treatment with diazepam, 10 and 20mg/kg, and chlormethiazole, 50 and 100mg/kg, attenuated the development of hyperthermia."1.32Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2003)
"Numbers of ictal events (seizure) and latency to the first event were reduced by prophylactic DZP."1.32Diazepam prophylaxis for bicuculline-induced seizures: a rat dose-response model. ( Anschel, DJ; Fisher, RS; Ortega, E, 2004)
"Treatment with imipramine (3 x 30 mg/kg i."1.32Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances? ( Allain, H; Amiot, N; Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Reymann, JM, 2004)
"Using an amygdala-kindled seizure paradigm, we evaluated the acute and chronic anticonvulsant effects of lamotrigine (LTG)."1.31Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. ( Heynen, T; Krupp, E; Li, XL; Post, RM; Weiss, SR, 2000)
"Pretreatment with diazepam (0."1.31Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice. ( Cazala, P; David, V; Gold, LH; Koob, GF, 2001)
"The decrease in the seizure threshold for pentylenetetrazole during diazepam withdrawal was inhibited by pretreatment with MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cycloheptan-5,10-imine maleate), 7-chlorokynurenic acid and ifenprodil."1.30Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists. ( Misawa, M; Suzuki, T; Tsuda, M, 1997)
"Like devazepide, IQM-95,333 was a more potent antagonist of CCK-8S- than of CCK-4-induced contraction of the longitudinal muscle from guinea-pig ileum, suggesting selective antagonism at CCKA receptors."1.30Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models. ( Ballaz, S; Barber, A; Del Río, J; Fortuño, A; García-López, MT; Gómez-Monterrey, I; González-Muñiz, R; Herranz, R; Martin-Martínez, M, 1997)
"Pretreatment with diazepam completely prevents both penicillin-induced hypothermia and SWDs."1.30The connection between absence-like seizures and hypothermia induced by penicillin: possible implication on other animal models of petit mal epilepsy. ( Car, M; Ostojić, ZS; Rakić, L; Ruzdijić, S; Veskov, R, 1997)
"Myoclonic, clonic and tonic seizures were induced by i."1.29Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. ( Hönack, D; Löscher, W; Rundfeldt, C; Wlaź, P, 1995)
"After baseline recordings, seizures were induced with a pentylenetetrazol (PTZ) bolus and a 20 min infusion (5-6 mg/kg/min)."1.29Respiratory drive during status epilepticus and its treatment: comparison of diazepam and lorazepam. ( Fordyce, WE; Terndrup, TE, 1995)
"Pretreatment with diazepam (1."1.29Observations of novel behaviors as indices of ethanol withdrawal-induced anxiety. ( Knapp, DJ; Pohorecky, LA; Saiers, JA, 1993)
" Chronic administration of the selective serotonin re-uptake inhibitors fluoxetine and clomipramine (CMI) at 5 mg/kg per day and fluvoxamine at 10 mg/kg twice a day significantly decreased schedule-induced polydipsia (SIP) on day 15 and throughout the remainder of the study compared to control rats."1.29Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. ( Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A, 1993)
"Abecarnil is a beta-carboline agonist at benzodiazepine receptors with potent anxiolytic activity but no muscle relaxant side effects in rodents."1.29Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam. ( Stephens, DN; Turski, L, 1993)
"(-)-Baclofen was the only one of the three compounds tested that reversed in a dose-dependent manner the effects of tone exposure on both the amplitude of the click-evoked potentials recorded from the IC and on measures of the changes in temporal integration based on these potentials."1.29Effects of (-)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. ( Møller, AR; Szczepaniak, WS, 1996)
" Animals pretreated with this hepatotoxic agent showed a significant prolongation in the half-life of diazepam in plasma that is due more to an increase in volume of distribution rather than to a decrease in clearance."1.28Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury. ( Díaz-García, JM; Fos-Galve, D; Oliver-Botana, J, 1992)
"Evidence suggests that soman-induced convulsions may be associated with postexposure brain neuropathology."1.28Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. ( Capacio, BR; Koviak, TA; Shih, TM, 1991)
" In addition, the rewarding efficacy of the cocaine dosing parameters was subsequently confirmed in the runway subjects by conditioned place preference."1.28Animal model for investigating the anxiogenic effects of self-administered cocaine. ( Ettenberg, A; Geist, TD, 1991)
"Caffeine treatment at the dose 10 mg/kg b."1.28Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression. ( Golda, V; Petr, R, 1990)
"Diazepam treatment alleviates in the first session aversion towards open space and hight in the elevated plus-maze only in the genetically hypertensive rats of both sexes and in the normotensive males."1.28Animal model of anxiety: effect of acute diazepam treatment in the older adult genetically hypertensive rats of Koletsky type and in the older adult rats of Wistar strain. ( Golda, V; Petr, R, 1989)
"Diazepam treatment significantly reduced the frequency of dystonic movements in the mutant."1.27Alterations in cerebellar glutamic acid decarboxylase (GAD) activity in a genetic model of torsion dystonia (rat). ( Beales, M; Gordon, JH; Lorden, JF; Oltmans, GA, 1984)
" Improvement occurred after a single dose of the anxiolytic drugs but did not occur until 10-18 days after daily dosing with standard tricylic antidepressants and the MAO inhibitor isocarboxazid."1.27Effects of selected drugs on spontaneously occurring abnormal behavior in beagles. ( Barnett, A; Brody, PE; Eisenstein, N; Iorio, LC, 1983)
"QUIN seizures showed particular sensitivity to carbamazepine (5 mg/kg) but were resistant to diphenylhydantoin unless a relatively high dose was used (100 mg/kg)."1.27Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. ( Samanin, R; Tullii, M; Vezzani, A; Wu, HQ, 1986)
" +/- Pindolol, an antagonist at 5-HT1 receptors, showed a biphasic dose-response curve with a fall in entry ratio at one high dose."1.27Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. ( Critchley, MA; Handley, SL, 1987)
" These data suggest that antidepressants acquire anxiolytic properties following chronic administration and that this effect appears to be independent of the benzodiazepine receptor system."1.27The effects of chronic antidepressant treatment in an animal model of anxiety. ( Aitken, DH; Bodnoff, SR; Meaney, MJ; Quirion, R; Suranyi-Cadotte, B, 1988)
" In a separate experiment, Ro 15-1788 produced a PTZ-like stimulus when given at 2-day intervals during chronic administration of DZP."1.27Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. ( Emmett-Oglesby, MW; Harris, CM; Idemudia, SO; Lal, H; Mathis, DA, 1988)
"Carbamazepine and phenytoin were ineffective or aggravated the seizures."1.27Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat. ( Depaulis, A; Marescaux, C; Micheletti, G; Reis, J; Rumbach, L; Vergnes, M; Warter, JM, 1985)
"The "spontaneous" myoclonus which followed vermisectomy (MV) was "massive", but involved firstly the trunk and secondarily the face and limbs; no ECoG paraoxysm accompanied this myoclonus, but we observed a parietal evoked potential of small amplitude, 10--15 msec after its onset."1.26Myoclonus developing after vermisectomy in photosensitive Papio papio. ( Brailowsky, S; Menini, C; Naquet, R, 1978)
"Phenytoin and diazepam were maximally effective at concentrations of 20 microgram/ml and 3-4 microgram/ml, respectively, in good agreement with their effective concentrations in clinical practice."1.26The hippocampal slice: a system for studying the pharmacology of seizures and for screening anticonvulsant drugs. ( Hoffer, BJ; Oliver, AP; Wyatt, RJ, 1977)
"Of particular importance are the arrhythmias observed immediately after experimentally induced acute myocardial infarction (AMI)."1.25Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system. ( Kniffen, FJ; Lucchesi, BR, 1975)

Research

Studies (488)

TimeframeStudies, this research(%)All Research%
pre-199063 (12.91)18.7374
1990's61 (12.50)18.2507
2000's131 (26.84)29.6817
2010's204 (41.80)24.3611
2020's29 (5.94)2.80

Authors

AuthorsStudies
Goodacre, SC1
Street, LJ1
Hallett, DJ1
Crawforth, JM1
Kelly, S1
Owens, AP1
Blackaby, WP1
Lewis, RT1
Stanley, J1
Smith, AJ1
Ferris, P1
Sohal, B1
Cook, SM1
Pike, A1
Brown, N1
Wafford, KA1
Marshall, G1
Castro, JL1
Atack, JR2
Herrera-Ruiz, M1
González-Cortazar, M1
Jiménez-Ferrer, E1
Zamilpa, A1
Alvarez, L1
Ramírez, G1
Tortoriello, J1
Liu, H2
Altenbach, RJ1
Carr, TL1
Chandran, P1
Hsieh, GC1
Lewis, LG1
Manelli, AM1
Milicic, I1
Marsh, KC1
Miller, TR1
Strakhova, MI1
Vortherms, TA1
Wakefield, BD1
Wetter, JM1
Witte, DG1
Honore, P1
Esbenshade, TA1
Brioni, JD1
Cowart, MD1
Avdeef, A1
Tam, KY1
Lima, Mda S1
Evangelista, AF1
Santos, GG1
Ribeiro, IM1
Tomassini, TC1
Pereira Soares, MB1
Villarreal, CF1
Nikalje, APG1
Shaikh, AN1
Shaikh, SI1
Kalam Khan, FA1
Sangshetti, JN1
Shinde, DB1
Zagórska, A1
Kołaczkowski, M1
Bucki, A1
Siwek, A1
Kazek, G1
Satała, G1
Bojarski, AJ1
Partyka, A1
Wesołowska, A3
Pawłowski, M1
Eltahawy, NA1
Ibrahim, AK1
Radwan, MM1
Zaitone, SA1
Gomaa, M1
ElSohly, MA1
Hassanean, HA1
Ahmed, SA1
Gunia-Krzyżak, A1
Żelaszczyk, D1
Rapacz, A1
Żesławska, E1
Waszkielewicz, AM1
Pańczyk, K1
Słoczyńska, K1
Pękala, E1
Nitek, W1
Filipek, B1
Marona, H1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Said, ES1
Elsayed, AM1
Rashed, LA1
Nadwa, EH1
Alsuhaibani, NA1
Alfuraih, BS1
Mahmoud, RH1
Loeza-Alcocer, E1
Gold, MS1
Zhou, R1
Wang, Y3
Cao, X1
Li, Z1
Yu, J2
West, PJ1
Thomson, K1
Billingsley, P1
Pruess, T1
Rueda, C1
Saunders, GW1
Smith, MD1
Metcalf, CS1
Wilcox, KS1
Gurrell, R1
Iredale, P1
Evrard, A1
Duveau, V1
Ruggiero, C1
Roucard, C1
Fontana, BD1
Parker, MO2
de Lima Rosa, G1
Guzzo, EFM1
Nunes, SEB1
Padilha, RB1
Domingues, AM1
Barbosa, BB1
Siqueira, IR1
Coitinho, AS2
Boudjafad, Z1
Lguensat, A1
Elmardadi, K1
Dahi, A1
Bennis, M1
Ba-M'hamed, S1
Garcia, R1
Danis, A1
Baranoglu Kilinc, Y1
Torun, IE2
Hanci, F1
Kilinc, E1
Ankarali, H1
Türel, CA1
Çelik, H1
Çetinkaya, A1
Türel, İ1
de Labra, C1
Cudeiro, J1
Rivadulla, C1
Tsutsumi, H1
Yonemitsu, K1
Sasao, A1
Ohtsu, Y1
Furukawa, S1
Nishitani, Y1
Walia, V1
Garg, C1
Garg, M1
Aghamiri, H1
Shafaroodi, H1
Asgarpanah, J1
Tiraboschi, E1
Martina, S1
van der Ent, W1
Grzyb, K1
Gawel, K1
Cordero-Maldonado, ML1
Poovathingal, SK1
Heintz, S1
Satheesh, SV1
Brattespe, J1
Xu, J1
Suster, M1
Skupin, A1
Esguerra, CV2
Ren, XJ1
Wang, GY1
Zhang, XP1
Wang, QQ1
Peng, ZP1
Rojas, A1
Wang, J1
Glover, A1
Dingledine, R1
Ramos-Hryb, AB1
Ramirez, MF1
Lino-de-Oliveira, C1
Pagani, MR1
Yu, Y2
Li, L1
Nguyen, DT1
Mustafa, SM1
Moore, BM1
Jiang, J1
Fortea, JI1
Puerto, M1
Fernández-Mena, C1
Asensio, I1
Arriba, M1
Almagro, J1
Bañares, J1
Ripoll, C1
Bañares, R1
Vaquero, J1
Nascimento, GC1
Malzone, BL1
Iyomasa, DM1
Pereira, YCL1
Issa, JPM1
Leite-Panissi, CRA1
Watanabe, IS1
Iyomasa, MM1
Fuentes, R1
Del Bel, E1
Dias, FJ1
Koneval, Z1
Knox, KM1
Memon, A1
Zierath, DK1
White, HS1
Barker-Haliski, M1
Matias Pereira, AC1
Sánchez-Ortíz, BL1
de Melo, EL1
da Silva Hage-Melim, LI1
Borges, RS1
Hu, X1
Carvalho, JCT2
Fokoua, AR1
Ndjenda, MK1
Kaptué Wuyt, A1
Tatsinkou Bomba, FD1
Dongmo, AK1
Chouna, R1
Nkeng-Efouet, PA1
Nguelefack, TB1
Victorino, DB1
Pinheiro, DJLL1
Scott-McKean, JJ1
Barker, S1
Stasko, MR1
Faber, J1
Scorza, CA1
Costa, ACS1
Macías-Carballo, M1
Rosas-Navarro, S1
López-Meraz, ML2
Beltran-Parrazal, L1
Morgado-Valle, C1
Falcón, CR1
Hurst, NF1
Vivinetto, AL1
López, PHH1
Zurita, A1
Gatti, G1
Cervi, L1
Monferran, CG1
Roth, GA2
González-Trujano, ME2
Hernández-Sánchez, LY1
Muñoz Ocotero, V1
Dorazco-González, A1
Guevara Fefer, P1
Aguirre-Hernández, E1
Xiao, Z1
Peng, J1
Gan, N1
Arafat, A1
Yin, F1
Yoshizawa, K1
Okumura, A1
Nakashima, K1
Sato, T1
Higashi, T1
Mante, PK2
Adongo, DW2
Woode, E2
Maggio, N1
Shavit Stein, E1
Segal, M2
Kuniishi, H1
Ichisaka, S1
Yamamoto, M1
Ikubo, N1
Matsuda, S1
Futora, E1
Harada, R1
Ishihara, K1
Hata, Y1
Niquet, J2
Suchomelova, L2
Thompson, K1
Klitgaard, H2
Matagne, A2
Wasterlain, C1
Benneh, CK1
Biney, RP1
Tandoh, A1
Carreno-Munoz, MI1
Martins, F1
Medrano, MC1
Aloisi, E1
Pietropaolo, S1
Dechaud, C1
Subashi, E1
Bony, G1
Ginger, M1
Moujahid, A1
Frick, A1
Leinekugel, X1
Umeda, T1
Kimura, T1
Yoshida, K1
Takao, K2
Fujita, Y1
Matsuyama, S1
Sakai, A1
Yamashita, M1
Yamashita, Y1
Ohnishi, K1
Suzuki, M1
Takuma, H1
Miyakawa, T1
Takashima, A1
Morita, T1
Mori, H1
Tomiyama, T1
Mesdaghinia, A1
Alinejad, M1
Abed, A1
Heydari, A1
Banafshe, HR1
Andreasen, SR1
Lundbye, CJ1
Christensen, TB1
Thielsen, KD1
Schmitt-John, T1
Holm, MM1
Morud, J1
Strandberg, J1
Andrén, A1
Ericson, M1
Söderpalm, B1
Adermark, L1
Fernández Hurst, N1
Zanetti, SR1
Báez, NS1
Bibolini, MJ1
Bouzat, C1
da Costa E Silva, LD1
Pereira, P3
Regner, GG2
Boaretto, FBM1
Hoffmann, C1
Pflüger, P2
da Silva, LL2
Steffens, LR1
Morás, AM1
Moura, DJ1
Picada, JN2
Terrone, G1
Pauletti, A1
Salamone, A1
Rizzi, M1
Villa, BR1
Porcu, L1
Sheehan, MJ1
Guilmette, E1
Butler, CR1
Piro, JR1
Samad, TA1
Vezzani, A2
Kosari-Nasab, M2
Shokouhi, G2
Ghorbanihaghjo, A2
Abbasi, MM1
Salari, AA2
Taylor, GT1
Lerch, S1
Chourbaji, S1
Zhao, Y2
Lin, Z1
Chen, L3
Ouyang, L1
Gu, L1
Chen, F1
Zhang, Q2
Apland, JP1
Aroniadou-Anderjaska, V1
Figueiredo, TH1
Pidoplichko, VI1
Rossetti, K1
Braga, MFM1
Fraga, DB1
Olescowicz, G1
Moretti, M1
Siteneski, A1
Tavares, MK1
Azevedo, D1
Colla, ARS1
Rodrigues, ALS1
Gajbhiye, SV1
Tripathi, RK1
Petare, A1
Potey, AV1
Shankar, A1
Wilkerson, JL1
Curry, ZA1
Kinlow, PD1
Mason, BL1
Hsu, KL1
van der Stelt, M1
Cravatt, BF2
Lichtman, AH2
Sherdil, A1
Chabardès, S1
Guillemain, I1
Michallat, S1
Prabhu, S1
Pernet-Gallay, K1
David, O1
Piallat, B1
Tchekalarova, J1
da Conceição Machado, K1
Gomes Júnior, AL2
de Carvalho Melo Cavalcante, AA1
Momchilova, A1
Tzoneva, R1
Tonelli, LC1
Wöhr, M1
Schwarting, R1
Melo-Thomas, L1
Tchekalarova, JD1
Machado, KDC1
Moura, AKS1
Paz, MFCJ1
da Mata, AMOF1
Nogueira, TR1
Islam, MT1
Rios, MAS1
Graças Lopes Citó, AMD1
Uddin, SJ1
Shilpi, JA1
Das, AK1
Lopes, LDS1
Melo-Cavalcante, AAC1
Lima-Maximino, MG1
Cueto-Escobedo, J4
Rodríguez-Landa, JF5
Maximino, C1
Dominguez, G1
Henkous, N1
Pierard, C1
Belzung, C1
Mons, N1
Beracochea, D1
Arrifano, GPF1
Lichtenstein, MP1
Souza-Monteiro, JR1
Farina, M2
Rogez, H1
Suñol, C1
Crespo-López, ME1
Kuruba, R1
Wu, X1
Reddy, DS4
Kawano, T1
Oshibuchi, H1
Kawano, M1
Muraoka, H1
Tsutsumi, T1
Yamada, M1
Ishigooka, J1
Nishimura, K1
Inada, K1
Kunisawa, N1
Shimizu, S1
Kato, M1
Iha, HA1
Iwai, C1
Hashimura, M1
Ogawa, M1
Kawaji, S1
Kawakita, K1
Abe, K1
Ohno, Y1
Hamoy, M1
Dos Santos Batista, L1
de Mello, VJ1
Gomes-Leal, W1
Farias, RAF1
Dos Santos Batista, P1
do Nascimento, JLM1
Marcondes, HC1
Taylor, JG1
Hutchison, WD1
Torres, MF1
Barbas, LAL1
Tonetti Ciaramicoli, M1
Kabadayan, F1
Bernardi, MM1
Barbosa Suffredini, I1
Coury Saraceni, CH1
Stojiljković, MP1
Škrbić, R1
Jokanović, M1
Bokonjić, D1
Kilibarda, V1
Vulović, M1
Villasana, LE1
Peters, A1
McCallum, R1
Liu, C1
Schnell, E1
Venkatesh, G1
Sankar, V1
Ramanathan, M1
Mesgari-Abbasi, M1
Pantazis, CB1
Aston-Jones, G1
Wang, S1
Lévesque, M1
Avoli, M2
Bregin, A1
Mazitov, T1
Aug, I1
Philips, MA1
Innos, J1
Vasar, E1
Bernal-Morales, B3
Guillén-Ruiz, G2
Contreras, CM4
Li, Y1
Song, D1
Bo, F1
Deng, M1
Tang, X2
Chen, LL1
Feng, HF1
Mao, XX1
Ye, Q1
Zeng, LH1
Lee, DS1
Ryu, HJ1
Kim, JE1
Choi, HC1
Kim, YI1
Song, HK1
Kang, TC1
Sun, Y1
Evans, J1
Russell, B1
Kydd, R1
Connor, B1
Bhutada, P2
Dixit, P2
Thakur, K1
Deshmukh, P1
Kaulaskar, S1
Monsef-Esfahani, HR1
Amini, M1
Goodarzi, N1
Saiedmohammadi, F1
Hajiaghaee, R1
Faramarzi, MA1
Tofighi, Z1
Ghahremani, MH1
Besio, W1
Cuellar-Herrera, M1
Luna-Munguia, H1
Orozco-Suárez, S1
Rocha, L2
Ngoupaye, GT1
Ngo Bum, E1
Ngah, E1
Talla, E1
Moto, FC1
Taiwe, GS1
Rakotonirina, A1
Rakotonirina, SV1
Bhatt, S1
Mahesh, R1
Devadoss, T1
Jindal, A1
Hoeller, AA1
Duzzioni, M1
Duarte, FS1
Leme, LR1
Costa, AP1
Santos, EC1
de Pieri, CH1
dos Santos, AA1
Naime, AA1
de Lima, TC1
Nochi, R1
Kaneko, J1
Okada, N1
Terazono, Y1
Matani, A1
Hisatsune, T1
Zdebik, AA1
Mahmood, F1
Stanescu, HC1
Kleta, R1
Bockenhauer, D1
Russell, C1
Hazim, AI1
Ramanathan, S1
Parthasarathy, S1
Muzaimi, M1
Mansor, SM1
Gill, KM2
Cook, JM2
Poe, MM1
Grace, AA4
El Zahaf, NA1
Salem Elhwuegi, A1
Do, TM1
Alata, W1
Dodacki, A1
Traversy, MT1
Chacun, H1
Pradier, L1
Scherrmann, JM1
Farinotti, R1
Calon, F1
Bourasset, F1
Ahmad, A1
Vohora, D1
Deshpande, LS1
Carter, DS1
Phillips, KF1
Blair, RE2
DeLorenzo, RJ3
Wu, S2
Li, J1
Wang, R1
Xie, X1
Yu, X1
Pan, J1
Xu, Y1
Zheng, L1
de Moura, JC1
Noroes, MM1
Rachetti, Vde P1
Soares, BL1
Preti, D1
Nassini, R1
Materazzi, S1
Marone, IM1
Minocci, D1
Geppetti, P1
Gavioli, EC3
André, E2
Fajemiroye, JO1
Galdino, PM1
Florentino, IF1
Da Rocha, FF1
Ghedini, PC1
Polepally, PR1
Zjawiony, JK1
Costa, EA1
Quiroga, C1
Chaparro, RE1
Karlnoski, R1
Erasso, D1
Gordon, M1
Morgan, D1
Bosco, G1
Rubini, A1
Parmagnani, A1
Paoli, A1
Mangar, D1
Camporesi, EM1
Papp, M2
Gruca, P2
Lason-Tyburkiewicz, M1
Litwa, E2
Willner, P1
Gogolla, N1
Takesian, AE1
Feng, G1
Fagiolini, M1
Hensch, TK1
Gilhotra, N2
Dhingra, D2
Asadi-Shekaari, M1
Eslami, A1
Kalantaripour, T1
Joukar, S1
Gupta, D1
Radhakrishnan, M1
Kurhe, Y1
Solhjoo, S1
O'Rourke, B1
Mehrzadi, S1
Sadr, S1
Hosseinzadeh, A1
Gholamine, B1
Shahbazi, A1
FallahHuseini, H1
Ghaznavi, H1
Vito, ST2
Austin, AT2
Banks, CN1
Inceoglu, B2
Bruun, DA2
Zolkowska, D1
Tancredi, DJ2
Rogawski, MA5
Hammock, BD2
Lein, PJ2
Trandafir, CC1
Pouliot, WA1
Dudek, FE2
Ekstrand, JJ1
Klein, S3
Bankstahl, M2
Gramer, M1
Hausknecht, M1
Löscher, W13
Brandt, C3
Töllner, K2
Klee, R1
Bröer, S1
Kasahara, K1
Hashimoto, S1
Hattori, T1
Kawasaki, K1
Tsujita, R1
Nakazono, O1
Kawakubo, H1
Nagatani, T1
Oliveira, CV1
Grigoletto, J1
Funck, VR1
Ribeiro, LR1
Royes, LF1
Fighera, MR1
Furian, AF1
Oliveira, MS1
Leclercq, K2
Afrikanova, T1
Langlois, M1
De Prins, A1
Buenafe, OE1
Rospo, CC1
Van Eeckhaut, A1
de Witte, PA1
Crawford, AD1
Smolders, I2
Kaminski, RM4
Cao, Z1
Hulsizer, S1
Pessah, IN1
Sanders, RD1
Grover, V1
Goulding, J1
Godlee, A1
Gurney, S1
Snelgrove, R1
Ma, D1
Singh, S1
Maze, M1
Hussell, T1
Bulos, EM1
Pobbe, RL2
Zangrossi, H1
Puttachary, S1
Sharma, S1
Tse, K1
Beamer, E2
Sexton, A1
Crutison, J1
Thippeswamy, T2
Joshi, S1
Rajasekaran, K1
Hawk, KM1
Brar, J1
Ross, BM1
Tran, CA1
Chester, SJ1
Goodkin, HP1
Kubova, H1
Wasterlain, CG2
Giacomini, ACVV1
Abreu, MS1
Giacomini, LV1
Siebel, AM1
Zimerman, FF1
Rambo, CL1
Mocelin, R1
Bonan, CD1
Piato, AL2
Barcellos, LJG1
Luo, Y1
Hu, Q1
Hong, S1
Cheng, L1
Jiang, L1
Pospelov, AS1
Yukin, AY1
Blumberg, MS1
Puskarjov, M1
Kaila, K1
Stepan, J1
Hladky, F1
Uribe, A1
Holsboer, F2
Schmidt, MV1
Eder, M1
Rasgado, LA1
Reyes, GC1
Díaz, FV1
Gould, SA1
Doods, H1
Lamla, T1
Pekcec, A1
Mansouri, MT1
Farbood, Y1
Naghizadeh, B1
Shabani, S1
Mirshekar, MA1
Sarkaki, A1
Baiamonte, M1
Vinson, GP1
Brennan, CH1
Twele, F1
Du, Y2
Xu, ZH1
Tao, AF1
Wang, XY1
Zu, YY1
Zhang, SH1
Chen, Z1
Taguchi, R1
Shikata, K1
Furuya, Y1
Ino, M1
Shin, K1
Shibata, H1
Kaur, A1
Singla, N1
Dhawan, DK1
Song, Y1
Liu, J1
Ma, F1
Mao, L1
Zolotarev, YA1
Kovalev, GI1
Kost, NV1
Voevodina, ME1
Sokolov, OY1
Dadayan, AK1
Kondrakhin, EA1
Vasileva, EV1
Bogachuk, AP1
Azev, VN1
Lipkin, VM1
Myasoedov, NF1
Coelho, VR1
Vieira, CG1
de Souza, LP1
Papke, DK1
Vieira, V1
Glassmann, D1
Marafon, P1
Gomez, R1
Carnevali, L1
Andrews, PL1
Neumann, ID3
Nalivaiko, E1
Sgoifo, A1
Santos, P1
Herrmann, AP1
Benvenutti, R1
Noetzold, G1
Giongo, F1
Gama, CS1
Elisabetsky, E1
Murakami, M1
Nagahama, M1
Maruyama, T1
Niikura, T1
Onaolapo, AY1
Adebayo, AN1
Onaolapo, OJ1
Singh, J1
Kumar, A1
Sharma, A1
Hernandez-Leon, A1
Fernández-Guasti, A2
Santana-Gómez, CE1
Orozco-Suárez, SA1
Talevi, A1
Bruno-Blanch, L1
Magdaleno-Madrigal, VM1
Fernández-Mas, R1
Kasian, A1
Kolomin, T1
Andreeva, L1
Bondarenko, E1
Myasoedov, N1
Slominsky, P1
Shadrina, M1
Junqueira-Ayres, DD1
Asth, L2
Ayres, AS1
Lobão-Soares, B2
Soares-Rachetti, VP1
Auta, J2
Impagnatiello, F1
Kadriu, B2
Guidotti, A2
Costa, E1
Farook, JM1
Krazem, A1
Lewis, B1
Morrell, DJ1
Littleton, JM1
Barron, S1
Biagini, G1
Baldelli, E1
Longo, D1
Contri, MB1
Guerrini, U1
Sironi, L1
Gelosa, P1
Zini, I1
Ragsdale, DS1
Mikati, MA1
Zeinieh, M1
Habib, RA1
El Hokayem, J1
Rahmeh, A1
El Sabban, M1
Usta, J1
Dbaibo, G1
Stone, EA1
Lin, Y1
Quartermain, D1
Barros, M1
Maior, RS1
Huston, JP1
Tomaz, C2
Bankstahl, JP1
Hirase, M1
Ishida, T1
Kamei, C1
Knabl, J2
Zeilhofer, UB2
Crestani, F1
Rudolph, U3
Zeilhofer, HU2
Lehmkuhle, MJ1
Thomson, KE1
Scheerlinck, P1
Pouliot, W1
Greger, B1
Rong, CL1
Dai, YX1
Cui, Y1
Kaledin, VI1
Llnitskaya, SI1
Nikolin, VP1
Popova, NA1
Smagin, DA1
Kudryavtseva, NN1
Raol, YH1
Lapides, DA1
Keating, JG1
Brooks-Kayal, AR1
Cooper, EC1
Nachkebia, N1
Dzadzamia, Sh1
Chkhartishvili, E1
Mchedlidze, O1
Oniani, T1
Wang, NC1
Good, LB1
Marsh, ST1
Treiman, DM2
Singh, D1
Goel, RK1
Vasconcelos, SM1
Lima, SR1
Soares, PM1
Assreuy, AM1
de Sousa, FC1
Lobato, Rde F1
Vasconcelos, GS1
Santi-Gadelha, T1
Bezerra, EH1
Cavada, BS1
Patrocínio, MC1
Messaoudi, M1
Lalonde, R1
Schroeder, H1
Desor, D1
Porecha, S1
shah, T1
Jogani, V1
Naik, S1
Misra, A1
Umathe, SN1
Manna, SS1
Utturwar, KS1
Jain, NS1
Micale, V1
Cristino, L1
Tamburella, A1
Petrosino, S1
Leggio, GM1
Drago, F1
Di Marzo, V1
Bencan, Z1
Sledge, D1
Levin, ED1
Fritsch, B1
Stott, JJ1
Joelle Donofrio, J1
Curio, M1
Jacone, H1
Perrut, J1
Pinto, AC1
Filho, VF1
Silva, RC1
Vinkers, CH1
Oosting, RS2
van Bogaert, MJ2
Olivier, B2
Groenink, L2
Coppola, A1
Moshé, SL2
Cysneiros, RM1
Ferrari, D1
Arida, RM1
Terra, VC1
de Almeida, AC1
Cavalheiro, EA4
Scorza, FA2
Bourin, M2
Hascoët, M1
Cachat, J1
Canavello, P1
Elegante, M1
Bartels, B1
Hart, P1
Bergner, C1
Egan, R1
Duncan, A1
Tien, D1
Chung, A1
Wong, K1
Goodspeed, J1
Tan, J1
Grimes, C1
Elkhayat, S1
Suciu, C1
Rosenberg, M1
Chung, KM1
Kadri, F1
Roy, S1
Gaikwad, S1
Stewart, A1
Zapolsky, I1
Gilder, T1
Mohnot, S1
Beeson, E1
Amri, H1
Zukowska, Z1
Soignier, RD1
Kalueff, AV2
Nicolazzo, JA1
Steuten, JA1
Charman, SA1
Taylor, N1
Davies, PJ1
Petrou, S1
Ennaceur, A1
Michalikova, S1
van Rensburg, R1
Chazot, PL1
Valcheva-Kuzmanova, S1
Zhelyazkova-Savova, M1
Matrisciano, F1
Nasca, C1
Molinaro, G1
Riozzi, B1
Scaccianoce, S1
Raggi, MA1
Mercolini, L1
Biagioni, F1
Mathè, AA1
Sanna, E1
Maciocco, E1
Pignatelli, M1
Biggio, G1
Nicoletti, F1
Prigol, M1
Wilhelm, EA1
Nogueira, CW1
Zeni, G1
Vermoesen, K1
Massie, A1
Michotte, Y1
Clinckers, R1
Gibson, CJ1
Meyer, RC1
Hamm, RJ1
Nicolas, LB1
Lopez-Lopez, C1
Jacobson, LH1
McArthur, SG1
Grundschober, C1
Prinssen, EP2
Jiménez-Velázquez, G1
López-Muñoz, FJ1
Casarrubea, M2
Sorbera, F2
Santangelo, A1
Crescimanno, G2
Jayaraman, R1
Manisenthil, KT1
Anitha, T1
Joshi, VD1
Palei, NN1
Gajera, K1
Ladani, K1
Hambrecht-Wiedbusch, VS1
Gauthier, EA1
Baghdoyan, HA1
Lydic, R1
Mundhada, Y1
Bansod, K1
Umathe, S1
Mundhada, D1
Kumar, R1
Murugananthan, G1
Nandakumar, K1
Talwar, S1
Joshi, V1
Arora, T1
Mehta, AK1
Sharma, AK1
Rathor, N1
Mehta, KD1
Mahajan, P1
Mediratta, PK1
Banerjee, BD1
Sharma, KK1
Lu, H1
Cheng, PL1
Lim, BK1
Khoshnevisrad, N1
Poo, MM1
Mani, V1
Parle, M1
Ramasamy, K1
Abdul Majeed, AB1
Nobre, MJ3
Cabral, A1
Brandão, ML3
Freeman-Daniels, E1
Beck, SG1
Kirby, LG1
Defensor, EB1
Pearson, BL1
Bolivar, VJ1
Blanchard, DC1
Blanchard, RJ1
Gannon, RL1
Lungwitz, E1
Batista, N1
Hester, I1
Huntley, C1
Peacock, A1
Delagrange, P1
Millan, MJ1
Feifel, D1
Shilling, PD1
Melendez, G1
Kinsey, SG1
O'Neal, ST1
Long, JZ1
Magnusson, MS1
Buckmaster, PS2
Lew, FH1
Karakaş, A1
Coşkun, H1
Kaya, A1
Kücük, A1
Gündüz, B1
Barrenha, GD1
Coon, LE1
Chester, JA1
Lodge, DJ1
Aras, S1
Perez-Mendes, P1
Blanco, MM1
Calcagnotto, ME2
Cinini, SM1
Bachiega, J1
Papoti, D1
Covolan, L1
Tannus, A1
Mello, LE1
Quintero, L1
Cardenas, R1
Suarez-Roca, H1
Venturin, GT1
Greggio, S1
Marinowic, DR1
Zanirati, G1
Cammarota, M1
Machado, DC1
DaCosta, JC1
Yeung, M1
Treit, D1
Dickson, CT1
Jeon, D1
Chu, K1
Lee, ST1
Jung, KH1
Kang, KM1
Ban, JJ1
Kim, S1
Seo, JS1
Won, CH1
Kim, M2
Lee, SK1
Roh, JK1
Jakovcevski, M1
Schachner, M1
Morellini, F1
Gocel, J1
Larson, J1
Davis, JM1
Nambiar, MP1
Wu, G1
Zhu, G1
Su, Y1
Chen, Y1
Sun, J1
Gutiérrez-García, AG2
Mendoza-López, MR2
García-Ríos, RI1
Jimenez-Gomez, C1
Osentoski, A1
Woods, JH1
Lkhagvasuren, B1
Nakamura, Y1
Oka, T1
Sudo, N1
Nakamura, K2
Stachowicz, K4
Wierońska, J1
Domin, H1
Chaki, S2
Pilc, A1
Sowemimo, AA1
Adio, O1
Fageyinbo, S1
Contó, MB1
Hipólide, DC1
de Carvalho, JG1
Venditti, MA1
Richendrfer, H1
Pelkowski, SD1
Colwill, RM1
Creton, R1
Tan, GH1
Liu, YY1
Hu, XL1
Yin, DM1
Mei, L1
Xiong, ZQ1
Wang, Z1
Dai, J1
Huang, Y1
Zhan, Z1
Fukuhara, A1
Nakajima, H1
Miyamoto, Y1
Inoue, K1
Kume, S1
Lee, YH1
Noda, M1
Uchiyama, S1
Shimamoto, S1
Nishimura, S1
Ohkubo, T1
Goto, Y1
Takeuchi, T1
Inui, T1
Toth, I1
Slattery, DA1
Kolik, LG1
Kadnikov, IA1
Zhukov, VN1
Gudasheva, TA1
Seredenin, SB1
Parent, AJ1
Beaudet, N1
Beaudry, H1
Bergeron, J1
Bérubé, P1
Drolet, G1
Sarret, P1
Gendron, L1
Goeldner, C1
Spooren, W1
Wichmann, J1
Heulens, I1
D'Hulst, C1
Van Dam, D1
De Deyn, PP1
Kooy, RF1
Açikmeşe, B1
Haznedar, S1
Hatipoğlu, I1
Enginar, N1
Kaziakhmetova, VN1
Valeeva, IKh1
Ziganshina, LE1
Santos Rosa, D1
Faggion, SA1
Gavin, AS1
Anderson de Souza, M1
Fachim, HA1
Ferreira dos Santos, W1
Soares Pereira, AM1
Cunha, AO2
Beleboni, RO1
Soares, Vde P1
Gould, J1
Gangisetty, O1
Sayers, KW1
Nguyen, PT1
Sim-Selley, LJ1
Tamaddonfard, E1
Hamzeh Gooshchi, N1
Seiednejad-Yamchi, S1
Ziv, L1
Muto, A1
Schoonheim, PJ1
Meijsing, SH1
Strasser, D1
Ingraham, HA1
Schaaf, MJ1
Yamamoto, KR1
Baier, H2
Švob Štrac, D1
Muck-Šeler, D1
Pivac, N1
Haney, MM1
Drexel, M1
Preidt, AP1
Sperk, G1
Ochoa-Sanchez, R1
Rainer, Q1
Comai, S1
Spadoni, G1
Bedini, A1
Rivara, S1
Fraschini, F1
Mor, M1
Tarzia, G1
Gobbi, G2
Senthilraja, M1
Alagarsamy, V1
Iijima, M1
Fukumoto, K1
Kazmi, I1
Afzal, M1
Gupta, G1
Anwar, F1
Otahal, J1
Sills, GJ1
Jesupillai, M1
Thillai Arasu, P1
Jasemine, S1
Bharathidhasan, P1
Mazzuferi, M1
Kumar, G1
Rospo, C1
Miyagawa, K1
Tsuji, M1
Takeda, H1
Boulay, J1
Chaillou, E1
Bertin, A1
Constantin, P1
Arnould, C1
Leterrier, C1
Calandreau, L1
Iwata, M1
Inoue, S1
Kawaguchi, M1
Furuya, H1
Molina-Hernández, M1
Téllez-Alcántara, NP1
Olivera-López, JI1
Jaramillo, MT1
Platt, B1
Schulenberg, J1
Klee, N1
Nizami, M1
Clark, JA1
da Cruz, GM1
Felipe, CF1
da Costa, MA1
Tavares, AF1
Menezes, ML1
de Andrade, GM1
Leal, LK1
Brito, GA1
da Graça Naffah-Mazzacoratti, M1
de Barros Viana, GS1
Kreiss, DS1
Coffman, CF1
Fiacco, NR1
Granger, JC1
Helton, BM1
Jackson, JC1
Kim, LV1
Mistry, RS1
Mizer, TM1
Palmer, LV1
Vacca, JA1
Winkler, SS1
Zimmer, BA1
Mussulini, BH1
Leite, CE1
Zenki, KC1
Moro, L1
Baggio, S1
Rico, EP1
Rosemberg, DB1
Dias, RD1
Souza, TM1
Campos, MM1
Battastini, AM1
de Oliveira, DL1
Jones, DM1
Esmaeil, N1
Maren, S1
Macdonald, RL3
Araki, T1
Simon, RP1
Taki, W1
Lan, JQ1
Henshall, DC1
Tsuji, S1
Akamatsu, N1
Bittigau, P1
Sifringer, M1
Genz, K1
Reith, E1
Pospischil, D1
Govindarajalu, S1
Dzietko, M1
Pesditschek, S1
Mai, I1
Dikranian, K1
Olney, JW1
Ikonomidou, C1
Santarelli, L1
Blier, P1
Hen, R1
Nisijima, K1
Shioda, K1
Yoshino, T1
Takano, K1
Kato, S1
Lazzarini, R1
Malucelli, BE1
Muscará, MN1
de Nucci, G1
Palermo-Neto, J1
Jelen, P1
Soltysik, S1
Zagrodzka, J1
Kliethermes, CL1
Finn, DA1
Crabbe, JC1
Lepicard, EM2
Venault, P2
Negroni, J1
Perez-Diaz, F2
Joubert, C2
Nosten-Bertrand, M1
Berthoz, A2
Chapouthier, G2
Ukai, M1
Mitsunaga, H1
Jourquin, J1
Tremblay, E1
Décanis, N1
Charton, G1
Hanessian, S1
Chollet, AM1
Le Diguardher, T1
Khrestchatisky, M1
Rivera, S1
Vielhaber, S1
Kudin, AP2
Kudina, TA1
Stiller, D1
Scheich, H1
Schoenfeld, A1
Feistner, H1
Heinze, HJ1
Elger, CE2
Kunz, WS2
Anschel, DJ1
Ortega, E1
Fisher, RS4
Hamann, M1
Meisler, MH1
Richter, A2
Borelli, KG1
Coimbra, NC1
Leroy, C1
Poisbeau, P1
Keller, AF1
Nehlig, A3
McDonough, JH1
Benjamin, A1
McMonagle, JD1
Rowland, T1
Shih, TM2
Kłodzińska, A2
Tatarczyńska, E3
Chojnacka-Wójcik, E2
Wu, J1
Ellsworth, K1
Ellsworth, M1
Schroeder, KM1
Smith, K1
Merali, Z1
Khan, S1
Michaud, DS1
Shippy, SA1
Anisman, H1
Aerden, LA1
Kessels, FA1
Rutten, BP1
Lodder, J1
Steinbusch, HW1
Chen, SW1
Min, L1
Li, WJ1
Kong, WX1
Li, JF1
Zhang, YJ1
Bantsiele, GB1
Bentué-Ferrer, D1
Amiot, N1
Allain, H1
Reymann, JM1
Besheer, J1
Hodge, CW1
Buznego, MT1
Pérez-Saad, H1
Becker, A1
Grecksch, G1
Nilsen, KE1
Walker, MC1
Cock, HR1
Fukumitsu, N2
Ogi, S2
Uchiyama, M2
Mori, Y2
Pitkänen, A2
Kharatishvili, I1
Narkilahti, S1
Lukasiuk, K1
Nissinen, J2
Baraban, SC1
Taylor, MR1
Castro, PA1
Krömer, SA1
Kessler, MS1
Milfay, D1
Birg, IN1
Bunck, M1
Czibere, L1
Panhuysen, M1
Pütz, B1
Deussing, JM1
Landgraf, R2
Turck, CW1
Marrs, TC1
Tsaltas, E1
Kontis, D1
Chrysikakou, S1
Giannou, H1
Biba, A1
Pallidi, S1
Christodoulou, A1
Maillis, A1
Rabavilas, A1
Begg, DP1
Hallam, KT1
Norman, TR1
Ding, HK1
Shum, FW1
Ko, SW1
Zhuo, M1
Park, JH1
Cha, HY1
Seo, JJ1
Hong, JT1
Han, K1
Oh, KW1
Schleimer, SB1
Johnston, GA1
Henderson, JM1
Narita, M1
Kaneko, C1
Miyoshi, K1
Nagumo, Y1
Kuzumaki, N1
Nakajima, M1
Nanjo, K1
Matsuzawa, K1
Yamazaki, M1
Suzuki, T2
Cruz-Sánchez, S1
García-Barradas, O1
Yee, BK1
Keist, R1
von Boehmer, L1
Studer, R1
Benke, D1
Hagenbuch, N1
Dong, Y1
Malenka, RC1
Fritschy, JM2
Bluethmann, H1
Feldon, J1
Möhler, H2
Picazo, O1
Estrada-Camarena, E1
Hernandez-Aragon, A1
Patel, HC1
Ross, FM1
Heenan, LE1
Davies, RE1
Rothwell, NJ1
Allan, SM1
Mocaër, E1
Statler, KD1
Alexander, H1
Vagni, V1
Dixon, CE1
Clark, RS1
Jenkins, L1
Kochanek, PM1
Dubreuil, CI1
Marklund, N1
Deschamps, K1
McIntosh, TK1
McKerracher, L1
Westphal, KG1
van der Gugten, J1
Leveleki, C1
Sziray, N1
Levay, G1
Barsvári, B1
Soproni, K1
Mikics, E1
Haller, J1
Morris, HV1
Dawson, GR1
Reynolds, DS1
Stephens, DN2
Nikiforuk, A2
Schmitt, FC1
Buchheim, K1
Meierkord, H1
Holtkamp, M1
Dhir, A1
Naidu, PS2
Kulkarni, SK3
François, J1
Koning, E1
Ferrandon, A1
Li, S1
Murakami, Y1
Wang, M1
Maeda, K1
Matsumoto, K1
Frisch, C1
Helmstaedter, C1
Blaszczak, P1
Dekundy, A1
Parada-Turska, J1
Calderazzo, L1
Turski, WA2
Liberato, JL1
Mortari, MR1
Gelfuso, EA1
Beleboni, Rde O1
Coutinho-Netto, J1
dos Santos, WF1
Grundmann, O1
Nakajima, J1
Seo, S1
Butterweck, V1
Mathiesen, C1
Rønn, LC1
Møller, A1
Wei, XY2
Yang, JY2
Wang, JH1
Wu, CF2
Strohl, KP1
Gallaugher, L1
Lynn, A1
Friedman, L1
Hill, A1
Singer, JB1
Lander, ES1
Nadeau, J1
Rorick-Kehn, LM1
Johnson, BG1
Knitowski, KM1
Salhoff, CR1
Witkin, JM1
Perry, KW1
Griffey, KI1
Tizzano, JP1
Monn, JA1
McKinzie, DL1
Schoepp, DD1
Dong, YX1
Ago, Y1
Takahashi, K1
Nakamura, S1
Hashimoto, H1
Baba, A1
Matsuda, T1
Cleveland, NR1
Krier, S1
Heard, K1
Glien, M1
Gastens, AM1
Fedrowitz, M1
Bethmann, K1
Volk, HA1
Potschka, H1
Jochum, T1
Boettger, MK1
Wigger, A1
Beiderbeck, D1
Sauer, H1
Bär, KJ1
Mongeau, R1
Marcello, S1
Andersen, JS1
Pani, L1
Keisala, T1
Minasyan, A1
Tuohimaa, P1
Nassiri-Asl, M1
Shariati-Rad, S1
Zamansoltani, F1
Bradley, BF1
Starkey, NJ1
Brown, SL1
Lea, RW1
Fredriksson, A1
Pontén, E1
Gordh, T1
Eriksson, P1
Ognibene, E1
Bovicelli, P1
Adriani, W1
Saso, L1
Laviola, G1
López-Patiño, MA1
Yu, L1
Cabral, H1
Zhdanova, IV1
Tang, FR1
Chen, PM1
Tang, YC1
Tsai, MC1
Lee, WL1
Martin, BS1
Kapur, J2
Salih, MA1
Mustafa, AA1
McLeod, MC1
Sundram, S1
Dean, B1
Witschi, R1
Hösl, K1
Reinold, H1
Ahmadi, S1
Brockhaus, J1
Sergejeva, M1
Hess, A1
Brune, K1
Pearl-Davis, MS1
Manini, AF1
Hoffman, RS1
Feng, HJ1
Mathews, GC1
Kao, C1
Pericić, D1
Vlainić, J1
Strac, DS1
De Ross, J1
Castilho, VM1
Hasson, H1
Rygula, R1
Abumaria, N1
Havemann-Reinecke, U1
Rüther, E1
Hiemke, C1
Zernig, G1
Fuchs, E1
Flügge, G1
Martino, G1
Perkins, MN1
Kilts, CD1
Commissaris, RL1
Rech, RH1
Bovier, P1
Broekkamp, CL1
Lloyd, KG1
Sethy, VH1
Hodges, DH1
Cook, L1
Asano, T1
Mizutani, A1
Frey, HH1
Reiche, R1
Schultz, D1
Tsuchiya, J1
Ito, Y1
Hino, T1
Ohashi, H1
Kunieda, T1
Sakata, K1
Okamoto, M1
Aaronson, L1
Hinman, D1
Emmett-Oglesby, MW2
Spencer, DG1
Elmesallamy, F1
Lal, H2
Schafer, DF1
Pappas, SC1
Brody, LE1
Jacobs, R1
Jones, EA2
Oltmans, GA1
Beales, M1
Lorden, JF1
Gordon, JH1
Albertson, TE1
Bowyer, JF2
Paule, MG1
Iorio, LC1
Eisenstein, N1
Brody, PE1
Barnett, A1
Banfi, S1
Fonio, W1
Allievi, E1
Raimondo, S1
Raymond, GG1
DeGennaro, MD1
Yau, M1
Buice, RG1
de Campos, CJ1
Izquierdo, I1
McNamara, JO1
Peper, AM1
Patrone, V1
Kawanishi, K1
Hashimoto, Y1
Fujiwara, M1
Kataoka, Y1
Ueki, S1
Petursson, H1
Lader, MH1
Frieder, B1
Karpiak, SE1
Rapport, MM1
Alberton, TE1
Rundfeldt, C1
Wlaź, P1
Hönack, D2
Terndrup, TE1
Fordyce, WE1
Knapp, DJ1
Saiers, JA1
Pohorecky, LA1
Shepherd, JK1
Grewal, SS1
Fletcher, A1
Bill, DJ1
Dourish, CT1
Woods, A1
Smith, C1
Szewczak, M1
Dunn, RW1
Cornfeldt, M1
Corbett, R1
Pesce, ME1
Acevedo, X1
Pinardi, G1
Miranda, HF1
Laino, CH1
Cordoba, NE1
Orsingher, OA1
Gallo, MA1
Smith, SS1
Smith, SE1
al-Zubaidy, ZA1
Chapman, AG1
Meldrum, BS3
Costall, B2
Naylor, RJ2
Molenaar, PC1
Van Kempen, GT1
Graeff, FG1
Viana, MB1
Turski, L1
Sánchez, C2
Overstreet, DH2
Pucilowski, O1
Rezvani, AH1
Janowsky, DS1
Rafiq, A1
Zhang, YF1
Coulter, DA1
Kitano, Y1
Usui, C1
Takasuna, K1
Hirohashi, M1
Nomura, M1
Miyamoto, M1
Takahashi, H1
Kato, K1
Hirai, K1
Ishihara, Y1
Goto, G1
Dodd, PR1
Thomas, GJ1
McCloskey, A1
Crane, DI1
Smith, ID1
Wu, WJ1
Pruett, SB1
Szczepaniak, WS1
Møller, AR1
Nielsen, CK1
Prasad, A1
Henry, M1
Prasad, C1
Jiang, Q1
Walton, NY1
Gunawan, S1
Tsuda, M1
Misawa, M1
Roychoudhury, M1
Eder, HG2
Jones, DB1
Ballaz, S1
Barber, A1
Fortuño, A1
Del Río, J1
Martin-Martínez, M1
Gómez-Monterrey, I1
Herranz, R1
González-Muñiz, R1
García-López, MT1
Suemaru, K1
Kawasaki, H1
Gomita, Y1
Hendrie, CA1
Eilam, D1
Weiss, SM1
Winkler, T1
Sharma, HS1
Stålberg, E1
Westman, J1
Stein, A1
Ostojić, ZS1
Ruzdijić, S1
Car, M1
Rakić, L1
Veskov, R1
Morimoto, K1
Sato, H1
Sato, K1
Sato, S1
Yamada, N1
Van Roey, G1
Lijnen, P1
Verbesselt, R1
Verbruggen, A1
Fevery, J1
Carley, DW1
Trbovic, SM1
Radulovacki, M1
Abe, M1
Nakai, H1
Tabata, R1
Saito, K1
Egawa, M1
Gobert, J1
Wülfert, E1
Khanna, N1
Khosla, R1
Kohli, J1
Rao, VS1
Santos, FA1
Paula, WG1
Silva, RM1
Campos, AR1
Fahlke, C1
Hansen, S1
McNaughton, N1
Urbanska, EM1
Tomczyk, T1
Haberek, G1
Pilip, S1
Matyska, J1
Kleinrok, Z1
Czuczwar, SJ1
Mazarati, AM2
Baldwin, RA2
Sofia, RD1
Wasterain, CG1
Krupp, E1
Heynen, T1
Li, XL1
Post, RM1
Weiss, SR1
Chakrabarti, E1
Ghosh, A1
Griebel, G1
Rodgers, RJ1
Perrault, G1
Sanger, DJ1
Shirasaka, Y1
Katsumori, H1
Thompson, KW1
Sankar, R1
Pereira de Vasconselos, A1
David, V1
Gold, LH1
Koob, GF1
Cazala, P1
Takahashi, RN1
Berton, O1
Mormède, P1
Chaouloff, F1
Khosla, P1
Pandhi, P1
Joel, D1
Avisar, A1
Kurasawa, M1
Val'dman, AV1
Kozlovskaia, MM1
Brailowsky, S1
Menini, C1
Naquet, R1
Ben-Ari, Y1
Lagowska, J1
Horton, RW2
Toseland, PA1
Wada, JA1
Weinberger, SB1
Killam, EK2
Kryzhanovskiĭ, GN1
Aliev, MN1
Oliver, AP1
Hoffer, BJ1
Wyatt, RJ1
Mertin, J1
Simon, O1
Schmiedek, P1
Anlezark, G1
Balzamo, E1
Trimble, M1
Lucchesi, BR1
Kniffen, FJ1
Ben Attia, M1
N'Gouemo, P1
Belaidi, M1
Rondouin, G1
Chicheportiche, R1
Lane, JD1
Díaz-García, JM1
Oliver-Botana, J1
Fos-Galve, D1
Peterson, CJ1
Vinayak, S1
Pazos, A1
Gale, K1
Kaltwasser, MT1
Little, HJ1
Koviak, TA1
Capacio, BR1
Costello, NL1
Carlson, JN1
Glick, SD1
Zeneroli, ML1
Baraldi, M1
Ventura, E1
Vezzelli, C1
Tofanetti, O1
Germini, M1
Casciarri, I1
Fredow, G2
Sheveleva, GA1
Filimonov, VG1
Sizov, PI1
Chesnokova, IaM1
Basile, AS1
Pannell, L1
Jaouni, T1
Gammal, SH1
Fales, HM1
Skolnick, P1
Schiller, GD1
Daws, LC1
Orbach, J1
Ettenberg, A1
Geist, TD1
Golda, V3
Petr, R3
Piot, O1
Betschart, J1
Stutzmann, JM1
Blanchard, JC1
Onaivi, ES1
Martin, BR1
Johnson, JV1
Jeske, AH1
McDaniel, HK1
Herrera, GQ1
Fisher, JE1
Schmidt, D1
Iturrian, WB1
Marczynski, TJ1
Urbancic, M1
Colpaert, FC1
Meert, TF1
Niemegeers, CJ1
Janssen, PA1
Barry, JM1
Kelly, ME1
Wu, HQ1
Tullii, M1
Samanin, R1
Olsen, RW1
Wamsley, JK1
McCabe, RT1
Lee, RJ1
Lomax, P1
Critchley, MA1
Handley, SL1
Bodnoff, SR1
Suranyi-Cadotte, B1
Aitken, DH1
Quirion, R1
Meaney, MJ1
Mathis, DA1
Harris, CM1
Idemudia, SO1
Riou, B1
Rimailho, A1
Galliot, M1
Bourdon, R1
Huet, Y1
Vidal, C1
Jacob, J1
Yanagita, T1
Siemkowicz, E1
Micheletti, G1
Vergnes, M1
Marescaux, C1
Reis, J1
Depaulis, A1
Rumbach, L1
Warter, JM1
Bircher, JL2
Barrada, O1
Oftedal, SI1
van Duijn, H1
Browne, TR1
Penry, JK1
De Jong, RH1
Heavner, JE1
Edmonds, HL1
Stark, LG2
Hollinger, MA1
Krsiak, M1
Goldstein, DB1
Voiculescu, V1
Ungher, J1
Sirian, S1
Killam, KF1
Baum, T1
Eckfeld, DK1
Shropshire, AT1
Rowles, G1
Varner, LL1

Clinical Trials (11)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. Double Blind and Randomized Clinical Trial Controlled With Alprazolam[NCT03702803]Phase 2122 participants (Anticipated)Interventional2016-03-16Recruiting
A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures[NCT04686786]Phase 2120 participants (Anticipated)Interventional2020-12-08Enrolling by invitation
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures (REALIZE Trial)[NCT04244175]Phase 2150 participants (Anticipated)Interventional2020-01-27Recruiting
The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822]550 participants (Anticipated)Observational2022-02-18Recruiting
The Efficacy of Strategic Memory Training Coupled With Non-invasive Brain Stimulation Techniques in Healthy Aging Population and Subjective Cognitive Decline Patients: a Randomized-controlled Study[NCT05929872]56 participants (Anticipated)Interventional2023-07-30Not yet recruiting
Thermoregulation Among Individuals With First-episode Psychosis[NCT04369677]20 participants (Anticipated)Observational2023-11-01Not yet recruiting
Mood Disorder Cohort Research Consortium (MDCRC) in Korea[NCT03088657]500 participants (Anticipated)Observational [Patient Registry]2015-09-30Recruiting
Effects of Perioperative Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery[NCT01505465]50 participants (Actual)Interventional2012-02-29Completed
A Randomized, Double-blind, Placebo- and Active Comparator-controlled, Crossover Trial to Examine the Effect of Multiple Doses of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subject[NCT04592536]Phase 156 participants (Actual)Interventional2020-10-06Completed
Efficacy of Combined Ketamine and Midazolam for Treatment of Generalized Convulsive Status Epilepticus in Children .[NCT05779657]Phase 2/Phase 3144 participants (Anticipated)Interventional2023-03-21Recruiting
Trial of Intracerebral Infusion in Patients With Medically Intractable Epilepsy[NCT00005925]Phase 13 participants (Actual)Interventional2000-06-23Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Perioperative Sleep Efficiency

Sleep time change from 96 hours before surgery to 72 hours after surgery (NCT01505465)
Timeframe: 96 hours before surgery to 72 hours after surgery

Interventionminutes (Mean)
Study: Melatonin20
Control: Placebo-55

Reviews

14 reviews available for diazepam and Disease Models, Animal

ArticleYear
Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
    Epilepsy & behavior : E&B, 2015, Volume: 49

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug T

2015
Predatory stress as an experimental strategy to measure fear and anxiety-related behaviors in non-human primates.
    Reviews in the neurosciences, 2008, Volume: 19, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Diazepam; Disease Models, Animal;

2008
Why is the developing brain more susceptible to status epilepticus?
    Epilepsia, 2009, Volume: 50 Suppl 12

    Topics: Animals; Animals, Newborn; Brain; Diazepam; Disease Models, Animal; Female; Humans; Male; Pentobarbi

2009
[Treatment of status epilepticus].
    Rinsho shinkeigaku = Clinical neurology, 2001, Volume: 41, Issue:12

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Electric Stimulation Therapy; Humans; Ma

2001
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 11

    Topics: Affect; Animals; Anxiety Disorders; Aprepitant; Autoreceptors; Behavior, Animal; Corticosterone; Dia

2002
The role of diazepam in the treatment of nerve agent poisoning in a civilian population.
    Toxicological reviews, 2004, Volume: 23, Issue:3

    Topics: Adult; Animals; Antidotes; Chemical Warfare Agents; Civil Defense; Diazepam; Disease Models, Animal;

2004
Benzodiazepine dependence.
    British journal of addiction, 1981, Volume: 76, Issue:2

    Topics: Animals; Benzodiazepines; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relation

1981
The pharmacology of the 5-HT4 receptor.
    International clinical psychopharmacology, 1993, Volume: 8 Suppl 2

    Topics: 4-Aminobenzoic Acid; 5-Hydroxytryptophan; Animals; Anxiety; Arousal; Brain; Diazepam; Disease Models

1993
Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.
    Psychopharmacology, 1995, Volume: 121, Issue:1

    Topics: Animals; Antidepressive Agents; Depression; Diazepam; Disease Models, Animal; Motor Activity; Rats

1995
Acute cellular alterations in the hippocampus after status epilepticus.
    Epilepsia, 1999, Volume: 40 Suppl 1

    Topics: Animals; Barbiturates; Benzodiazepines; Cerebellar Nuclei; Diazepam; Disease Models, Animal; Drug To

1999
Pharmacological prophylaxis in the kindling model of epilepsy.
    Archives of neurology, 1977, Volume: 34, Issue:7

    Topics: Amygdala; Anesthetics, Local; Animals; Antidepressive Agents, Tricyclic; Atropine; Aziridines; Carba

1977
The benzodiazepines: anxiolytic and withdrawal effects.
    Neuropeptides, 1991, Volume: 19 Suppl

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Diazepam; Disease Models, Animal; Ethanol; Flumaz

1991
Hyperalgesia induced by emotional stress in the rat: an experimental animal model of human anxiogenic hyperalgesia.
    Annals of the New York Academy of Sciences, 1986, Volume: 467

    Topics: Analgesia; Animals; Anxiety; Diazepam; Disease Models, Animal; Emotions; Humans; Hypophysectomy; Pai

1986
Benzodiazepines in the treatment of epilepsy. A review.
    Epilepsia, 1973, Volume: 14, Issue:3

    Topics: Adult; Animals; Anticonvulsants; Chlordiazepoxide; Diazepam; Disease Models, Animal; Eclampsia; Elec

1973

Other Studies

474 other studies available for diazepam and Disease Models, Animal

ArticleYear
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders.
    Journal of medicinal chemistry, 2006, Jan-12, Volume: 49, Issue:1

    Topics: Administration, Oral; Animals; Anxiety Disorders; Binding Sites; Biological Availability; Cell Line;

2006
Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives.
    Journal of natural products, 2006, Volume: 69, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Disease Models, Animal; Galphimia; Mexico; Mice; Molecular Structure;

2006
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Journal of medicinal chemistry, 2008, Nov-27, Volume: 51, Issue:22

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal;

2008
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological

2010
Antinociceptive properties of physalins from Physalis angulata.
    Journal of natural products, 2014, Nov-26, Volume: 77, Issue:11

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Edema; Freund's Adjuvant; Hyp

2014
Microwave assisted synthesis and docking study of N-(2-oxo-2-(4-oxo-2-substituted thiazolidin-3ylamino)ethyl)benzamide derivatives as anticonvulsant agents.
    Bioorganic & medicinal chemistry letters, 2014, Dec-15, Volume: 24, Issue:24

    Topics: Animals; Anticonvulsants; Benzamides; Binding Sites; Disease Models, Animal; Half-Life; Liver; Mice;

2014
Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
    European journal of medicinal chemistry, 2015, Jun-05, Volume: 97

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Disease Models, Animal; Models,

2015
Mechanism of action of antiepileptic ceramide from Red Sea soft coral Sarcophyton auritum.
    Bioorganic & medicinal chemistry letters, 2015, Dec-15, Volume: 25, Issue:24

    Topics: Allosteric Regulation; Animals; Anthozoa; Anticonvulsants; Binding Sites; Ceramides; Disease Models,

2015
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Respo

2017
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations.
    European journal of pharmacology, 2021, Dec-05, Volume: 912

    Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Caspase 3; Cell Death; Cognitive Dysfuncti

2021
Peripheral GABAA receptor signaling contributes to visceral hypersensitivity in a mouse model of colitis.
    Pain, 2022, 07-01, Volume: 163, Issue:7

    Topics: Animals; Bicuculline; Colitis; Colon; Dextran Sulfate; Diazepam; Disease Models, Animal; Inflammator

2022
Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model.
    Medical science monitor : international medical journal of experimental and clinical research, 2021, Dec-06, Volume: 27

    Topics: Analgesics; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Administration Schedule

2021
Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs.
    Experimental neurology, 2022, Volume: 349

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Convulsants; Diazepam; Disease Models, Animal;

2022
Pronounced antiseizure activity of the subtype-selective GABA
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:11

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistant Epilepsy; Electroencephal

2022
Pronounced antiseizure activity of the subtype-selective GABA
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:11

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistant Epilepsy; Electroencephal

2022
Pronounced antiseizure activity of the subtype-selective GABA
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:11

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistant Epilepsy; Electroencephal

2022
Pronounced antiseizure activity of the subtype-selective GABA
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:11

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistant Epilepsy; Electroencephal

2022
The larval diving response (LDR): Validation of an automated, high-throughput, ecologically relevant measure of anxiety-related behavior in larval zebrafish (Danio rerio).
    Journal of neuroscience methods, 2022, 11-01, Volume: 381

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Caffeine; Diazepam; Disease Models, Animal;

2022
Aerobic exercise, alone or combined with an anti-inflammatory drug, reduces the severity of epileptic seizures and levels of central pro-inflammatory cytokines in an animal model of epileptic seizures.
    Epilepsy research, 2022, Volume: 186

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Diazepam; Disease Models, Animal; Epilepsy; Exercise;

2022
The socially enriched environment test: a new approach to evaluate social behavior in a mouse model of social anxiety disorder.
    Learning & memory (Cold Spring Harbor, N.Y.), 2022, Volume: 29, Issue:11

    Topics: Animals; Anxiety; Diazepam; Disease Models, Animal; Extinction, Psychological; Fear; Male; Mice; Pho

2022
Esculetin alleviates pentylenetetrazole-induced seizures, cognitive impairment and pro-inflammatory cytokines and suppresses penicillin-induced epileptiform activity in rats.
    Life sciences, 2023, Jan-15, Volume: 313

    Topics: Animals; Anticonvulsants; Cognitive Dysfunction; Cytokines; Diazepam; Disease Models, Animal; Epilep

2023
The antiinflammatory and electrophysiological effects of fingolimod on penicillin-induced rats.
    Arquivos de neuro-psiquiatria, 2022, Volume: 80, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Contraindications, Drug; Diazepam; Disease Model

2022
Synergistic effects of applying static magnetic fields and diazepam to improve EEG abnormalities in the pilocarpine epilepsy rat model.
    Scientific reports, 2023, 01-05, Volume: 13, Issue:1

    Topics: Animals; Diazepam; Disease Models, Animal; Electroencephalography; Epilepsy; Magnetic Fields; Piloca

2023
Cerebrospinal fluid neurotransmitter levels and central nervous system depression in a rat drug overdose model.
    Toxicology mechanisms and methods, 2020, Volume: 30, Issue:2

    Topics: Administration, Oral; Animals; Biomarkers; Carboxymethylcellulose Sodium; Chromatography, Liquid; Di

2020
Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways.
    Behavioural brain research, 2020, 02-17, Volume: 380

    Topics: Amantadine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models

2020
Anticonvulsant Activity of Essential Oil From Leaves of Zhumeria majdae (Rech.) in Mice: The Role of GABA
    Clinical and translational science, 2020, Volume: 13, Issue:4

    Topics: Animals; Anticonvulsants; Arginine; Diazepam; Disease Models, Animal; Dose-Response Relationship, Dr

2020
New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Epilepsia, 2020, Volume: 61, Issue:3

    Topics: Animals; Anticonvulsants; Brain; Cell Proliferation; CRISPR-Cas Systems; Diazepam; Disease Models, A

2020
Sedative and Hypnotic Effects and Transcriptome Analysis of Polygala tenuifolia in Aged Insomnia Rats.
    Chinese journal of integrative medicine, 2020, Volume: 26, Issue:6

    Topics: Animals; China; Diazepam; Disease Models, Animal; Gene Expression Profiling; Hypnotics and Sedatives

2020
Urethane attenuates early neuropathology of diisopropylfluorophosphate-induced status epilepticus in rats.
    Neurobiology of disease, 2020, Volume: 140

    Topics: Acetylcholinesterase; Animals; Brain Injuries; Diazepam; Disease Models, Animal; Electroencephalogra

2020
Stress-mediated hyperactivity and anhedonia resistant to diazepam and fluoxetine in
    Stress (Amsterdam, Netherlands), 2021, Volume: 24, Issue:1

    Topics: Anhedonia; Animals; Diazepam; Disease Models, Animal; Drosophila; Fluoxetine; Stress, Psychological

2021
Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
    Molecular neurobiology, 2020, Volume: 57, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Benzophenones; Cytokines; Diazepam; Disease Models, Animal; Drug

2020
Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Anesthesia, Inhalation; Anesthesiology; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals;

2020
Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study.
    Scientific reports, 2020, 05-29, Volume: 10, Issue:1

    Topics: Animals; Benzodiazepines; Case-Control Studies; Diazepam; Disease Models, Animal; Male; Masticatory

2020
Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice.
    Epilepsia, 2020, Volume: 61, Issue:9

    Topics: Animals; Animals, Outbred Strains; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Cornea;

2020
Perillyl alcohol decreases the frequency and severity of convulsive-like behavior in the adult zebrafish model of acute seizures.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:6

    Topics: Animals; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Response Relation

2021
Anticonvulsant effects of the aqueous and methanol extracts from the stem bark of Psychotria camptopus Verdc. (Rubiacaea) in rats.
    Journal of ethnopharmacology, 2021, May-23, Volume: 272

    Topics: Animals; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models, Animal; Epilepsy; Methanol; Mi

2021
Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.
    Scientific reports, 2021, 05-04, Volume: 11, Issue:1

    Topics: Animals; Diazepam; Disease Models, Animal; Down Syndrome; Electrophysiological Phenomena; Female; Lo

2021
Anxiolytic effect of chronic intake of supplemental magnesium chloride in rat.
    Behavioural brain research, 2021, 09-10, Volume: 413

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Magnesium

2021
Diazepam Impairs Innate and Adaptive Immune Responses and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adaptive Immunity; Animals; Anti-Inflammatory Agents; Biomarkers; Diazepam; Disease Models, Animal;

2021
Pharmacological evaluation of the anxiolytic-like effects of Lippia graveolens and bioactive compounds.
    Pharmaceutical biology, 2017, Volume: 55, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Resp

2017
Interleukin-1β Plays a Pivotal Role via the PI3K/Akt/mTOR Signaling Pathway in the Chronicity of Mesial Temporal Lobe Epilepsy.
    Neuroimmunomodulation, 2016, Volume: 23, Issue:5-6

    Topics: Animals; Anticonvulsants; Cells, Cultured; Child; Diazepam; Disease Models, Animal; Enzyme Inhibitor

2016
Role of allopregnanolone biosynthesis in acute stress-induced anxiety-like behaviors in mice.
    Synapse (New York, N.Y.), 2017, Volume: 71, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Animals; Anxiety Disorders; Diazepam; Disease Models, Animal; Dose-Res

2017
Anticonvulsant effects of antiaris toxicaria aqueous extract: investigation using animal models of temporal lobe epilepsy.
    BMC research notes, 2017, Apr-26, Volume: 10, Issue:1

    Topics: Animals; Antiaris; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Drug Administra

2017
Complex modulation by stress of the effect of seizures on long term potentiation in mouse hippocampal slices.
    Hippocampus, 2017, Volume: 27, Issue:8

    Topics: Animals; Anticonvulsants; Atropine; Corticosterone; Diazepam; Disease Models, Animal; Electric Stimu

2017
Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats.
    Neuroscience research, 2017, Volume: 123

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal; Exploratory Behavior; Femal

2017
Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus.
    Epilepsia, 2017, Volume: 58, Issue:7

    Topics: Animals; Anticonvulsants; Dentate Gyrus; Diazepam; Disease Models, Animal; Dose-Response Relationshi

2017
Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish-Involvement of GABAergic and 5-HT systems.
    Journal of ethnopharmacology, 2017, Jul-31, Volume: 207

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Capparaceae; Desipramine; Diazepam; Disease

2017
Potential Involvement of Impaired BK
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; Environment; Fragile X Mental Retard

2018
Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Acta neuropathologica communications, 2017, 07-31, Volume: 5, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Diazepam; Disease Models, Animal;

2017
Anticonvulsant effects of thiamine on pentylenetetrazole-induced seizure in mice.
    Nutritional neuroscience, 2019, Volume: 22, Issue:3

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Epilep

2019
Excitatory-inhibitory imbalance in the brain of the wobbler mouse model of amyotrophic lateral sclerosis substantiated by riluzole and diazepam.
    Neuroscience letters, 2017, Sep-29, Volume: 658

    Topics: Amyotrophic Lateral Sclerosis; Animals; Diazepam; Disease Models, Animal; Hippocampus; Mice, Inbred

2017
Progressive modulation of accumbal neurotransmission and anxiety-like behavior following protracted nicotine withdrawal.
    Neuropharmacology, 2018, Volume: 128

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Corpus Striatum; Dendritic Spines; Diazepam; Disease Models,

2018
Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis.
    Journal of neuroimmunology, 2017, 12-15, Volume: 313

    Topics: Animals; Carrier Proteins; CD11b Antigen; Central Nervous System; Cytokines; Diazepam; Disease Model

2017
DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism.
    Metabolic brain disease, 2018, Volume: 33, Issue:1

    Topics: Alcoholism; Animals; Anticonvulsants; Antioxidants; Diazepam; Disease Models, Animal; DNA Damage; Hi

2018
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
    Epilepsia, 2018, Volume: 59, Issue:1

    Topics: Animals; Brain; Brain Waves; Carbamates; Cognition Disorders; Diazepam; Disease Models, Animal; Dose

2018
Anxiolytic- and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury.
    Toxicology and applied pharmacology, 2018, 01-01, Volume: 338

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain Injuries, Traumatic; Diazepam; Disease Mo

2018
Marble burying as compulsive behaviors in male and female mice.
    Acta neurobiologiae experimentalis, 2017, Volume: 77, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Citalopram; Compulsive Behavio

2017
Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam.
    Progress in neuro-psychopharmacology & biological psychiatry, 2018, 04-20, Volume: 83

    Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depressive Disorder; Diazepam;

2018
Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.
    The Journal of pharmacology and experimental therapeutics, 2018, Volume: 365, Issue:2

    Topics: Animals; Anticonvulsants; Anxiety; Basolateral Nuclear Complex; Behavior, Animal; Child; Cyclopentan

2018
Anxiolytic effects of ascorbic acid and ketamine in mice.
    Journal of psychiatric research, 2018, Volume: 100

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Ascorbic Acid; Behavior, Animal; Diazepam; Disease Models, An

2018
Minocycline in Alcohol Withdrawal Induced Anxiety and Alcohol Relapse in Rats.
    Current clinical pharmacology, 2018, Volume: 13, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Animals; Anti-Bacterial Agents; Anxiety; Diazepam; Disease Models, Ani

2018
Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.
    Pain, 2018, Volume: 159, Issue:6

    Topics: Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Depression; Diazepam; Disease Models,

2018
An on demand macaque model of mesial temporal lobe seizures induced by unilateral intra hippocampal injection of penicillin.
    Epilepsy research, 2018, Volume: 142

    Topics: Animals; Anti-Bacterial Agents; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Rel

2018
Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.
    Seizure, 2018, Volume: 57

    Topics: Animals; Anticonvulsants; Cannabinoid Receptor Agonists; Diazepam; Disease Models, Animal; Dose-Resp

2018
Paradoxical kinesia induced by appetitive 50-kHz ultrasonic vocalizations in rats depends on glutamatergic mechanisms in the inferior colliculus.
    Neuropharmacology, 2018, Volume: 135

    Topics: Animals; Appetitive Behavior; Catalepsy; Diazepam; Disease Models, Animal; GABA Modulators; Glutamic

2018
Anxiolytic effect of anacardic acids from cashew (Anacardium occidentale) nut shell in mice.
    IUBMB life, 2018, Volume: 70, Issue:5

    Topics: Anacardic Acids; Anacardium; Animals; Anti-Anxiety Agents; Antioxidants; Anxiety; Catalase; Diazepam

2018
FGIN-1-27, an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 171

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Female; I

2018
Repeated diazepam administration reversed working memory impairments and glucocorticoid alterations in the prefrontal cortex after short but not long alcohol-withdrawal periods.
    Cognitive, affective & behavioral neuroscience, 2018, Volume: 18, Issue:4

    Topics: Alcoholism; Animals; Anxiety; Central Nervous System Depressants; Cyclic AMP Response Element-Bindin

2018
Clarified Açaí (
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Animals; Anticonvulsants; Cells, Cultured; Complex Mixtures; Diazepam; Disease Models, Animal; Euter

2018
Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:9 Pt B

    Topics: Animals; Antidotes; Brain; Diazepam; Disease Models, Animal; Humans; Interneurons; Male; Nerve Agent

2018
Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat.
    European journal of pharmacology, 2018, Aug-15, Volume: 833

    Topics: Amygdala; Animals; Behavior, Animal; Conditioning, Operant; Diazepam; Disease Models, Animal; Dopami

2018
Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents.
    Journal of pharmacological sciences, 2018, Volume: 137, Issue:2

    Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzeneacetamides; Calcium Channel Blockers; Carbama

2018
Cunaniol-elicited seizures: Behavior characterization and electroencephalographic analyses.
    Toxicology and applied pharmacology, 2018, 12-01, Volume: 360

    Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Electroencephalography; Pen

2018
Diazepam as attenuator of pain induced by dentin hypersensitivity in rats exposed to stress.
    Archives of oral biology, 2019, Volume: 97

    Topics: Animals; Dentin; Dentin Sensitivity; Diazepam; Disease Models, Animal; Male; Microscopy, Electron, S

2019
Prophylactic potential of memantine against soman poisoning in rats.
    Toxicology, 2019, 03-15, Volume: 416

    Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Behavior, Animal; Chemical Warfare Agents; Choli

2019
Diazepam Inhibits Post-Traumatic Neurogenesis and Blocks Aberrant Dendritic Development.
    Journal of neurotrauma, 2019, 08-15, Volume: 36, Issue:16

    Topics: Animals; Brain Injuries; Cell Movement; Cell Proliferation; Cell Shape; Dendrites; Diazepam; Disease

2019
Molecular mechanism of tuberoinfundibular peptide of 39 on glucocorticoid receptor mediated glutamate/GABA imbalance and cerebral abnormalities against cognitive deficit model.
    The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:6

    Topics: Animals; Cognitive Dysfunction; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug;

2019
Quercetin mitigates anxiety-like behavior and normalizes hypothalamus-pituitary-adrenal axis function in a mouse model of mild traumatic brain injury.
    Behavioural pharmacology, 2019, Volume: 30, Issue:2 and 3-Sp

    Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Anxiety Disorders; Brain Concussion; Corticosterone;

2019
Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam.
    Addiction biology, 2020, Volume: 25, Issue:2

    Topics: Animals; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Diazepam; Disease Models, Animal; Dop

2020
Transition from status epilepticus to interictal spiking in a rodent model of mesial temporal epilepsy.
    Epilepsy research, 2019, Volume: 152

    Topics: Animals; Anticonvulsants; Brain Waves; Diazepam; Disease Models, Animal; Drug Combinations; Electroe

2019
Increased sensitivity to psychostimulants and GABAergic drugs in Lsamp-deficient mice.
    Pharmacology, biochemistry, and behavior, 2019, Volume: 183

    Topics: Alprazolam; Animals; Behavior, Animal; Cell Adhesion Molecules, Neuronal; Central Nervous System Dep

2019
Sensitivity to diazepam after a single session of forced swim stress in weaning Wistar rats.
    Acta pharmaceutica (Zagreb, Croatia), 2018, Sep-01, Volume: 68, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Resp

2018
Diazepam inhibited lipopolysaccharide (LPS)-induced pyroptotic cell death and alleviated pulmonary fibrosis in mice by specifically activating GABA
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 118

    Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Diazepam; Disease Models, Animal; Humans; Inf

2019
One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death.
    Neuroscience bulletin, 2013, Volume: 29, Issue:3

    Topics: Animals; Cell Death; Diazepam; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Mossy Fibers, H

2013
The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus.
    Seizure, 2013, Volume: 22, Issue:5

    Topics: Animals; Behavior, Animal; Cell Death; Diazepam; Disease Models, Animal; Drug Therapy, Combination;

2013
A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress.
    Neuropharmacology, 2013, Volume: 72

    Topics: Animals; Antidepressive Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Diazepam; Diseas

2013
Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam.
    The Kaohsiung journal of medical sciences, 2013, Volume: 29, Issue:7

    Topics: Acetamides; Animals; Antidepressive Agents; Behavior, Animal; Bicuculline; Diazepam; Disease Models,

2013
Coumarin compounds of Biebersteinia multifida roots show potential anxiolytic effects in mice.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2013, Jun-27, Volume: 21, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Chromatography, Liquid; Coumaric Acids; Coumarins; Diazepam;

2013
Effects of transcranial focal electrical stimulation alone and associated with a sub-effective dose of diazepam on pilocarpine-induced status epilepticus and subsequent neuronal damage in rats.
    Epilepsy & behavior : E&B, 2013, Volume: 28, Issue:3

    Topics: Analysis of Variance; Animals; Anticonvulsants; Cell Count; Deep Brain Stimulation; Diazepam; Diseas

2013
The anticonvulsant and sedative effects of Gladiolus dalenii extracts in mice.
    Epilepsy & behavior : E&B, 2013, Volume: 28, Issue:3

    Topics: Analysis of Variance; Animals; Anticonvulsants; Brain; Diazepam; Disease Models, Animal; Dose-Respon

2013
Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Indian journal of experimental biology, 2013, Volume: 51, Issue:7

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Resp

2013
GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety.
    Brain research, 2013, Sep-26, Volume: 1532

    Topics: Animals; Anxiety; Diazepam; Disease Models, Animal; Electroencephalography; Emotions; GABA Antagonis

2013
Diazepam treatment blocks the elevation of hippocampal activity and the accelerated proliferation of hippocampal neural stem cells after focal cerebral ischemia in mice.
    Journal of neuroscience research, 2013, Volume: 91, Issue:11

    Topics: Animals; Brain Ischemia; Cell Proliferation; Diazepam; Disease Models, Animal; Electrophysiology; GA

2013
Defensive burying test in postweaning rats: use of a small round chamber.
    Behavioural pharmacology, 2013, Volume: 24, Issue:8

    Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Fe

2013
Epilepsy in kcnj10 morphant zebrafish assessed with a novel method for long-term EEG recordings.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Anticonvulsants; Brain; Convulsants; Diazepam; Disease Models, Animal; Electroencephalograp

2013
Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats.
    The journal of physiological sciences : JPS, 2014, Volume: 64, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Do

2014
Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Schizophrenia bulletin, 2014, Volume: 40, Issue:2

    Topics: Allosteric Regulation; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disea

2014
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
    The Libyan journal of medicine, 2014, Volume: 9, Issue:1

    Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug;

2014
Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Neuropharmacology, 2014, Volume: 81

    Topics: Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Blood-Brain Barrier; Brain;

2014
Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:10

    Topics: Animals; Anticonvulsants; Clomiphene; Convulsants; Diazepam; Disease Models, Animal; Estriol; Female

2014
Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication.
    Neurotoxicology, 2014, Volume: 44

    Topics: Animals; Anticonvulsants; Atropine; Brain; Calcium; Diazepam; Disease Models, Animal; Electroencepha

2014
The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.
    Metabolic brain disease, 2015, Volume: 30, Issue:1

    Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Colon; Curcumin; Cyclic AMP Response Element-Bi

2015
The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice.
    British journal of pharmacology, 2014, Volume: 171, Issue:18

    Topics: Acetanilides; Acrolein; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Anim

2014
Plurality of anxiety and depression alteration mechanism by oleanolic acid.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:10

    Topics: alpha-Methyltyrosine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Brain-Derived Neur

2014
Effects of repetitive exposure to anesthetics and analgesics in the Tg2576 mouse Alzheimer's model.
    Neurotoxicity research, 2014, Volume: 26, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analgesics; Anesthetics; A

2014
Effects of chronic mild stress on the development of drug dependence in rats.
    Behavioural pharmacology, 2014, Volume: 25, Issue:5-6

    Topics: Animals; Chronic Disease; Citalopram; Depressive Disorder; Diazepam; Disease Models, Animal; Flumaze

2014
Sensory integration in mouse insular cortex reflects GABA circuit maturation.
    Neuron, 2014, Aug-20, Volume: 83, Issue:4

    Topics: Animals; Autistic Disorder; Cerebral Cortex; Diazepam; Disease Models, Animal; GABAergic Neurons; Gl

2014
Possible involvement of GABAergic and nitriergic systems for antianxiety-like activity of piperine in unstressed and stressed mice.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:5

    Topics: Alkaloids; Animals; Anti-Anxiety Agents; Anxiety; Benzodioxoles; Diazepam; Disease Models, Animal; D

2014
Potential mechanisms involved in the anticonvulsant effect of walnut extract on pentylenetetrazole-induced seizure.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2014, Volume: 23, Issue:6

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug S

2014
Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
    European journal of pharmacology, 2014, Nov-05, Volume: 742

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Diazepam; Disease Models, Animal; Dose-Res

2014
Mitochondrial instability during regional ischemia-reperfusion underlies arrhythmias in monolayers of cardiomyocytes.
    Journal of molecular and cellular cardiology, 2015, Volume: 78

    Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Cell Culture Techniques; Diazepam; Disease Models,

2015
Anticonvulsant activity of the ethanolic extract of Punica granatum L. seed.
    Neurological research, 2015, Volume: 37, Issue:6

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Lythra

2015
Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.
    Toxicology and applied pharmacology, 2014, Dec-01, Volume: 281, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Brain; Brain Waves; Bridged-Ring Compounds; Diaz

2014
Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.
    Neuroscience, 2015, Jan-22, Volume: 284

    Topics: Animals; Anticonvulsants; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diazepam; Disease Models, A

2015
Low doses of ethanol markedly potentiate the anti-seizure effect of diazepam in a mouse model of difficult-to-treat focal seizures.
    Epilepsy research, 2014, Volume: 108, Issue:10

    Topics: Animals; Anticonvulsants; Brain; Diazepam; Disease Models, Animal; Drug Compounding; Drug Synergism;

2014
Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Neuropharmacology, 2015, Volume: 90

    Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Drug Resistance; Electrod

2015
Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers.
    Neurobiology of disease, 2015, Volume: 75

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Electrodes, Implanted; Electroencephalog

2015
The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
    Journal of pharmacological sciences, 2015, Volume: 127, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Cells, Cultured; Citalopram; Diazepam; Disease Models, Animal

2015
Evaluation of potential gender-related differences in behavioral and cognitive alterations following pilocarpine-induced status epilepticus in C57BL/6 mice.
    Physiology & behavior, 2015, May-01, Volume: 143

    Topics: Age Factors; Analysis of Variance; Animals; Anticonvulsants; Cognition Disorders; Diazepam; Disease

2015
Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish.
    Epilepsy & behavior : E&B, 2015, Volume: 45

    Topics: Allylglycine; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Fructose; Levetiracetam; M

2015
Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures.
    Neuropharmacology, 2015, Volume: 95

    Topics: Animals; Anticonvulsants; Bridged-Ring Compounds; Calcium; Cells, Cultured; Diazepam; Disease Models

2015
Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection.
    Journal of neuroimmunology, 2015, May-15, Volume: 282

    Topics: Animals; Body Weight; Diazepam; Disease Models, Animal; Female; GABA Modulators; Gene Expression Reg

2015
Behavioral consequences of predator stress in the rat elevated T-maze.
    Physiology & behavior, 2015, Jul-01, Volume: 146

    Topics: Analysis of Variance; Animals; Antiemetics; Cats; Diazepam; Disease Models, Animal; Male; Maze Learn

2015
Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
    Epilepsy & behavior : E&B, 2015, Volume: 49

    Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Levetiracetam; Male; Mice

2015
Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electr

2015
Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.
    Epilepsia, 2015, Volume: 56, Issue:9

    Topics: Animals; Animals, Newborn; Anticonvulsants; Cells, Cultured; Diazepam; Disease Models, Animal; Enzym

2015
Hyperthermia aggravates status epilepticus-induced epileptogenesis and neuronal loss in immature rats.
    Neuroscience, 2015, Oct-01, Volume: 305

    Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Anticonvulsants; Apoptosis; Brain; Cell Death; Di

2015
Fluoxetine and diazepam acutely modulate stress induced-behavior.
    Behavioural brain research, 2016, Jan-01, Volume: 296

    Topics: Aggression; Animals; Behavior, Animal; Diazepam; Disease Models, Animal; Female; Fluoxetine; GABA Mo

2016
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
    Brain research, 2015, Nov-19, Volume: 1627

    Topics: Animals; Cell Differentiation; Diazepam; Disease Models, Animal; Epilepsy; Hippocampus; Muscarinic A

2015
Forebrain-independent generation of hyperthermic convulsions in infant rats.
    Epilepsia, 2016, Volume: 57, Issue:1

    Topics: Animals; Animals, Newborn; Anticonvulsants; Body Temperature; Denervation; Diazepam; Disease Models,

2016
High-Speed imaging reveals opposing effects of chronic stress and antidepressants on neuronal activity propagation through the hippocampal trisynaptic circuit.
    Frontiers in neural circuits, 2015, Volume: 9

    Topics: Animals; Antidepressive Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Central Ner

2015
Modulation of brain glutamate dehydrogenase as a tool for controlling seizures.
    Acta pharmaceutica (Zagreb, Croatia), 2015, Volume: 65, Issue:4

    Topics: Animals; Anticonvulsants; Brain; Deamination; Diazepam; Disease Models, Animal; Enzyme Inhibitors; G

2015
Pharmacological characterization of intraplantar Complete Freund's Adjuvant-induced burrowing deficits.
    Behavioural brain research, 2016, Mar-15, Volume: 301

    Topics: Amines; Analgesics; Animals; Antibodies; Behavior, Animal; Celecoxib; Cyclohexanecarboxylic Acids; D

2016
Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
    Pharmaceutical biology, 2016, Volume: 54, Issue:10

    Topics: Amnesia; Animals; Avoidance Learning; Behavior, Animal; Cognition; Cognition Disorders; Diazepam; Di

2016
Sustained Effects of Developmental Exposure to Ethanol on Zebrafish Anxiety-Like Behaviour.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Animals; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Embryo, Nonmammalian; Environm

2016
Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
    Epilepsy & behavior : E&B, 2016, Volume: 57, Issue:Pt A

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistance; Epilepsy; GABA Antagoni

2016
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:10

    Topics: Action Potentials; Administration, Oral; Amygdala; Animals; Animals, Newborn; Anti-Anxiety Agents; A

2016
Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice.
    Neuroscience, 2016, 07-22, Volume: 328

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistant Epilepsy; Hippocampus; In

2016
Selective corticotropin-releasing factor 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models.
    Behavioural brain research, 2016, 10-01, Volume: 312

    Topics: Acetylcholine; Administration, Oral; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Di

2016
Low dose X-irradiation mitigates diazepam induced depression in rat brain.
    Regulatory toxicology and pharmacology : RTP, 2016, Volume: 80

    Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Depression; Diazepam; Disease Models, Animal

2016
Diazepam reduces excitability of amygdala and further influences auditory cortex following sodium salicylate treatment in rats.
    Acta oto-laryngologica, 2016, Volume: 136, Issue:12

    Topics: Amygdala; Animals; Anti-Anxiety Agents; Auditory Cortex; Diazepam; Disease Models, Animal; Drug Eval

2016
Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
    The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:11

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disease Models, Animal; Down-Regulation;

2016
Anxiolytic activity of the neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB/c and C57BL/6 mice.
    Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:9

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Diazepam; Disease Models, Animal; Dose-Response Relati

2016
Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:11

    Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Caffeic Acids; Cinnamates; Comet Assay; Depsides;

2016
Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model.
    Epilepsy research, 2016, Volume: 127

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Cerebral Cortex; Diazepam; Diclof

2016
Autonomic changes induced by provocative motion in rats bred for high (HAB) and low (LAB) anxiety-related behavior: Paradoxical responses in LAB animals.
    Physiology & behavior, 2016, 12-01, Volume: 167

    Topics: Animals; Anticonvulsants; Anxiety; Autonomic Nervous System; Body Temperature; Breeding; Diazepam; D

2016
Anxiolytic properties of N-acetylcysteine in mice.
    Behavioural brain research, 2017, 01-15, Volume: 317

    Topics: Acetylcysteine; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Body Temperature; Dark

2017
Humanin ameliorates diazepam-induced memory deficit in mice.
    Neuropeptides, 2017, Volume: 62

    Topics: Alzheimer Disease; Animals; Anticonvulsants; Cognition; Diazepam; Disease Models, Animal; Intracellu

2017
Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:2

    Topics: Age Factors; Animals; Anti-Anxiety Agents; Antioxidants; Behavior, Animal; Biomarkers; Brain; Chroni

2017
Antianxiety activity guided isolation and characterization of bergenin from Caesalpinia digyna Rottler roots.
    Journal of ethnopharmacology, 2017, Jan-04, Volume: 195

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzopyrans; Caesalpinia; Chemical Fraction

2017
The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala.
    Behavioural pharmacology, 2017, Volume: 28, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Basolateral Nuclear Complex; Diazepam; Disease Models, Animal

2017
Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in rats.
    Neurotoxicology, 2017, Volume: 59

    Topics: Action Potentials; Animals; Anticonvulsants; Cell Count; Diazepam; Disease Models, Animal; Electric

2017
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.
    Behavioural neurology, 2017, Volume: 2017

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal; Male; Motor Activity; Oligo

2017
Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats.
    Experimental and clinical psychopharmacology, 2017, Volume: 25, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Diazepam; Disease Models

2017
Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.
    Neuropharmacology, 2008, Volume: 55, Issue:2

    Topics: Animals; Anticonvulsants; Behavior, Animal; Benzodiazepines; Bicuculline; Diazepam; Differential Thr

2008
Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.
    Physiology & behavior, 2008, Sep-03, Volume: 95, Issue:1-2

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Withdrawal Seizures; Alcohols; Analysis of Variance; Animal

2008
Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticus.
    Journal of neuropathology and experimental neurology, 2008, Volume: 67, Issue:7

    Topics: Age Factors; Animals; Animals, Newborn; Anticonvulsants; Brain Injuries; Diazepam; Disease Models, A

2008
Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.
    Epilepsy research, 2008, Volume: 81, Issue:2-3

    Topics: Animals; Anticonvulsants; bcl-2-Associated X Protein; Caspase 3; Cell Death; Ceramides; Diazepam; Di

2008
Evaluation of the repeated open-space swim model of depression in the mouse.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 91, Issue:1

    Topics: Adaptation, Psychological; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation;

2008
Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Epilepsy research, 2008, Volume: 82, Issue:1

    Topics: Amygdala; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; Diazepam; Disease

2008
Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
    European journal of pharmacology, 2008, Nov-12, Volume: 597, Issue:1-3

    Topics: Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Sch

2008
Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
    Pain, 2009, Volume: 141, Issue:3

    Topics: Analysis of Variance; Anesthetics; Animals; Arginine; Diazepam; Disease Models, Animal; Dose-Respons

2009
A simple quantitative method for analyzing electrographic status epilepticus in rats.
    Journal of neurophysiology, 2009, Volume: 101, Issue:3

    Topics: Action Potentials; Analysis of Variance; Animals; Anticonvulsants; Diazepam; Disease Models, Animal;

2009
[Effects of Semen Ziziphi Spinosae on the anxiety behavior of the yin deficiency mice].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2008, Volume: 31, Issue:11

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Dr

2008
Limiting effect of diazepam on Lewis Lung carcinoma metastasis in anxious male mice.
    Experimental oncology, 2009, Volume: 31, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Carcinoma, Lewis Lung; Diazepam; Disease Models, Animal; Lung

2009
A KCNQ channel opener for experimental neonatal seizures and status epilepticus.
    Annals of neurology, 2009, Volume: 65, Issue:3

    Topics: Aminopyridines; Animals; Animals, Newborn; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-R

2009
Influence of diazepam on different behavioral states of sleep-waking cycle.
    Georgian medical news, 2009, Issue:168

    Topics: Animals; Cats; Diazepam; Disease Models, Animal; Electroencephalography; Hypnotics and Sedatives; Sl

2009
EEG stages predict treatment response in experimental status epilepticus.
    Epilepsia, 2009, Volume: 50, Issue:4

    Topics: Analysis of Variance; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Disease Progressio

2009
Anticonvulsant effect of Ficus religiosa: role of serotonergic pathways.
    Journal of ethnopharmacology, 2009, Jun-22, Volume: 123, Issue:2

    Topics: Animals; Anticonvulsants; Cyproheptadine; Diazepam; Disease Models, Animal; Dose-Response Relationsh

2009
Central action of Araucaria angustifolia seed lectin in mice.
    Epilepsy & behavior : E&B, 2009, Volume: 15, Issue:3

    Topics: Analysis of Variance; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Rela

2009
Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats.
    Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:3

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; C

2009
Microemulsion based intranasal delivery system for treatment of insomnia.
    Drug delivery, 2009, Volume: 16, Issue:3

    Topics: Administration, Intranasal; Alprazolam; Animals; Diazepam; Disease Models, Animal; Drug Compounding;

2009
High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy.
    Epilepsia, 2010, Volume: 51, Issue:1

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Respons

2010
Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Oct-01, Volume: 33, Issue:7

    Topics: Acetaminophen; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Behavior, Animal; Cannabino

2009
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Neurobiology of disease, 2009, Volume: 36, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Anxiety

2009
Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Buspirone; Chlordiazepoxid

2009
Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
    Epilepsia, 2010, Volume: 51, Issue:1

    Topics: Animals; Anticonvulsants; Behavior, Animal; Benzodiazepines; Blood Pressure; Diazepam; Disease Model

2010
Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:8

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Balsams; Diazepam; Disease Models, Animal; Dose-Response Rela

2009
Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity.
    Biological psychiatry, 2010, Feb-15, Volume: 67, Issue:4

    Topics: Age Factors; Animals; Animals, Newborn; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Diazepam; Dis

2010
Qualitative analysis of hippocampal plastic changes in rats with epilepsy supplemented with oral omega-3 fatty acids.
    Epilepsy & behavior : E&B, 2010, Volume: 17, Issue:1

    Topics: Administration, Oral; Animals; Anticonvulsants; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine

2010
Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
    Behavioural brain research, 2010, Apr-02, Volume: 208, Issue:2

    Topics: Amphetamines; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepa

2010
Modeling withdrawal syndrome in zebrafish.
    Behavioural brain research, 2010, Apr-02, Volume: 208, Issue:2

    Topics: Animals; Anxiety; Behavior, Animal; Caffeine; Diazepam; Disease Models, Animal; Ethanol; Exploratory

2010
Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:5-6

    Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Chromatography, L

2010
Tolerance, sensitization and dependence to diazepam in Balb/c mice exposed to a novel open space anxiety test.
    Behavioural brain research, 2010, May-01, Volume: 209, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal; Dose-Response Relationship,

2010
Anxiolytic-like effect of Aronia melanocarpa fruit juice in rats.
    Methods and findings in experimental and clinical pharmacology, 2009, Volume: 31, Issue:10

    Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Beverages; Diazepam; Disease Models, Animal; Dose-Re

2009
Enhanced expression of the neuronal K+/Cl- cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats.
    Brain research, 2010, Apr-14, Volume: 1325

    Topics: Animals; Central Nervous System Agents; Cerebellum; Cerebral Cortex; Depressive Disorder; Diazepam;

2010
Diphenyl diselenide-induced seizures in rat pups: possible interaction with GABAergic system.
    Neurological research, 2010, Volume: 32, Issue:9

    Topics: Acetanilides; Animals; Animals, Newborn; Benzene Derivatives; Diazepam; Disease Models, Animal; Dose

2010
The control of kainic acid-induced status epilepticus.
    Epilepsy research, 2010, Volume: 90, Issue:1-2

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug S

2010
Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus.
    Journal of biomedical science, 2010, May-18, Volume: 17

    Topics: Animals; Blotting, Western; Brain Injuries; Calcium Channel Blockers; Calcium Signaling; Chlorides;

2010
Examining face and construct validity of a noninvasive model of panic disorder in Lister-hooded rats.
    Psychopharmacology, 2010, Volume: 211, Issue:2

    Topics: Amygdala; Animals; Anti-Anxiety Agents; Body Temperature; Diazepam; Disease Models, Animal; Escape R

2010
Parallel anxiolytic-like and antinociceptive actions of diazepam in the anterior basolateral amygdala and dorsal periaqueductal gray.
    Brain research, 2010, Aug-19, Volume: 1349

    Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Area Under Curve; Behavior, Animal; Diazepam; Disea

2010
Microstructure of rat behavioral response to anxiety in hole-board.
    Neuroscience letters, 2010, Sep-06, Volume: 481, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Explorato

2010
Influence of etoricoxib on anticonvulsant activity of phenytoin and diazepam in experimental seizure models in mice.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:5

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug I

2010
Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.
    Sleep, 2010, Volume: 33, Issue:7

    Topics: Acetylcholine; Animals; Azabicyclo Compounds; Brain; Diazepam; Disease Models, Animal; Dose-Response

2010
Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice.
    Epilepsy & behavior : E&B, 2010, Volume: 18, Issue:3

    Topics: Animals; Anticonvulsants; Berberine; Diazepam; Disease Models, Animal; Dose-Response Relationship, D

2010
Isolation of anxiolytic principle from ethanolic root extract of Cardiospermum halicacabum.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Jan-15, Volume: 18, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Glucoside

2011
Effect of phosphamidon on convulsive behavior and biochemical parameters: modulation by progesterone and 4'-chlorodiazepam in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2010, Volume: 382, Issue:4

    Topics: Acetylcholinesterase; Acute Disease; Animals; Antioxidants; Behavior, Animal; Brain; Chronic Disease

2010
Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition.
    Neuron, 2010, Sep-09, Volume: 67, Issue:5

    Topics: Animals; Animals, Newborn; Biophysics; Brain-Derived Neurotrophic Factor; Carbazoles; Cocaine; Cocai

2010
Reversal of memory deficits by Coriandrum sativum leaves in mice.
    Journal of the science of food and agriculture, 2011, Jan-15, Volume: 91, Issue:1

    Topics: Aging; Animals; Anticholesteremic Agents; Avoidance Learning; Brain; Cholesterol; Cholinesterase Inh

2011
GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure.
    Neuroscience, 2010, Dec-29, Volume: 171, Issue:4

    Topics: Acoustic Stimulation; Animals; Anxiety; Behavior, Animal; Benzodiazepines; Bicuculline; Clonixin; Co

2010
Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.
    Psychopharmacology, 2011, Volume: 213, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Diazepam; Disease Models, Animal; Excitatory Post

2011
A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice.
    Behavioural brain research, 2011, Mar-01, Volume: 217, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Autistic Disorder; Behavior, Animal; Di

2011
The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
    Behavioural brain research, 2011, Mar-17, Volume: 218, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cricetinae; Diazepam; Disease Models, Anima

2011
Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:6

    Topics: Animals; Antipsychotic Agents; Chlorpromazine; Diazepam; Disease Models, Animal; Female; Imipramine;

2011
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 98, Issue:1

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodioxoles; Cannabinoid Recepto

2011
T-pattern analysis of diazepam-induced modifications on the temporal organization of rat behavioral response to anxiety in hole board.
    Psychopharmacology, 2011, Volume: 215, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Behavioral Research; Diazepam; Disease Mode

2011
Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Feb-09, Volume: 31, Issue:6

    Topics: Analysis of Variance; Animals; Anticonvulsants; Cation Transport Proteins; Diazepam; Disease Models,

2011
The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats.
    Behavioural brain research, 2011, Sep-12, Volume: 222, Issue:1

    Topics: Amygdala; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Ani

2011
Effects of alcohol on the acquisition and expression of fear-potentiated startle in mouse lines selectively bred for high and low alcohol preference.
    Psychopharmacology, 2011, Volume: 218, Issue:1

    Topics: Alcohol-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal;

2011
A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:9

    Topics: Allosteric Regulation; Amphetamine; Animals; Benzodiazepines; Diazepam; Disease Models, Animal; Dopa

2011
Modeling epileptogenesis and temporal lobe epilepsy in a non-human primate.
    Epilepsy research, 2011, Volume: 96, Issue:1-2

    Topics: Analysis of Variance; Animals; Anticonvulsants; Benzoxazines; Callithrix; Diazepam; Disease Models,

2011
Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord.
    Pain, 2011, Volume: 152, Issue:8

    Topics: Analgesics; Animals; Diazepam; Disease Models, Animal; Excitatory Postsynaptic Potentials; Flumazeni

2011
Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats.
    Life sciences, 2011, Aug-15, Volume: 89, Issue:7-8

    Topics: Animals; Bone Marrow Cells; Cell Transplantation; Chronic Disease; Cognition Disorders; Diazepam; Di

2011
A critical test of the hippocampal theta model of anxiolytic drug action.
    Neuropharmacology, 2012, Volume: 62, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Biophysics; Diazepam; Disease Models, A

2012
A cell-free extract from human adipose stem cells protects mice against epilepsy.
    Epilepsia, 2011, Volume: 52, Issue:9

    Topics: Adipose Tissue; Animals; Animals, Newborn; Anticonvulsants; Blood-Brain Barrier; Cell Extracts; Cell

2011
Susceptibility to the long-term anxiogenic effects of an acute stressor is mediated by the activation of the glucocorticoid receptors.
    Neuropharmacology, 2011, Volume: 61, Issue:8

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Anti-Anxiety Agents; Cocaine;

2011
Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzoquinones; Brain; Cyclic GMP; Diazepam;

2011
Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage.
    Neuropharmacology, 2011, Volume: 61, Issue:8

    Topics: Animals; Anticonvulsants; Benzodiazepines; Cholinesterase Inhibitors; Diazepam; Disease Models, Anim

2011
Psychological stress induces alterations in temporomandibular joint ultrastructure in a rat model of temporomandibular disorder.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 112, Issue:6

    Topics: Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Cartilage, Articular; Collagen; Diazepam;

2011
Anxiolytic-like effects of human amniotic fluid and its fatty acids in Wistar rats.
    Behavioural pharmacology, 2011, Volume: 22, Issue:7

    Topics: Amniotic Fluid; Animals; Anti-Anxiety Agents; Behavior, Animal; Diazepam; Diestrus; Disease Models,

2011
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
    Behavioural pharmacology, 2011, Volume: 22, Issue:7

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Benzothiazoles; Carbolin

2011
Social defeat stress induces hyperthermia through activation of thermoregulatory sympathetic premotor neurons in the medullary raphe region.
    The European journal of neuroscience, 2011, Volume: 34, Issue:9

    Topics: Adrenergic beta-3 Receptor Antagonists; Analysis of Variance; Animals; Anti-Anxiety Agents; Body Tem

2011
Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Bridged Bicyclo Compounds; Diazepam; Dicarboxylic Acids; Dise

2011
Anticonvulsant activity of the methanolic extract of Justicia extensa T. Anders.
    Journal of ethnopharmacology, 2011, Dec-08, Volume: 138, Issue:3

    Topics: Acanthaceae; Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Female; Male;

2011
Rats with different thresholds for DMCM-induced clonic convulsions differ in the sleep-time of diazepam and [(3)H]-Ro 15-4513 binding.
    Epilepsy research, 2012, Volume: 98, Issue:2-3

    Topics: Animals; Anticonvulsants; Autoradiography; Azides; Benzodiazepines; Carbolines; Convulsants; Diazepa

2012
On the edge: pharmacological evidence for anxiety-related behavior in zebrafish larvae.
    Behavioural brain research, 2012, Mar-01, Volume: 228, Issue:1

    Topics: Animals; Anxiety; Caffeine; Cues; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug

2012
Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.
    Nature neuroscience, 2011, Dec-11, Volume: 15, Issue:2

    Topics: Analysis of Variance; Animals; Anticonvulsants; Calcium-Calmodulin-Dependent Protein Kinase Type 2;

2011
Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice.
    Behavioural brain research, 2012, Mar-17, Volume: 228, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Brain-Derived Neurotrophic Factor; Corticosteron

2012
Drug delivery system for poorly water-soluble compounds using lipocalin-type prostaglandin D synthase.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Apr-10, Volume: 159, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain Ischemia; CA1 Region, Hippocampal; Diazepam; Di

2012
Social fear conditioning: a novel and specific animal model to study social anxiety disorder.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Diazepam; Disease Models, Animal; Dose-Re

2012
[Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety Diso

2011
Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain.
    Behavioural brain research, 2012, Apr-01, Volume: 229, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Chronic Disease; Dark Adaptation; Diaze

2012
Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
    Psychopharmacology, 2012, Volume: 222, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Conflict, Psychological;

2012
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.
    Behavioural brain research, 2012, Apr-01, Volume: 229, Issue:1

    Topics: Analysis of Variance; Anesthetics; Animals; Diazepam; Disease Models, Animal; Dose-Response Relation

2012
Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats.
    Behavioural pharmacology, 2012, Volume: 23, Issue:2

    Topics: Amines; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanecarboxylic Acids; Diazepam; Disease Models

2012
[Anti-inflammatory effects of amitriptyline, diazepam and mebicar using model of acute carrageenan-induced paw edema in rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:12

    Topics: Amitriptyline; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biureas; Carrageenan; Diazepam; Dis

2011
Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu Mart. ex Benth: evaluating its anticonvulsant and anxiolytic potential.
    Epilepsy & behavior : E&B, 2012, Volume: 23, Issue:3

    Topics: Alkaloids; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Convulsants; Diazepam; Disease Mo

2012
The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice.
    Brain research bulletin, 2012, Apr-10, Volume: 87, Issue:6

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Biperiden; Diazepam; Disease Models, An

2012
A mouse kindling model of perimenstrual catamenial epilepsy.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Animals; Diazepam; Disease Models, Animal; Epilepsy; Female; Finasteri

2012
Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.
    Epilepsia, 2012, Volume: 53, Issue:5

    Topics: Animals; Anticonvulsants; Benzoxazines; Brain; Brain Mapping; Diazepam; Disease Models, Animal; Epil

2012
Central effect of crocin on penicillin-induced epileptiform activity in rats.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:1

    Topics: Animals; Anticonvulsants; Brain; Carotenoids; Diazepam; Disease Models, Animal; Dose-Response Relati

2012
An affective disorder in zebrafish with mutation of the glucocorticoid receptor.
    Molecular psychiatry, 2013, Volume: 18, Issue:6

    Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Anti-Anxiety Agents; Arginine; Brain;

2013
The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.
    Croatian medical journal, 2012, Volume: 53, Issue:3

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Adrenocorticotropic Hormone; alpha-Meth

2012
Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy.
    Epilepsy research, 2012, Volume: 102, Issue:3

    Topics: Age Factors; Animals; Anticonvulsants; Atropine; Body Weight; Diazepam; Disease Models, Animal; Epil

2012
Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex.
    Neuropharmacology, 2012, Volume: 63, Issue:5

    Topics: Animals; Anticonvulsants; Astrocytes; Diazepam; Disease Models, Animal; Drug Resistance; Entorhinal

2012
Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Dec-03, Volume: 39, Issue:2

    Topics: Acetamides; Aniline Compounds; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Anim

2012
Synthesis and pharmacological investigation of 2-(4-dimethylaminophenyl)-3,5-disubstituted thiazolidin-4-ones as anticonvulsants.
    Archiv der Pharmazie, 2012, Volume: 345, Issue:10

    Topics: Acetamides; Animals; Anticonvulsants; Benzamides; Diazepam; Disease Models, Animal; Epilepsy; Male;

2012
Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test.
    Behavioural brain research, 2012, Dec-01, Volume: 235, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Carbazoles; Diazepam; Disease Models, A

2012
Antiepileptic potential of ursolic acid stearoyl glucoside by GABA receptor stimulation.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:9

    Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship,

2012
N (w) -propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses.
    The European journal of neuroscience, 2012, Volume: 36, Issue:9

    Topics: Animals; Arginine; Brain Waves; Dentate Gyrus; Diazepam; Disease Models, Animal; Gliosis; Immunohist

2012
Evaluation of anti convulsant activity of aerial parts of Phyllanthus longiflorus heyne ex hook.
    European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 3

    Topics: Administration, Oral; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Rela

2012
Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization.
    Experimental neurology, 2012, Volume: 238, Issue:2

    Topics: Analysis of Variance; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Rela

2012
Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice.
    Behavioural brain research, 2012, Dec-01, Volume: 235, Issue:2

    Topics: Acetylation; Analysis of Variance; Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; D

2012
A higher inherent trait for fearfulness is associated with increased anxiety-like behaviours and diazepam sensitivity in Japanese quail.
    Behavioural brain research, 2013, Jan-15, Volume: 237

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Coturnix; Diazepam; D

2013
Effects of diazepam and flumazenil on forebrain ischaemia in a rat model of benzodiazepine tolerance.
    British journal of anaesthesia, 2012, Volume: 109, Issue:6

    Topics: Analysis of Variance; Animals; Benzodiazepines; Brain Ischemia; Diazepam; Disease Models, Animal; Dr

2012
Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Conditioning, Operant; Diazepam; Disease Models, Animal; Dose

2013
A depressive phenotype induced by Bacille Calmette Guérin in 'susceptible' animals: sensitivity to antidepressants.
    Psychopharmacology, 2013, Volume: 226, Issue:3

    Topics: Animals; Antidepressive Agents; BCG Vaccine; Chronic Disease; Depression; Desipramine; Diazepam; Dis

2013
Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Alkaloids; Amino Acids; Animals; Anticonvulsants; Antioxidants; Atropine; Benzodioxoles; Biogenic Mo

2013
Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Animals; Behavior, Animal; Clomipramine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Flu

2013
Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Animals; Behavior, Animal; Brain; Convulsants; Diazepam; Disease Models, Animal; Dose-Response Relat

2013
Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus.
    Epilepsy research, 2002, Volume: 50, Issue:3

    Topics: Animals; Anticonvulsants; Benzodiazepines; Chi-Square Distribution; Diazepam; Disease Models, Animal

2002
Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse.
    Journal of neuroscience research, 2002, Sep-01, Volume: 69, Issue:5

    Topics: Analysis of Variance; Animals; Anticonvulsants; Cell Death; Diazepam; Disease Models, Animal; Electr

2002
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Nov-12, Volume: 99, Issue:23

    Topics: Animals; Anticonvulsants; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Diazepam; Disease Mod

2002
Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome.
    Neurochemistry international, 2003, Volume: 43, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Brain; Chlormethiazole; Clorgyline; Diazepam; Diseas

2003
Reduction of inflammation in rats by diazepam: tolerance development.
    Life sciences, 2003, Apr-11, Volume: 72, Issue:21

    Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Corticosterone; Diazepam; Disease Models, Animal; Do

2003
22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state.
    Behavioural brain research, 2003, Apr-17, Volume: 141, Issue:1

    Topics: Animals; Anxiety; Behavior, Animal; Buspirone; Carbolines; Conditioning, Classical; Diagnosis, Diffe

2003
Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
    Psychopharmacology, 2003, Volume: 169, Issue:2

    Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety; Carbolines; Dextroamphetamine; Diaz

2003
Posture and balance responses to a sensory challenge are related to anxiety in mice.
    Psychiatry research, 2003, Jun-15, Volume: 118, Issue:3

    Topics: Animals; Anticonvulsants; Anxiety Disorders; Diazepam; Disease Models, Animal; Male; Mice; Mice, Inb

2003
Tail-swing behavior: a novel animal model for anxiety.
    Methods and findings in experimental and clinical pharmacology, 2003, Volume: 25, Issue:5

    Topics: Animals; Anxiety; Behavior, Animal; Desipramine; Diazepam; Disease Models, Animal; Haloperidol; Immo

2003
Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
    The European journal of neuroscience, 2003, Volume: 18, Issue:6

    Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Avian Proteins; Basigin; Blood Protein

2003
Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats.
    The European journal of neuroscience, 2003, Volume: 18, Issue:8

    Topics: Animals; Anticonvulsants; Aspartic Acid; Cell Count; Creatine; Diazepam; Disease Models, Animal; Epi

2003
Diazepam prophylaxis for bicuculline-induced seizures: a rat dose-response model.
    Neuroscience letters, 2004, Feb-06, Volume: 356, Issue:1

    Topics: Action Potentials; Animals; Bicuculline; Diazepam; Disease Models, Animal; Dose-Response Relationshi

2004
Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia.
    Experimental neurology, 2003, Volume: 184, Issue:2

    Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Brain; Diazepam; Disease Models, Animal

2003
Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 77, Issue:3

    Topics: Animals; Diazepam; Disease Models, Animal; Electric Stimulation; Escape Reaction; Fluoxetine; Immobi

2004
Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.
    The Journal of physiology, 2004, Jun-01, Volume: 557, Issue:Pt 2

    Topics: Animals; Anticonvulsants; Dentate Gyrus; Diazepam; Disease Models, Animal; Electric Conductivity; Ep

2004
Effects of fosphenytoin on nerve agent-induced status epilepticus.
    Drug and chemical toxicology, 2004, Volume: 27, Issue:1

    Topics: Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Diazepam; Disease Models, Animal; Dose-

2004
The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2004, Volume: 55, Issue:1 Pt 1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Conflict, Psychological

2004
Abnormal benzodiazepine and zinc modulation of GABAA receptors in an acquired absence epilepsy model.
    Brain research, 2004, Jul-09, Volume: 1013, Issue:2

    Topics: Androstenes; Animals; Anticonvulsants; Benzodiazepines; Diazepam; Disease Models, Animal; Enzyme Inh

2004
Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
    The European journal of neuroscience, 2004, Volume: 20, Issue:1

    Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Bombesin; Bra

2004
Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats.
    Neuroscience letters, 2004, Aug-26, Volume: 367, Issue:1

    Topics: Animals; Anticonvulsants; Body Weight; Brain Ischemia; Cerebral Infarction; Diazepam; Disease Models

2004
The effects of angelica essential oil in three murine tests of anxiety.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:2

    Topics: Angelica sinensis; Animals; Anti-Anxiety Agents; Anxiety; Darkness; Diazepam; Disease Models, Animal

2004
Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?
    Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Depression; Diazepam; Disea

2004
Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:4

    Topics: Alcoholism; Animals; Diazepam; Discrimination, Psychological; Disease Models, Animal; Drug Interacti

2005
Acute effect of an extract of Ambrosia paniculata (Willd.) O. E. Schultz (mugwort) in several models of experimental epilepsy.
    Epilepsy & behavior : E&B, 2004, Volume: 5, Issue:6

    Topics: Ambrosia; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Cerebral Cortex; Diazepa

2004
Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Behavior

2004
Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat.
    Epilepsia, 2005, Volume: 46, Issue:2

    Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Electroencephal

2005
Benzodiazepine effect of (125)I-iomazenil-benzodiazepine receptor binding and serum corticosterone level in a rat model.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:1

    Topics: Animals; Brain; Corticosterone; Diazepam; Disease Models, Animal; Flumazenil; Male; Radionuclide Ima

2005
Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat.
    Epilepsy research, 2005, Volume: 63, Issue:1

    Topics: Action Potentials; Amygdala; Animals; Anticonvulsants; Behavior, Animal; Chi-Square Distribution; Di

2005
The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzamides; Conflict, Psychological; Diazepam; Disea

2005
Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression.
    Neuroscience, 2005, Volume: 131, Issue:3

    Topics: Animals; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Response Relation

2005
Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Apr-27, Volume: 25, Issue:17

    Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Anxiety Agents; Anxiety Disorders; Avoidance L

2005
Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
    Biological psychiatry, 2005, May-15, Volume: 57, Issue:10

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Desipramine; Diazepam; Disease Model

2005
Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists.
    Behavioural brain research, 2005, Jun-20, Volume: 161, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Interpers

2005
A new assay of thermal-based avoidance test in freely moving mice.
    The journal of pain, 2005, Volume: 6, Issue:7

    Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Avoidance Learning; Behavior, Animal; Biological A

2005
Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng.
    Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:6

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Mod

2005
Novel oral drug administration in an animal model of neuroleptic therapy.
    Journal of neuroscience methods, 2005, Aug-15, Volume: 146, Issue:2

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Brain; Clozapine

2005
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:4

    Topics: Amygdala; Analgesics, Opioid; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Benzamides;

2006
A single session of emotional stress produces anxiety in Wistar rats.
    Behavioural brain research, 2006, Feb-15, Volume: 167, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Mod

2006
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Nov-22, Volume: 102, Issue:47

    Topics: Amphetamine; Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; Dopamine; Electrophysio

2005
Influence of the post-ovariectomy time frame on the experimental anxiety and the behavioural actions of some anxiolytic agents.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety;

2006
Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity.
    Journal of neuroscience research, 2006, Feb-15, Volume: 83, Issue:3

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Anticonvuls

2006
Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety.
    Behavioural pharmacology, 2006, Volume: 17, Issue:1

    Topics: Acetamides; Animals; Anti-Anxiety Agents; Arousal; Brain; Buspirone; Chronotherapy; Conditioning, Cl

2006
Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats.
    Journal of neurotrauma, 2006, Volume: 23, Issue:1

    Topics: Anesthetics; Animals; Brain; Brain Injuries; Cell Survival; Cognition Disorders; Diazepam; Disease M

2006
Activation of Rho after traumatic brain injury and seizure in rats.
    Experimental neurology, 2006, Volume: 198, Issue:2

    Topics: Animals; Anticonvulsants; Brain Injuries; Cerebral Cortex; Diazepam; Disease Models, Animal; Drug In

2006
Mouse strain differences in autonomic responses to stress.
    Genes, brain, and behavior, 2006, Volume: 5, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Autonomic Nervous System; Autonomic Nervous System

2006
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
    Brain research bulletin, 2006, Mar-31, Volume: 69, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disea

2006
Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm.
    The European journal of neuroscience, 2006, Volume: 23, Issue:9

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Central Nervous System

2006
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Neuropharmacology, 2006, Volume: 51, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Behav

2006
Anticonvulsant properties of hypothermia in experimental status epilepticus.
    Neurobiology of disease, 2006, Volume: 23, Issue:3

    Topics: Animals; Anticonvulsants; Body Temperature; Brain; Cold Temperature; Dentate Gyrus; Diazepam; Diseas

2006
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Dec-30, Volume: 30, Issue:8

    Topics: Animals; Anticonvulsants; Convulsants; Cyclooxygenase Inhibitors; Diazepam; Disease Models, Animal;

2006
The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
    Epilepsy research, 2006, Volume: 72, Issue:2-3

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Therapy, Combination; Electroenceph

2006
The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 85, Issue:2

    Topics: Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Mi

2006
Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent.
    Epilepsy research, 2007, Volume: 73, Issue:2

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Fructo

2007
Lithium-methomyl induced seizures in rats: a new model of status epilepticus?
    Toxicology and applied pharmacology, 2007, Volume: 219, Issue:2-3

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Synergism; Electroencephalography;

2007
Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae).
    Brain research, 2006, Dec-08, Volume: 1124, Issue:1

    Topics: Analysis of Variance; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Bicuculline; Choice Behav

2006
Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Journal of ethnopharmacology, 2007, Apr-04, Volume: 110, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Apocynum; Behavior, Animal; Buspirone; Diazepam; Disease Mode

2007
Effects of diazepam on 125I-iomazenil-benzodiazepine receptor binding and epileptic seizures in the El mouse.
    Annals of nuclear medicine, 2006, Volume: 20, Issue:8

    Topics: Animals; Anticonvulsants; Autoradiography; Brain; Diazepam; Disease Models, Animal; Epilepsy; Flumaz

2006
Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
    Epilepsy research, 2007, Volume: 74, Issue:1

    Topics: Amygdala; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Dr

2007
Anxiolytic effect of saponins from Panax quinquefolium in mice.
    Journal of ethnopharmacology, 2007, May-22, Volume: 111, Issue:3

    Topics: Aggression; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Darkness; Diazepam; Disease Mod

2007
Sleep-related epilepsy in the A/J mouse.
    Sleep, 2007, Volume: 30, Issue:2

    Topics: Alleles; Animals; Anticonvulsants; Chromosomes, Mammalian; Diazepam; Disease Models, Animal; Electro

2007
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
    Psychopharmacology, 2007, Volume: 193, Issue:1

    Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic

2007
Anxiolytic-like effects of oleamide in group-housed and socially isolated mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Aug-15, Volume: 31, Issue:6

    Topics: Aggression; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Diazepam; Disease Models, Anim

2007
Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
    Journal of pharmacological sciences, 2007, Volume: 104, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbolines; Central N

2007
Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2007, Volume: 14, Issue:8

    Topics: Animals; Cocaine; Cocaine-Related Disorders; Confidence Intervals; Diazepam; Disease Models, Animal;

2007
Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
    Neuropharmacology, 2007, Volume: 53, Issue:2

    Topics: Amygdala; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Brain Damage, Chronic; D

2007
Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment.
    Behavioural brain research, 2007, Oct-01, Volume: 183, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiet

2007
Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice.
    Behavioural brain research, 2007, Nov-02, Volume: 183, Issue:2

    Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Central Nervous S

2007
Pharmacological modulation of anxiety-related behaviors in the murine Suok test.
    Brain research bulletin, 2007, Sep-14, Volume: 74, Issue:1-3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Circadian Rhythm; Diazepam; Disease Models,

2007
Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors.
    BMC complementary and alternative medicine, 2007, Aug-08, Volume: 7

    Topics: Animals; Anticonvulsants; Antidotes; Convulsants; Diazepam; Disease Models, Animal; Dose-Response Re

2007
The effects of prolonged rose odor inhalation in two animal models of anxiety.
    Physiology & behavior, 2007, Dec-05, Volume: 92, Issue:5

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Choice Behavior; Diaz

2007
Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits.
    Anesthesiology, 2007, Volume: 107, Issue:3

    Topics: Analgesics; Anesthetics, Combined; Anesthetics, Intravenous; Animals; Animals, Newborn; Anti-Anxiety

2007
Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
    Behavioural pharmacology, 2007, Volume: 18, Issue:5-6

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Diazepam; Disease Models,

2007
Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jan-01, Volume: 32, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Mod

2008
Anxiogenic effects of cocaine withdrawal in zebrafish.
    Physiology & behavior, 2008, Jan-28, Volume: 93, Issue:1-2

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cocaine; Diazepam; Disease Models, Anim

2008
Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus.
    Neuropharmacology, 2007, Volume: 53, Issue:7

    Topics: Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Diazepam; Disease Models, Animal; D

2007
A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation.
    Epilepsia, 2008, Volume: 49, Issue:2

    Topics: Animals; Cerebral Cortex; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug S

2008
A substance in broad beans (Vicia faba) is protective against experimentally induced convulsions in mice.
    Epilepsy & behavior : E&B, 2008, Volume: 12, Issue:1

    Topics: Analysis of Variance; Animals; Anticonvulsants; Chromatography, Thin Layer; Diazepam; Disease Models

2008
Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2

    Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Binding Sites; Brain; Diazepam; Dis

2008
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
    Nature, 2008, Jan-17, Volume: 451, Issue:7176

    Topics: Analgesics; Animals; Brain; Capsaicin; Chronic Disease; Diazepam; Disease Models, Animal; Fluorobenz

2008
Use of antipsychotics to treat cocaine toxicity?
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2008, Volume: 15, Issue:1

    Topics: Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Diazepam; Disease Models, Animal;

2008
Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus.
    Journal of neurophysiology, 2008, Volume: 99, Issue:3

    Topics: Allosteric Regulation; Animals; Anticonvulsants; Benzodiazepines; Diazepam; Disease Models, Animal;

2008
Sedative and anticonvulsant effects of zolpidem in adult and aged mice.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:6

    Topics: Age Factors; Animals; Anticonvulsants; Brain; Convulsants; Diazepam; Disease Models, Animal; Dose-Re

2008
Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Apr-01, Volume: 32, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; D

2008
Effective treatments of prolonged status epilepticus in developing rats.
    Epilepsy & behavior : E&B, 2008, Volume: 13, Issue:1

    Topics: Age Factors; Animals; Animals, Newborn; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models,

2008
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.
    Behavioural pharmacology, 2008, Volume: 19, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Depress

2008
Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo.
    Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:7

    Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diazepam; Diseas

2008
Comparison of anti-conflict drug effects in three experimental animal models of anxiety.
    Psychopharmacology, 1981, Volume: 74, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Conflict, Psychological; Diazepam; Disease Models, Animal; Dr

1981
Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region.
    Brain research, 1982, Sep-30, Volume: 248, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal; Drug Interactions; Electric

1982
Alprazolam in a biochemical model of depression.
    Biochemical pharmacology, 1982, Oct-01, Volume: 31, Issue:19

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Depression; Diazepam; Disease Models, Ani

1982
Animal psychopharmacological models: use of conflict behavior in predicting clinical effects of anxiolytics and their mechanism of action.
    Progress in neuro-psychopharmacology & biological psychiatry, 1982, Volume: 6, Issue:4-6

    Topics: Animals; Anti-Anxiety Agents; Arousal; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Co

1982
Brain benzodiazepine receptors and their rapid changes after seizures in the Mongolian gerbil.
    Japanese journal of pharmacology, 1980, Volume: 30, Issue:6

    Topics: Animals; Binding Sites; Brain; Diazepam; Disease Models, Animal; Epilepsy; Gerbillinae; Receptors, D

1980
High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:3

    Topics: Alkynes; Aminocaproates; Aminooxyacetic Acid; Animals; Anticonvulsants; Diazepam; Disease Models, An

1983
Stress ulcer accompanying subarachnoid hemorrhage--a new rat model.
    The Japanese journal of surgery, 1983, Volume: 13, Issue:4

    Topics: Animals; Cimetidine; Diazepam; Disease Models, Animal; Gastric Mucosa; Male; Pentobarbital; Phenytoi

1983
Comparison of effects of diazepam on barbiturate and on ethanol withdrawal.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 225, Issue:3

    Topics: Animals; Behavior, Animal; Cats; Diazepam; Disease Models, Animal; Ethanol; Female; Humans; Male; Pe

1983
The pentylenetetrazol model of anxiety detects withdrawal from diazepam in rats.
    Life sciences, 1983, Jul-11, Volume: 33, Issue:2

    Topics: Animals; Anxiety; Diazepam; Discrimination Learning; Disease Models, Animal; Humans; Male; Pentylene

1983
Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.
    Gastroenterology, 1984, Volume: 86, Issue:3

    Topics: Animals; Diazepam; Disease Models, Animal; Electrodes; Electroencephalography; Evoked Potentials, Vi

1984
Alterations in cerebellar glutamic acid decarboxylase (GAD) activity in a genetic model of torsion dystonia (rat).
    Experimental neurology, 1984, Volume: 85, Issue:1

    Topics: Animals; Brain; Cerebellum; Diazepam; Disease Models, Animal; Dystonia; Glutamate Decarboxylase; His

1984
Modification of the anticonvulsant efficacy of diazepam by Ro-15-1788 in the kindled amygdaloid seizure model.
    Life sciences, 1982, Oct-11, Volume: 31, Issue:15

    Topics: Amygdala; Animals; Anticonvulsants; Benzodiazepinones; Diazepam; Disease Models, Animal; Dose-Respon

1982
Effects of selected drugs on spontaneously occurring abnormal behavior in beagles.
    Pharmacology, biochemistry, and behavior, 1983, Volume: 18, Issue:3

    Topics: Amobarbital; Animals; Antidepressive Agents; Arousal; Behavior, Animal; Chlordiazepoxide; Diazepam;

1983
Experimental chronic epilepsy in rats: a screening method for antiepileptic drugs.
    Pharmacological research communications, 1983, Volume: 15, Issue:5

    Topics: Animals; Anticonvulsants; Chlorides; Chronic Disease; Clonazepam; Diazepam; Disease Models, Animal;

1983
Effect of hyperbilirubinemia on the pharmacokinetics of diazepam in the rat.
    Research communications in chemical pathology and pharmacology, 1980, Volume: 28, Issue:1

    Topics: Animals; Diazepam; Disease Models, Animal; Half-Life; Humans; Hyperbilirubinemia; Hyperbilirubinemia

1980
A study of the action of anticonvulsant drugs on an experimental model of epilepsy.
    Acta physiologica latino americana, 1980, Volume: 30, Issue:4

    Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Electric Stimulation; Epi

1980
Repeated seizures induce long-term increase in hippocampal benzodiazepine receptors.
    Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:5

    Topics: Amygdala; Animals; Benzodiazepines; Cerebral Cortex; Diazepam; Disease Models, Animal; Electroshock;

1980
Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice.
    Journal of pharmacobio-dynamics, 1981, Volume: 4, Issue:7

    Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Antidepressive Agents; Behavior, Animal; Diazepam; Disease

1981
Effect of antiepileptic drugs and an anticonvulsant on epileptiform activity induced by antibodies to ganglioside.
    Experimental neurology, 1982, Volume: 78, Issue:3

    Topics: Action Potentials; Aminooxyacetic Acid; Animals; Anticonvulsants; Cobalt; Diazepam; Disease Models,

1982
Effect of diazepam (Valium) on chronic stress-induced hypertension in the rat.
    Experientia, 1981, Mar-15, Volume: 37, Issue:3

    Topics: Animals; Blood Pressure; Body Weight; Diazepam; Disease Models, Animal; Hypertension; Male; Rats; St

1981
The anticonvulsant effects of diazepam and phenobarbital in prekindled and kindled cortical seizures.
    Neuropharmacology, 1981, Volume: 20, Issue:11

    Topics: Amygdala; Animals; Anticonvulsants; Cerebral Cortex; Diazepam; Disease Models, Animal; Epilepsy; Mal

1981
Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:2

    Topics: Animals; Anticonvulsants; Benzodiazepinones; Carbolines; Diazepam; Disease Models, Animal; Drug Tole

1995
(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: Analgesics; Animals; Benzoxazines; Cricetinae; Diazepam; Disease Models, Animal; Dose-Response Relat

1994
Respiratory drive during status epilepticus and its treatment: comparison of diazepam and lorazepam.
    Epilepsy research, 1995, Volume: 20, Issue:1

    Topics: Animals; Diazepam; Disease Models, Animal; Epilepsy, Tonic-Clonic; Hydrogen-Ion Concentration; Loraz

1995
Observations of novel behaviors as indices of ethanol withdrawal-induced anxiety.
    Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1993, Volume: 2

    Topics: Animals; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Ethanol; Exploratory Behavior;

1993
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
    Psychopharmacology, 1994, Volume: 116, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chl

1994
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
    Psychopharmacology, 1993, Volume: 112, Issue:2-3

    Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinkin

1993
Gender differences in diazepam withdrawal syndrome in mice.
    Pharmacology & toxicology, 1994, Volume: 75, Issue:6

    Topics: Animals; Body Weight; Castration; Diazepam; Disease Models, Animal; Estrogens; Female; Flumazenil; I

1994
Perinatally protein-deprived rats and reactivity to anxiolytic drugs in the plus-maze test: an animal model for screening antipanic agents?
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Conflict, Psychological; Diazepam; Disease Models, Animal; Do

1993
Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Electrosh

1993
Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
    Epilepsy research, 1993, Volume: 15, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Acoustic Stimulation; Amino Acids; Amino Acids, Cyclic; Analysis of Var

1993
Effect of diazepam on muscle weakness in a model of myasthenia gravis in rats.
    Journal of neural transmission. General section, 1993, Volume: 93, Issue:3

    Topics: Animals; Bungarotoxins; Diazepam; Disease Models, Animal; Female; Lip; Male; Muscle Contraction; Mus

1993
The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1993, Volume: 26, Issue:1

    Topics: Animals; Anxiety; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Memory; Rats;

1993
Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:3

    Topics: Animals; Anticonvulsants; Carbolines; Diazepam; Disease Models, Animal; Electromyography; Female; Ma

1993
Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
    Pharmacology & toxicology, 1995, Volume: 77, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; A

1995
Long-duration self-sustained epileptiform activity in the hippocampal-parahippocampal slice: a model of status epilepticus.
    Journal of neurophysiology, 1995, Volume: 74, Issue:5

    Topics: Animals; Diazepam; Disease Models, Animal; Electric Stimulation; Entorhinal Cortex; Hippocampus; In

1995
Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice.
    Journal of pharmacological and toxicological methods, 1996, Volume: 35, Issue:1

    Topics: Analgesics, Opioid; Animals; Anticonvulsants; Carbamazepine; Convulsants; Diazepam; Disease Models,

1996
Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1 -H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:3

    Topics: Acetylcholinesterase; Analysis of Variance; Animals; Benzazepines; Brain; Diazepam; Disease Models,

1996
The neurochemical pathology of thiamine deficiency: GABAA and glutamateNMDA receptor binding sites in a goat model.
    Metabolic brain disease, 1996, Volume: 11, Issue:1

    Topics: Alcoholism; Amprolium; Animals; Brain Chemistry; Diazepam; Disease Models, Animal; Dizocilpine Malea

1996
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepi

1996
Effects of (-)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis.
    Hearing research, 1996, Volume: 97, Issue:1-2

    Topics: Acoustic Stimulation; Animals; Auditory Threshold; Baclofen; Clonazepam; Diazepam; Disease Models, A

1996
Effect of chronic diazepam treatment on footshock-induced ultrasonic vocalization in adult male rats.
    Pharmacology & toxicology, 1995, Volume: 77, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Disease Models, Animal; Dose-

1995
Heterogeneity in the performance of outbred Sprague-Dawley rats in an elevated-plus maze test: a possible animal model for anxiety disorder.
    Life sciences, 1996, Volume: 59, Issue:18

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Male; Rat

1996
High-performance liquid chromatographic determination of midazolam in rat brain.
    Journal of chromatography. B, Biomedical applications, 1996, Aug-30, Volume: 683, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Brain Chemistry; Chromatography, High Pressure Liquid; Diazepam; Disea

1996
Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists.
    European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1

    Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Dizocilpine Maleate; Drug I

1997
Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
    Methods and findings in experimental and clinical pharmacology, 1997, Volume: 19, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Conflict, Psychological; Diazepam; Disease

1997
Local perfusion of diazepam attenuates interictal and ictal events in the bicuculline model of epilepsy in rats.
    Epilepsia, 1997, Volume: 38, Issue:5

    Topics: Administration, Topical; Animals; Bicuculline; Cerebral Cortex; Diazepam; Disease Models, Animal; Do

1997
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    British journal of pharmacology, 1997, Volume: 121, Issue:4

    Topics: Amylases; Animals; Anorexia; Anti-Anxiety Agents; Benzodiazepinones; Carbamates; Cholecystokinin; De

1997
[Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Clonazepam; Diazepam; Disease Models, Ani

1997
Effects of diazepam and buspirone on the behaviour of wild voles (Microtus socialis) in two models of anxiety.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Arvicolinae; Behavior, Animal; Buspirone; Diazepam; Disease M

1997
Benzodiazepine receptors influence spinal cord evoked potentials and edema following trauma to the rat spinal cord.
    Acta neurochirurgica. Supplement, 1997, Volume: 70

    Topics: Animals; Diazepam; Disease Models, Animal; Edema; Evoked Potentials; GABA-A Receptor Agonists; Male;

1997
Interictal and ictal activity in the rat cobalt/pilocarpine model of epilepsy decreased by local perfusion of diazepam.
    Epilepsy research, 1997, Volume: 29, Issue:1

    Topics: Animals; Anticonvulsants; Cobalt; Diazepam; Disease Models, Animal; Electroencephalography; Epilepsy

1997
The connection between absence-like seizures and hypothermia induced by penicillin: possible implication on other animal models of petit mal epilepsy.
    Brain research, 1997, Nov-28, Volume: 777, Issue:1-2

    Topics: Animals; Anticonvulsants; Body Temperature; Cerebral Cortex; Diazepam; Disease Models, Animal; Elect

1997
BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.
    European journal of pharmacology, 1997, Nov-19, Volume: 339, Issue:1

    Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Dose-Response R

1997
Effect of narcotic agents and of bleeding on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic rats.
    Clinical science (London, England : 1979), 1997, Volume: 93, Issue:6

    Topics: Animals; Blood Pressure; Butyrophenones; Carbon Tetrachloride; Diazepam; Disease Models, Animal; Dru

1997
Diazepam suppresses sleep apneas in rats.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:3 Pt 1

    Topics: Analysis of Variance; Animals; Diazepam; Disease Models, Animal; Electroencephalography; Electromyog

1998
Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.
    Japanese journal of pharmacology, 1998, Volume: 76, Issue:3

    Topics: Aggression; Animals; Anti-Anxiety Agents; Anxiety; Buspirone; Diazepam; Dioxanes; Dioxoles; Disease

1998
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    European journal of pharmacology, 1998, Jul-24, Volume: 353, Issue:2-3

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbolines; Convulsants; Diazepam; Disease Mod

1998
Opioid receptor mediated anticonvulsant effect of pentazocine.
    Indian journal of medical sciences, 1998, Volume: 52, Issue:1

    Topics: Analgesics, Opioid; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relati

1998
Effects of acute and repeated dose administration of caffeine and pentoxifylline on diazepam-induced mouse behavior in the hole-board test.
    Psychopharmacology, 1999, Volume: 144, Issue:1

    Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Caffeine; Diazepam; Disease Models, Animal

1999
Alcohol responsiveness, hyperreactivity, and motor restlessness in an animal model for attention-deficit hyperactivity disorder.
    Psychopharmacology, 1999, Sep-01, Volume: 146, Issue:1

    Topics: Alcohol Drinking; Animals; Attention Deficit Disorder with Hyperactivity; Brain Chemistry; Diazepam;

1999
A gene promotes anxiety in mice-and also in scientists.
    Nature medicine, 1999, Volume: 5, Issue:10

    Topics: Animals; Anxiety Disorders; Diazepam; Disease Models, Animal; Mice; Mice, Mutant Strains; Models, Ps

1999
NMDA- but not kainate-mediated events reduce efficacy of some antiepileptic drugs against generalized tonic-clonic seizures in mice.
    Epilepsia, 1999, Volume: 40, Issue:11

    Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Dose-Response Relationshi

1999
Felbamate in experimental model of status epilepticus.
    Epilepsia, 2000, Volume: 41, Issue:2

    Topics: Animals; Anticonvulsants; Dentate Gyrus; Diazepam; Disease Models, Animal; Dose-Response Relationshi

2000
Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam.
    Experimental neurology, 2000, Volume: 162, Issue:2

    Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Dose-Response R

2000
Impact of diazepam on pineal-adrenal axis in an avian model.
    Cytobios, 2000, Volume: 101, Issue:398

    Topics: Adrenal Glands; Animals; Columbidae; Corticosterone; Diazepam; Disease Models, Animal; Epinephrine;

2000
The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Neuropharmacology, 2000, Jul-24, Volume: 39, Issue:10

    Topics: Aminopyridines; Animals; Anxiety; Cyclohexane Monoterpenes; Diazepam; Disease Models, Animal; Dose-R

2000
Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3

    Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Enzyme Inhibitors; Epilepsy

2000
Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators.
    Epilepsia, 2000, Volume: 41 Suppl 6

    Topics: Age Factors; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Electroencephalography; Ele

2000
Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice.
    Behavioural brain research, 2000, Dec-20, Volume: 117, Issue:1-2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbolines; Diazepam; Disease Models, Anima

2000
Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Caudate Nucleus; Cocaine; Conditioning, Operant; Diaze

2001
Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2001, Volume: 34, Issue:5

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Hypertens

2001
Anticonvulsant effect of nimodipine alone and in combination with diazepam and phenytoin in a mouse model of status epilepticus.
    Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:10

    Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Diazepam; Disease Models, Animal; Drug Therapy,

2000
Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
    Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:10

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anticonvulsants; Antipsychotic

2000
Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?
    Behavioural brain research, 2001, Aug-27, Volume: 123, Issue:1

    Topics: Animals; Behavior, Animal; Conditioning, Operant; Cues; Diazepam; Disease Models, Animal; Fluoxetine

2001
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
    European journal of pharmacology, 2001, May-18, Volume: 420, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bro

2001
Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.
    Epilepsia, 2001, Volume: 42, Issue:3

    Topics: Allosteric Regulation; Animals; Anticonvulsants; Benzodiazepinones; Desoxycorticosterone; Diazepam;

2001
[An experimental study of the spectrum of individual psychotropic activity of clozapine (Leponex)].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1975, Volume: 75, Issue:11

    Topics: Animals; Antipsychotic Agents; Cats; Clozapine; Diazepam; Dibenzazepines; Disease Models, Animal; Ha

1975
Myoclonus developing after vermisectomy in photosensitive Papio papio.
    Electroencephalography and clinical neurophysiology, 1978, Volume: 45, Issue:1

    Topics: Animals; Cerebellum; Diazepam; Disease Models, Animal; Electroencephalography; Haplorhini; Ketamine;

1978
[Epileptogenic action of intra-amygdaloid injection of kainic acid].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1978, Oct-09, Volume: 287, Issue:8

    Topics: Amygdala; Animals; Diazepam; Disease Models, Animal; Hippocampus; Injections; Kainic Acid; Male; Pyr

1978
A primate model for testing anticonvulsant drugs.
    Archives of neurology, 1975, Volume: 32, Issue:5

    Topics: Allyl Compounds; Animals; Anticonvulsants; Carbamazepine; Chromatography, Gas; Diazepam; Disease Mod

1975
A comparison of the effects of chronically administered diazepam and phenobarbital and learning in the Papio papio model of epilepsy.
    Proceedings of the Western Pharmacology Society, 1977, Volume: 20

    Topics: Animals; Diazepam; Disease Models, Animal; Haplorhini; Learning; Papio; Phenobarbital; Seizures; Sti

1977
[Pathogenesis of stereotyped behavior].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1979, Volume: 79, Issue:9

    Topics: Animals; Behavior; Caudate Nucleus; Diazepam; Disease Models, Animal; gamma-Aminobutyric Acid; Halop

1979
The hippocampal slice: a system for studying the pharmacology of seizures and for screening anticonvulsant drugs.
    Epilepsia, 1977, Volume: 18, Issue:4

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Electroenc

1977
The influence of aldosterone and anticonvulsant drugs on electroencephalographic and clinical disturbances induced by the spirolactone derivative, potassium canrenoate.
    Journal of the neurological sciences, 1975, Volume: 24, Issue:1

    Topics: Aldosterone; Animals; Anticonvulsants; Brain; Diazepam; Disease Models, Animal; Dogs; Electroencepha

1975
Photically induced epilepsy in Papio papio as a model for drug studies.
    Advances in neurology, 1975, Volume: 10

    Topics: Acetylcholine; Animals; Carbamazepine; Clonazepam; Diazepam; Disease Models, Animal; Dopamine; Dose-

1975
Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Circulation, 1975, Volume: 52, Issue:6 Suppl

    Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Chlordiaz

1975
Kindling and electrode effects on the benzodiazepine receptors density of olfactory bulb and hippocampus after olfactory bulb kindling.
    Neuroscience letters, 1992, Aug-31, Volume: 143, Issue:1-2

    Topics: Animals; Diazepam; Disease Models, Animal; Electric Stimulation; Epilepsy, Generalized; Hippocampus;

1992
Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).
    Neurochemical research, 1992, Volume: 17, Issue:5

    Topics: Amino Acids; Animals; Anxiety; Aspartic Acid; Behavior, Animal; Biogenic Monoamines; Brain; Conditio

1992
Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury.
    Journal of pharmaceutical sciences, 1992, Volume: 81, Issue:8

    Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Proteins; Ca

1992
A rodent model of focally evoked self-sustaining status epilepticus.
    European journal of pharmacology, 1992, Oct-06, Volume: 221, Issue:1

    Topics: Animals; Bicuculline; Diazepam; Disease Models, Animal; Electroencephalography; Lithium; Male; Piloc

1992
Acoustic startle induced ultrasonic vocalization in the rat: a novel animal model of anxiety?
    Behavioural brain research, 1991, May-15, Volume: 43, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Arousal; Carbolines; Diazepam; Disease

1991
Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms.
    Neuroscience and biobehavioral reviews, 1991,Fall, Volume: 15, Issue:3

    Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidotes; Atropine; Brain Chemistry;

1991
Acute administration of diazepam and buspirone in rats trained on conflict schedules having different degrees of predictability.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Buspirone; Conditioning, Psychological; Conflict, Psychologic

1991
Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy.
    Life sciences, 1991, Volume: 48, Issue:1

    Topics: Animals; Brain; Diazepam; Dimethylnitrosamine; Disease Models, Animal; Dogs; Dopamine; Glutamate Dec

1991
Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.
    European journal of pharmacology, 1991, Jan-10, Volume: 192, Issue:2

    Topics: Animals; Baclofen; Carbamazepine; Cricetinae; Diazepam; Disease Models, Animal; Dystonia; gamma-Amin

1991
[Experimental study of the effects of fenibut and seduxen on fetal development in the last third of pregnancy].
    Akusherstvo i ginekologiia, 1991, Issue:5

    Topics: Abortion, Threatened; Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; E

1991
Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy.
    Proceedings of the National Academy of Sciences of the United States of America, 1990, Volume: 87, Issue:14

    Topics: Animals; Anti-Anxiety Agents; Brain; Chromatography, High Pressure Liquid; Diazepam; Disease Models,

1990
Lack of anxiety in an animal model of depression with cholinergic supersensitivity.
    Brain research bulletin, 1991, Volume: 26, Issue:3

    Topics: Animals; Anxiety; Depression; Diazepam; Disease Models, Animal; Female; Male; Motor Activity; Parasy

1991
Animal model for investigating the anxiogenic effects of self-administered cocaine.
    Psychopharmacology, 1991, Volume: 103, Issue:4

    Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Conditioning, Operant; Conflict, Psychological; Diazepa

1991
Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression.
    Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove, 1990, Volume: 33, Issue:5

    Topics: Animals; Anxiety; Behavior, Animal; Caffeine; Depressive Disorder; Diazepam; Disease Models, Animal;

1990
Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.
    Neuroscience letters, 1990, Sep-04, Volume: 117, Issue:1-2

    Topics: Animals; Azabicyclo Compounds; Carbolines; Convulsants; Diazepam; Disease Models, Animal; Flunitraze

1990
Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety.
    Progress in neuro-psychopharmacology & biological psychiatry, 1989, Volume: 13, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Body Temperature; Computers; Corticosterone

1989
Animal model of anxiety: effect of acute diazepam treatment in the older adult genetically hypertensive rats of Koletsky type and in the older adult rats of Wistar strain.
    Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove, 1989, Volume: 32, Issue:4

    Topics: Age Factors; Animals; Anxiety; Behavior, Animal; Body Temperature; Corticosterone; Diazepam; Disease

1989
Animal model of anxiety: effect of diazepam in the rats with cholinergic supersensitivity and reduced turnover-rate of brain norepinephrine.
    Activitas nervosa superior, 1989, Volume: 31, Issue:4

    Topics: Animals; Anxiety; Brain; Cholinergic Fibers; Diazepam; Disease Models, Animal; Norepinephrine; Rats

1989
Development of an in vivo model for assessment of drug-induced vascular injury.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1989, Volume: 47, Issue:8

    Topics: Animals; Diazepam; Disease Models, Animal; Ear; Female; Infusions, Intravenous; Lidocaine; Male; Pre

1989
The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?
    Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:3

    Topics: Animals; Cricetinae; Diazepam; Disease Models, Animal; Dystonia; Electroencephalography; Electromyog

1989
Animal models of chronic anxiety and "fearlessness".
    Brain research bulletin, 1988, Volume: 21, Issue:3

    Topics: Animals; Anxiety; Brain; Cats; Diazepam; Disease Models, Animal; Fear; Female; Flumazenil; Flunitraz

1988
Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.
    Psychopharmacology, 1985, Volume: 86, Issue:1-2

    Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Diazepam; Disease Mode

1985
Withdrawal syndrome following subchronic treatment with anxiolytic agents.
    Pharmacology, biochemistry, and behavior, 1987, Volume: 27, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; Exploratory Behavior; Male; Rats; Su

1987
Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 239, Issue:1

    Topics: Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Chlorpromazine; Diazepam; Disease Models,

1986
Benzodiazepine/gamma-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil.
    Proceedings of the National Academy of Sciences of the United States of America, 1985, Volume: 82, Issue:19

    Topics: Animals; Bicuculline; Diazepam; Disease Models, Animal; Flunitrazepam; Gerbillinae; Mesencephalon; M

1985
Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors.
    Psychopharmacology, 1987, Volume: 93, Issue:4

    Topics: Animals; Anxiety; Diazepam; Disease Models, Animal; Drug Combinations; Exploratory Behavior; Male; P

1987
The effects of chronic antidepressant treatment in an animal model of anxiety.
    Psychopharmacology, 1988, Volume: 95, Issue:3

    Topics: Amitriptyline; Animals; Antidepressive Agents; Anxiety; Desipramine; Diazepam; Disease Models, Anima

1988
Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Animals; Diazepam; Discrimination Learning; Disease Models, Animal; Flumazenil; Male; Pentylenetetra

1988
Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning.
    Intensive care medicine, 1988, Volume: 14, Issue:6

    Topics: Animals; Chloroquine; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiog

1988
Dependence potential of the benzodiazepines: use of animal models for assessment.
    Clinical neuropharmacology, 1985, Volume: 8 Suppl 1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Diazepam; Disease Models, Animal;

1985
The effect of glucose upon restitution after transient cerebral ischemia: a summary.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:6

    Topics: Animals; Blood Glucose; Brain; Diazepam; Disease Models, Animal; Insulin; Ischemic Attack, Transient

1985
Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat.
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:2

    Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Drug Evaluation, Preclini

1985
[Clinical prevention and therapy of Sudeck's syndrome. Bases of animal experiments].
    Experimentelle Medizin, Pathologie und Klinik, 1971, Volume: 34

    Topics: Adult; Animals; Biopsy; Diazepam; Disease Models, Animal; Ergoloid Mesylates; Female; Histocytochemi

1971
The effect of diazepam (Valium) and nitrazepam (Mogadon) on picrotoxin induced seizures in rabbits.
    Electroencephalography and clinical neurophysiology, 1970, Volume: 29, Issue:2

    Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Electrocardiography; Electroencephalogra

1970
Superiority of clonazepam over diazepam in experimental epilepsy.
    Epilepsia, 1973, Volume: 14, Issue:2

    Topics: Animals; Anticonvulsants; Bemegride; Benzazepines; Cats; Cobalt; Diazepam; Disease Models, Animal; E

1973
[Reflex algodystrophy and fractures of the hand].
    Acta orthopaedica Belgica, 1973, Volume: 39, Issue:6

    Topics: Animals; Arteries; Diazepam; Disease Models, Animal; Ergoloid Mesylates; Female; Fractures, Bone; Ha

1973
Diazepam prevents and aborts lidocaine convulsions in monkeys.
    Anesthesiology, 1974, Volume: 41, Issue:3

    Topics: Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Injections,

1974
The effects of diphenylhydantoin, phenobarbital, and diazepam on the penicillin-induced epileptogenic focus in the rat.
    Experimental neurology, 1974, Volume: 45, Issue:2

    Topics: Animals; Autoradiography; Brain; Carbon Radioisotopes; Diazepam; Disease Models, Animal; Electroence

1974
Proceedings: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs.
    Activitas nervosa superior, 1974, Volume: 16, Issue:4

    Topics: Animals; Anxiety Disorders; Barbiturates; Chlordiazepoxide; Chlorpromazine; Dextroamphetamine; Diaze

1974
Quantitative study of alcohol withdrawal signs in mice.
    Annals of the New York Academy of Sciences, 1973, Apr-30, Volume: 215

    Topics: Alcoholism; Animals; Barbiturates; Behavior, Animal; Chlorpromazine; Diazepam; Disease Models, Anima

1973
Paroxysmal manifestations generated by a cobalt-induced focus localized within the mesencephalic reticular formation in cats with bilaterally destroyed habenular nuclei.
    Revue roumaine de neurologie et de psychiatrie, 1974, Volume: 11, Issue:1

    Topics: Animals; Anticonvulsants; Cats; Cerebral Cortex; Cobalt; Diazepam; Disease Models, Animal; Electroen

1974
The anticonvulsant effects of phenobarbital, diphenylhydantoin and two benzodiazepines in the baboon, Papio papio.
    The Journal of pharmacology and experimental therapeutics, 1970, Volume: 173, Issue:1

    Topics: Animals; Anticonvulsants; Benzazepines; Diazepam; Disease Models, Animal; Electrodes; Electroencepha

1970
Observations on models used for the evaluation of antiarrhythmic drugs.
    Archives internationales de pharmacodynamie et de therapie, 1971, Volume: 193, Issue:1

    Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutte

1971